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1. THYREOSTATIC DRUGS 
Thyreostatic drugs are thyroid inhibiting synthetic compounds, which originally 
were elaborated for therapeutic use only, in humans and some domestic animals 
(e.g. cat, dog). Their primary application consists of constraining an overly active 
thyroid gland. This condition is called hyperthyroidism and causes an increase in 
thyroid hormones, thyroxine (T4 or 3,5,3’,5’-tetraiodothyronine) and triiodothyronine 
(T3 or 3,5,3’-triiodothyronine), which have a broad influence on the organism’s basal 
metabolism [1]. Subsequent life-deteriorating symptoms (e.g. anxiety, heart racing, 
weight loss despite an increased appetite, excessive sweating, more frequent bowl 
movements and fatigue) are associated with hyperthyroidism. Thyreostatic drugs 
influence the iodine uptake mechanism and as such block the exponential 
production of thyroid hormones. In general hyperthyroidism can be related to many 
causes, including autoimmune diseases (Graves’ disease [2]), neoplastic (toxic 
thyroid adenoma, carcinoma) [2] and inflammatory processes (thyroiditis) [2], as well 
as, external factors (dietary iodine deficiency, medication [3]) and environmental 
factors (dioxins, pesticides, polychlorinated biphenyls (PCBs), polybrominated 
diphenylethers (PBDEs), bisphenol-A (BPA) and triclosan) [2,4,5]. The origins of 
hyperthyroidism, however, differ considerably with respect to their prevalence in 
humans and domestic animals. 
 
1.1. Origin and specificities  
Thyroid inhibiting compounds embody a diverse group of components 
belonging to various chemical entities, exerting different mechanisms of action. 
Collectively, they inhibit the thyroid function and as such referred to as goitrogens 
since they all induce a decrease of thyroid hormone production, with goitrogenic 
symptoms (goiter) as a result [1,6]. This effect can be caused either by synthetic 
thyreostatic drugs, dietary goitrogens or other chemicals with goitrogenic side effects. 
The least toxic and most effective synthetic thyreostatic compounds are usually used 
as therapeutic drugs in human (e.g. propylthiouracil) and veterinary (e.g. 
methimazole or carbimazole) medicine in the treatment of hyperthyroidism [1]. 
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1.1.1. Synthetic goitrogenic therapeutics 
 
 
 
 
 
 
 
 
Figure I.1: Different chemical structure groups of the anti-thyroid drugs. 
 
 
The synthetic or therapeutic thyreostats comprise of 3 distinct structural 
groups. The first group consists of sulphated heterocyclic aromatic compounds 
containing two nitrogen atoms at positions 1 and 3, forming a pyrimidine structure 
(Figure I.1). The different analogues within this group have a variable substitution on 
position 6 with either an ethyl (E), dimethyl (DM), propyl (P), phenyl (Ph) or no side 
chain at all (= thiouracil) (Figure I.1). The second group only comprises tapazole (TAP) 
also known as, 1-methyl-2-mercaptoimidazole or methimazole, consisting of 
sulphated and methylated (Me) imidazole type structure. The third group refers to 2-
mercaptobenzimidazole (MBI), an aromatic heterocyclic substance consisting of a 
benzene ring conjoined with a sulphated imidazole structure (Figure I.1) [6]. 
Physicochemical properties of these thiated nucleic acid bases, in which the oxygen 
atom in the nucleic acid base uracil is substituted by sulphur, arise from the heavier 
sulphur atom and the extensively conjugated π-electron system. This thioamide bond 
‘N-C-S’ has been related to the thyroid-inhibiting activity [7-8]. For thiouracil this 
causes more then for the other uracil analogues acidic properties because the 
sulphur atom is a stronger Lewis base towards soft electron-pair acceptors.  
Furthermore, for thiouracil for example, 12 tautomeric forms (four are thio-enols, four 
are keto-enols, three are di-enols (keto-enol and thio-enol) and one is a keto 
tautomer) have been described due to significant polarizability of the conjugated π-
electron system [1,9,10]. Six tautomers (Figure I.2) are commonly observed compared 
to the other forms [9].  
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Figure I.2: The six main tautomeric forms of thiouracil [1,10]. 
 
Overall synthetic therapeutic goitrogens are very polar, amphoteric, low molecular 
structures with masses ranging from 114.2 Da for TAP to 204.3 Da for PhTU [1,11]. 
Certain of these synthetic thyreostats have been widely used as part of therapeutic 
plans in human and domestic animal medicine. Nevertheless, these compounds 
have also been misused at some point for illegal fattening in animal husbandry 
[11,12]. Illicit administration of thyreostats causes weight gain, which is induced by 
water retention in the gastro-intestinal (GI) tract and the edible tissues, through 
blockage of the iodium oxidation pathway, decreasing thyroid hormone production. 
This shrewd technique of fattening was most of all profitable to the producer, since 
this type of weight gain was not correlated to feed conversion. Irrefutable the 
consumer was the victim of such practices since meat of lower quality was produced 
selling water for the price of meat [13-14]. Furthermore, the residues of thyreostatic 
drugs may cause teratogenic and carcinogenic effects [15-18]. For example in Spain, 
the consumption of meat contaminated with TAP has been related to an increased 
incidence of aplasia cutis, a characteristic scalp defect [16]. For these reasons, the 
use of thyreostatic drugs for animal fatting purposes has been prohibited in Belgium 
since 1974 [19]. Later on the European Union (EU) followed, setting a general 
agreement on the ban of these substances in place, in 1981 [20]. Within the 
framework of residue control of xenobiotic thyreostats, 2-thiouracil, 6-methyl-2-
thiouracil, 6-propyl-2-thiouracil, 1-methyl-2-mercaptoimidazole and 2-
mercaptoimidazole are of most interest [11].  
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1.1.2. Dietary goitrogens 
Besides the synthetic thyreostats, also naturally occurring compounds with 
goitrogenic effects have been described, which can affect organisms through 
ingestion of specific crops (dietary), respectively: the oxazolidine-2-thiones (OZTs) and 
thiocyanates [12,21]. Besides, these thiocyanates may be chemically synthesized as 
well. The thioamide group of these naturally occurring thyreostats is, just as for the 
synthetic therapeutic drugs, responsible for its thyroid inhibiting activities. 
The origin of natural thyreostats lies in the interaction between secondary 
plant metabolites, called glucosinolates (GLs) (precursor), and the plant enzyme, 
myrosinase, which are both involved in the plant’s defense against tissue damaging 
pests [22,23]. GLs are known to be most abundantly present in Brassicaceae (syn. 
Cruciferae) and related crop families [24-26]. 
 
Notwithstanding, GLs are by no means confined to the Brassicaceae family [26,27], 
their affluence in the Brassicaceae is however not comparable to other crops 
(Capparaceae, Caricaceae), who merely contain traces of these secondary 
metabolites. Chemically, GLs are characterized by a common chemical structure, 
constituted out of a β-thioglucoside, β-D-glucopyranoside, N-hydroxysulfate and a 
variable side chain derived from an amino acid [21,29-31], which makes them water-
soluble phytochemicals [27]. Depending on the amino acid precursor GLs can be 
divided into three groups: (i) aliphatic GLs derived from leucine, isoleucine, valine, 
and methionine; (ii) aromatic GLs derived from phenylalanine and tyrosine; and (iii) 
indolic GLs derived from tryptophan. The biosynthesis of GLs proceeds through three 
separate phases, the chain elongation of selected precursor amino acids, the 
formation of the core GLs structure, and finally modifications of the side chain [32].   
Nowadays about 200 different GLs have been identified and described in literature 
[33-35,27], but still now and then new representatives are discovered [36].  
GLs can form degradation products resulting from hydrolysis through within-
plant or plant-bacterial interactions. In case of within-plant formation, the physically 
separated GLs in the idioblast cells and the plant-derived myrosinase enzyme (ß-
thioglucosidase, thioglucoside glucohydrolase, E.C 3.2.1.147) in the parenchymatous 
tissue [37] are freed upon cell disruption (e.g. chewing), causing formation of various 
degradation products (oxazolidine-thiones (5-vinyl-2-oxazolidinethione; 5-vinyl-1,3-
oxazolodine-2-thione (5-VOT)), nitriles, epithionitriles (R=alkene), thiocyanates, 
isothiocyanates (goitrin), thiourea) [22,24,33] through enzymatic hydrolysis dependent 
of specific pH conditions [22,28] (Figure I.3). Secondly, glucosinolate enzymolysis can 
also be induced by microbiota of the GI tract [21,38,39]. In humans different intestinal 
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microbial strains were found capable of metabolising GLs, e.g. Bacteroides 
thetaiotaomicron, Bacteroides vulgates, Bifidobacterium (B.) adolescentis, B. longum, 
B. pseudocatenulatum, Escherichia coli and Lactobacillus agilis strain R16 [40-43]. 
Based on these findings the theory grew that natural occurrence of thiouracil could 
possibly be induced by the interaction between intestinal bacteria and GL-rich feeds.  
 
Upon hydrolysis, a glucose molecule and an unstable aglucone moiety are 
formed, rapidly undergoing spontaneous rearrangement, eliminating sulphur, to yield 
a variety of biological active compounds, e.g. isothiocyanates, thiocyanates, 
oxazolidine-2-thiones, and nitriles (Figure I.3). The specific metabolite formation 
depends entirely upon the pH and the nature of the GL side chain (R) [24,29,22]. At 
acidic pH (2-5) epithionitrile, thiocyanates and nitriles are formed. Between pH of 3-4 
sulphur is split off and a nitrile is produced, which can split further to form cyanide 
(CN-). At pH 5 to 9 isothiocyanates (i-SCN-) are formed, from which the naturally 
occurring thyreostats, thiocyanates (SCN-) and oxazolidine-2-thiones (OZTs) (e.g. 5-
VOT) can be generated. This formation depends upon the structure of the variable 
side chain (R). At a pH above 8 and in case the R group consists of an indolic or 
benzenoid structure, the instable isothiocyanates may rearrange to form 
thiocyanates. An appropriately located β-hydroxyl group is further needed for 
spontaneous cyclisation to take place and oxazolidine-thiones to form [1,6]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure I.3: Overview of myrosinase hydrolysis of glucosinolates [6]. 
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Of the VOTs, 5-VOT or goitrin is the most commonly screened and detected analyte 
within the framework of residue analysis for the naturally occurring thyreostats 
[26,21,44-49]. Its goitrogenic activity is well know, i.e. 133 % if compared to the activity 
of propylthiouracil [12,46]. 5-VOT is formed from the glucosinolate progoitrin or 2-
hydroxybut-3-enylglucosinolate, as a result of a myrosinase catalysed hydrolysis 
reaction [21,49].   
 
1.1.3. Other goitrogenic substances 
Finally, a large number of other goitrogenic molecules exist including simple 
monovalent anions, such as lithium (Li+) [50-55], perchlorate (ClO4-) [56-59], SCN- 
[56,60,61], and nitrates (NO3-) and a large amount of complex anions like 
monofluorosulfonate, difluorophosphate and fluoroborate. All these components 
inhibit the iodide transport into the thyroid gland, depressing iodide uptake and 
subsequent thyroid hormone formation. Besides, also other substances, like 
sulphonamides [7,62-65], ketoconazole and acetylsalicylic acid [1], phenylbutazone, 
interferon-γ (IFN-γ), interleukine-2 and minerals (calcium, colbalt) [1] may exert a 
thyreostatic action [66-67]. Some of these components inhibit thyroid hormone 
secretion, but others act through yet unknown mechanisms [1]. Moreover iodide, 
which is an essential element for the synthesis of thyroid hormones, at high 
concentrations can also modulate the function of the thyroid gland by producing a 
mild and transient inhibition of organic binding of iodide and hence of hormone 
synthesis. This inhibition is known as the Wolff-Chaikoff effect [68,61].  
 
1.2. Implications of thyreostats in animal production: 
legislation duality 
The goal of up to date legislation concerning food safety is maintaining a healthy 
food chain with as little harmful residues as possible. Therefore, research lies at the 
base of food safety legislation. For thyreostats, a risk exists that when administered to 
livestock, residues could remain in their edible tissues or produce (eggs, milk), which 
are predestined for human consumption. Based on the potential of causing 
deleterious effects on human health, the EU has made a strong statement by 
banishing them from animal production [18,20].  
Subsequently, the detection of thyreostat abuse is strictly regulated, with a minimum 
required performance limit (MRPL) of 100 µg L-1 to be achieve by the applied 
analytical techniques (urine). Over the years, however, a great evolution in mass 
spectrometrical techniques took place [6], causing TU concentration at low-level 
	  Chapter I 9 	  
 
General Introduction 
	  
	   	  
concentrations to emerge, which were far below the set MRPL. This brings about a 
legislative duality since at the European level a zero-tolerance is still in place for 
thyreostat residues in food products from animal origin, but research has shown that 
also natural occurrence of thyreostats is possible originating from feed (<10 ppb) [69]. 
This discrepancy, between the harsh legislation at hand and the actual prevalence 
of thyreostats in national control plans, as well as, the repercussions subsequent to 
non-compliancy need a more tailored approach. Therefore this paragraph presents 
the most relevant legislation and latest up-dates concerning thyreostatic drug 
residues in matrices from animal origin. 
Belgium was the first European country to prohibit substances with thyreostatic 
action in 1974 [19]. The EU only adopted this legislation 7 years later in 1981, as 
Council Directive 81/602/EC [20]. Later on, Council Directive 85/358/EC [70] 
amended Council Directive 81/602/EC [20], to guarantee a uniform application for 
detection and monitoring of thyreostatic drugs in all member states. Council Directive 
96/22/EC [71], the revision of Council Directive 81/602/EC [20] described the 
prohibition on the use of certain substances with hormonal or thyreostatic action in 
stock farming. Additionally, it promulgates that member states have to prohibit the 
import of meat from third countries hailing from animals treated with in the EU 
prohibited substances.  
For an effective control of residues in animal matrices, adequate measures 
had to be taken and up-to-scale detection methods needed to be developed. 
Therefore, measures to monitor (e.g.: establish (self-) monitoring plans, 
responsibilization of operators, measures in case of infringement) the residue control 
of certain substances (listed in Annex I), e.g. thyreostats in live animals and animal 
products were described by Council Directive 96/23/EC [72]. Two groups of 
substances, Group A and Group B, were included here, in Directive 96/23/EC [72] 
listed in Annex I, based on Commission Regulation (EU) No. 37/2010 [73]. Group A 
substances comprise substances with hormonal or thyreostatic action, resorcyclic 
acid lactones, stilbenes and analogues, steroids, β-agonists (Directive 96/22/EC) [71] 
and banned veterinary drugs (included in Annex IV of Council Regulation (EU) No. 
2377/90) [74]. Group B contains other veterinary drugs (antibacterial components 
(e.g. sulphonamides), anthelmintics, anticoccidials, sedatives, non-steroidal anti-
inflammatory drugs, unlicensed drugs for veterinary use etc.) and contaminants 
(organochlorine (PCBs) and organophosphorus compounds, mycotoxins, heavy 
metals, dyes etc.).  
To be able to implement all the rules and regulation described in Directive 
96/23/EC [72], it is necessary to attain a standardised interpretation of results in official 
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control laboratories. And in particular for substances that are not authorized or 
prohibited by the EU, the progressive establishment of a MRPL for analytical methods 
is crucial. For thyreostats, a suggested MRPL has been fixed at 100 µg L−1 or µg kg−1. 
Additionally, in December 2007 a recommended concentration (RC) for TU, MTU, PTU 
and TAP of 10 µg L−1 or µg kg−1 in urine or thyroid has been proposed by the EU 
Reference Laboratories (EURLs) in the EURL guidance paper [75]. However, this 
document has no legal force of action, it can serve as a technical guidance for the 
laboratories performing analytical thyreostatic drugs detection for the residue control 
plan. This RC is considered as a more up-to-date value for setting the sensitivity level 
of the analytical detection method for thyreostatic drugs, even though nowadays 
most applied methods even perform below this concentration. Nevertheless, an 
adapted EU supported legislation concerning the sensitivity level for thyreostat 
detection is required for further standardization. Therefore Council Regulation (EC) No 
470/2009 introduces the concept of reference points for action (RPA) [76]. This is the 
lowest residue concentration of a residue for which no maximum residue limit has 
been set, and which can be quantified with an analytical method validated in 
accordance with Community requirements. So, in case the RPA is exceeded the EU 
country will reject the consignment, as it is not legally marketable at that point. Lately 
the European food safety authority published a guidance paper with a step-wise 
approach to establish RPAs taking into consideration factors such as analytical 
capability, toxic potential and pharmacological activity of the substance in question, 
and including the identification of the Reasonably Achievable Lowest Limit of 
Quantification (RALLOQ), the establishment of a Toxicological Screening Value (TSV) 
and the derivation of a Toxicologically Based Limit of Quantification (TBLOQ) [78]. So 
far, no RPA has been set for thyreostats, but if so the MRPL or RC should be declined 
[78]. 
To ensure a harmonized implementation of Directive 96/23/EC [72], 
Commission Decision 2002/657/EC [79] lays down the technical guidelines and 
performance criteria for residue control. Within this Commission Decision 
(2002/657/EC) [79], a system of identification points (IPs) is introduced in order to 
interpret the obtained data (chromatograms, spectra) when detection methods are 
used other than full-scan mass spectrometer (MS) techniques. This system is based on 
the number and the ratio of the ions in the obtained MS spectrum. For the 
confirmation of the banned substances, listed as group A (e.g. thyreostats), a 
minimum of four IPs is required. Since the implementation of the 2002/657/EC criteria 
[79], few studies describe the applicability of these guidelines for determination of 
thyreostats in urine and thyroid [80-83]. Parameters that can be evaluated during the 
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validation procedure are: selectivity, specificity, linearity, trueness, recovery, 
applicability, ruggedness, stability, repeatability, reproducibility, decision limit (CCα) 
and detection capability (CCβ). 
 
The occurrence of thiouracil in urine of livestock can be characterised as sporadic 
and unpredictable. In Table I.1 the overall prevalence of thiouracil in urine has been 
described based on collected data from European national control plan campaigns 
(Belgium, France, Netherlands, Poland, Norway and the United Kingdom) throughout 
the period 2010-2012 [84]. During that period Belgium primarily collected bovine 
urines of which 7.0% were above the 10 µg L-1 RC range. This number rose to 10.2% 
when zero-tolerance was applied (> CCα). 
 
Table I.1: Representation of the results of the national control campaigns in various EU 
countries from 2010-2012, showing number of samples collected [84] (CCα=3.9 µg TU L-1) 
 
 
 
n.a.= not available, only 85 animals were sampled so no 99% percentile was predicted. 
 
 
 
 
 
Porcines Bovines Small livestock 
Member states ♀  + ♂ ♀  + ♂ ♀  + ♂ 
The Netherlands 139 273 0 
Belgium 4 244 0 
France 0 1718 0 
United Kingdom 2 871 5 
Norway 124 432 79 
Poland 385 356 1 
The Netherlands 139 273 0 
Belgium 4 244 0 
n (TOTAL) 654 3894 85 
Mean (µg TU L-1) 1.5 1.7 1.6 
Median (µg TU L-1) 0 0 0 
s.d. (µg TU L-1) 2.8 4.6 3.9 
Min (µg TU L-1) CCα CCα CCα 
Max (µg TU L-1) 26.6 145.0 27.0 
95% percentile [95% C.I.] (µg TU L-1) 7.4 [6.4-8.4] 8.1 [7.2-8.9] 7.3 [4.3-17.0] 
99% percentile [95% C.I.] (µg TU L-1) 13.5 [10.5-17.0] 18.2 [15.5-20.0] n.a. 
% n > 10 ppb 2.3% 3.6% 2.4% 
% n > CCα  22.9% 12.4% 14.1% 
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2. THYROID HORMONES 
The thyroid gland is one of the smaller organs of the mammalian organism, but 
notwithstanding, this endocrine gland has quite an important impact on the general 
metabolism of vertebrates [85]. Moreover, it is the target organ for the effects of 
therapeutic and dietary goitrogens. 
 
2.1. Thyroid anatomy and physiology in animals  
 The thyroid gland is a small organ (only 0.20% of the body weight) situated in the 
neck region, just below the larynx, located ventrally on the trachea [1,86,87]. 
Depending on the species, anatomy varies but in most mammals the thyroid consists 
of a bilobed structure. In ruminants (D) and horses the lobes are joined by a tissue 
bridge, called isthmus (B) (Figure I.4). In pigs the lobes closely joined with an isthmus 
consisting of a small, central pyramidal lobe as part of that structure. The thyroid 
originates from the branchial arches of the foetus, which starts migrating to the neck 
region during early foetal development [86]. Occasionally, these cells do not migrate 
properly and ectopic thyroid tissue remains e.g. at the tongue base. 
 
Figure I.4: Representation of the topographical anatomy of the thyroid gland in pig 
(C) and cow (D) with representation of the subtracheal connection in pigs (A) [1]. 
Dissection of a fetal pig showing the thyroid in situ (ventral aspect) (E) 
(©faculty.clintoncc.suny.edu). 
  
The thyroid tissue consists of interconnected globular sacs, called follicles, which are 
separately enfolded by a single layer of epithelial cells. In response to the down- or 
up-regulation of the thyroid gland, these cells can respectively become cubical to 
cylindrical or even flattened. This is due to the viscous protein-rich fluid in the lumen of 
E  
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the follicles also called colloid, which decreases with up-regulation of the gland. The 
follicles themselves are surrounded by a basal membrane beneath which an 
elaborate capillary network is situated to transport nutrients and the produced 
thyroid hormones triiodothyronine (T3) and thyroxine (T4) (Figure I.5). In the surrounding 
connective tissue, the thyroid C-cells (parafollicular cells) are located, which produce 
the calcium-regulating hormone, calcitonin. In most animals spherical clusters of 
parathyroidal cells are also embedded in the thyroid tissue, which in combination 
with the C-cells regulate Ca2+ concentrations in the extracellular tissues [1,86,87]. 
 
  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
Figure I.5:  Chemical structures of the thyroid hormones, T4 (3,5,3’,5’-
tetraiodothyronine) and T3 (3,5,3’-triiodothyronine). 
 
The thyroid hormones, T3 and T4 (Figure I.5) are the only iodine containing water 
insoluble hormonal compounds in vertebrates [1].  Therefore, ingested iodine (I-) is 
absorbed in the small intestine and transported directly to the thyroid gland through 
the bloodstream, entering the organ passively through a Na+/I- symporter activated 
by the gradient of a Na+/K+ adenosine triphosphatase (Figure I.6). In the follicle cells, 
iodine will be oxidized (I- à I2) by thyroid peroxidase (TPO) in the presence of 
hydrogen peroxide (H2O2). TPO is either located in the apical membrane of the cell or 
attached to it, thus providing the oxidized iodine at exactly the point in the cell where 
the thyroglobulin (Tg) molecule issues forth from the Golgi apparatus and through the 
cell membrane into the stored thyroid gland colloid. The more reactive iodide (I2) 
binds to the double-bounds of the tyrosine residues on Tg, a colloid protein, forming 
monoiodotyrosine (MIT) and diiodotyrosine (DIT). These building blocks either dimerize 
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(T4) or couple (DIT+MIT= T3 (or less common rT3)) to form both thyroid hormones 
catalysed by TPO and H2O2 while remaining bound to Tg and stored in the lumen of 
the follicle (Figure I.6). Overall only 10% of the tyrosin residues on Tg molecules are 
iodinated; nevertheless the colloid contains enough thyroid hormone to provide the 
normal requirements of the body for 2 to 3 months [1,86,87]. 
 
Figure I.6: Schematic representation of thyroid hormone synthesis and secretion (NIS: 
sodium iodied symporter; TPO: thyroid peroxidase; MIT: monoiodotyrosine; DIT: 
diiodotyrosine) (©2014 Quizlet.com). 
 
Secretion of the formed hormones occurs through endocytosis of small colloid 
vesicles of iodinated Tg that fuse with lysosomes causing proteolysis of Tg, thereby 
recapturing MIT and DIT (deiodination) and releasing T3 and T4, which diffuse across 
the basal membrane into the interstitial fluid and into the capillaries (Figure I.6) 
[86,88]. T4 is more abundantly produced than T3, since the latters’ concentration is 50- 
to 60-times lower in total serum [86]. Moreover, in the bloodstream the majority of T4 
molecules are bound to carrier proteins (thyroxine binding globulin (TBG), albumin, 
thyroid binding prealbumin) with a remaining 0.03 % of T4, which occurs unbound. For 
T3 approximately 0.3% is free, with the remainder bound. Between both, free and 
protein-bound fractions, an equilibrium is installed. The small circulating free thyroid 
hormone fraction is solely responsible for interactions with target cells and the 
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subsequent generation biological response [1,86,88]. Furthermore, only T3 is directly 
biologically active whereas T4 first needs deiodination. Deiodinase (Type I and II) 
causes 5′-deiodination of the outer ring of T4, which accounts for the majority of 
circulating T3 [88]. Type I deiodinase is responsible for the majority of T4 to T3 
transformation and is found in peripheral tissues (liver and kidney). Type II deiodinase 
is found in the brain, pituitary gland, and brown adipose tissue and primarily converts 
T4 to T3 for intracellular use. Type III deiodinase, which is mostly found in placenta, 
brain, and skin, can along with Type I also lead to the inactive form of T3, i.e. reverse 
T3, which has a key role in the inactivation of thyroid hormones. Both, rT3 and T3, can 
be further deiodinated in the liver and are sulfo- and glucuronide-conjugated before 
excretion into the bile. Besides, there is also an enterohepatic circulation of thyroid 
hormones as intestinal microbiota deconjugate some of these compounds and 
promote their reuptake [88]. 
The regulation of thyroid hormone secretion is an example of a negative feedback 
mechanism between the hypothalamus, anterior pituitary and thyroid gland (Figure 
I.7). The hypothalamus produces thyroid-releasing hormone (TRH) under the influence 
of environmental (temperature) and internal stimuli (thyroid hormone imbalance) 
[86].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure I.7: Overview of the negative feedback mechanism for thyroid hormone 
regulation (TRH: thyroid-releasing hormone; TSH: thyroid stimulating hormone) (©2014 
Cram.com). 
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TRH in turn influences the anterior pituitary gland, which then produces thyroid 
stimulating hormone (TSH), activating the thyroid gland and subsequent thyroid 
hormone production. When homeostasis is reached, the thyroid hormones exert a 
negative influence on all the above contributors in the chain in order to cease 
stimulation. If TSH production is increased over a long period of time the number 
(hyperplasia) and volume (hypertrophy) of the follicle cells will increase, forming a 
goiter or non-neoplastic and non-inflammatory enlargement of the thyroid gland 
[89].  
 
2.2. Function of the thyroid hormones 
Within the bloodstream only the free fraction of thyroid hormones, T3 and T4, can be 
actively transported into the cell. First, T4 will be deiodinated to T3 in the cytosol, 
whereas T3 can directly proceed with binding to a nuclear thyroid hormone receptor 
on DNA. Second, because T3 has a higher affinity for the receptor and induces a 5-
times greater effect than T4, it is primarily T3 that mediates the biological effect. 
Subsequent to binding a cascade of changes occurs resulting in alteration of the 
synthesis of certain cellular proteins. Since these play a major role in cell metabolism, 
thyroid hormones can induce an effect on all types of cells, with a variety of 
mechanisms [86]: 
 
 Thyroid hormones will increase metabolic rates in all tissues (except in 
the brain, gonads, spleen), resulting in increased heat production and oxygen 
consumption.  
 Normal growth depends on adequate production of thyroid 
hormones, since a lack during growth causes depletion in growth hormones 
and subsequent impaired skeletal development. 
 Normal development of the central nervous system depends on 
normal thyroid concentrations with the most critical moments 6 months before 
and 6 months after birth. When shortage is sustained at those points in time, 
irreversible reduction of the development and maturation of the brain occurs. 
 The sympathic nervous system is stimulated by thyroid hormones (e.g.: 
heart rate increases), which results from the numeral augmentation of 
available epinephrine and norepinephrine receptors. 
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 Conduction velocity of the nervous system is also increased by thyroid 
hormones. Therefore, a shortfall will induce slower reflexes, impaired physical 
and cognitive performances. 
 Normal gonadal function requires thyroid hormones, thereby inducing 
sperm count depletion (male) and irregular reproductive cycles (female) 
when deficiency is encountered. 
 
2.3. Thyroid disruption and mode of action of  
thyreostatic agents  
Various compounds may induce either an up-regulation or a down-regulation 
of thyroid hormone secretion. This may result in two diametrically opposite clinical 
pictures, called hypothyroidism (down-regulation) or hyperthyroidism (up-regulation) 
[90,91]. In both clinical pathologies a distinction based on the cause of the illness can 
be made; either primary, which is related to the thyroid gland (inflammation, tumor) 
itself or secondary, when the cause is due to external factors (pituitary gland, 
hypothalamus, dietary iodine, iatrogenic substances).  
Hypothyroidism is induced by a diminished production of thyroid hormones. 
Symptoms include a.o. cold intolerance, animals become slow and sluggish, 
reluctant to move, reduced appetite, weight gain, alopecia, skin infections, impaired 
reproduction, reduced heart rate, slow bowl movements and constipation. Goiter 
formation may also be associated with hypothyroidism, e.g. due to lack or excess of 
iodine in feed, plant-derived goitrogenic substances, tumor or inflammation of the 
thyroid, inherited enzyme defects in the biosynthesis of thyroid hormones [86,89]. 
Therapeutically, most cases of hypothyroidism can be controlled through 
administration of T4, compensating the hormone paucity. This disorder is most 
common in dogs, and only rarely develops in other species, including cats, horses, 
and other large domestic animals [89]. 
Non-neoplastic and non-inflammatory goiter can develop in all domesticated 
animals [89]. Goiter caused by iodine deficiency is most common in pigs, lambs, 
calves and foals. In foals, a congenital hypothyroidism and dysmaturation syndrome 
has been described when pregnant mares graze plants that contain goitrogens, 
nitrate or are fed diets either deficient in or containing excessive amounts of iodine  
[89]. Young animals are born with thyroid lobes at least twice the normal size, soft and 
dark red, grossly enlarging the neck area. In severe cases total or partial alopecia 
(lack of hair especially pigs and wool in lambs), myxedema (thickened, flabby, 
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edematous skin) can develop. The mortality rate is high in these species, with majority 
of offspring born dead or dying within a few hours of birth [87].  Only in mildly affected 
cases of iodine deficiency administration of iodized salt might resolve the goiter and 
clinical symptoms [89]. Undoubtedly, this is an issue that if not controlled might lead to 
economic losses, from the loss of offspring and breeding animals due to difficulties at 
birth.  
In sheep, cattle, goats and pigs a familial dyshormonogenetic goiter has been 
described, an inherited autosomal recessive trait, causing an enzyme defect in the 
thyroid hormone biosynthesis [89]. Goiter in adult livestock, however, is usually of little 
significance in comparison and the general health of the animal is not impaired [87]. 
In contrast, increased thyroid hormone secretion leads to symptoms of 
hyperthyroidism, involving amongst others: increased appetite, weight loss, 
polydipsia, increased excitability, nervousness, reduced physical performance, tiring 
easily, increased heart and breathing rate, increased bowl movements and diarrhea 
[86]. This is quite a prevalent illness in middle-aged to older cats mostly due to (>70%) 
functional thyroid adenoma and only rarely occurs in dogs where it is mostly due to 
thyroid carcinoma. Disorders of the thyroid gland are clearly well known in 
companion animals but less so in livestock. In livestock, nutritional iodine deficiencies 
(due to iodine-deficient diet or geographical location) have been of greater 
importance than thyroid-gland diseases, particularly in the iodine-deficient areas [86].  
When treating hyperthyroidism, several strategies can be followed, including 
feeding an iodine-deficient diet, chronically administering anti-thyroid drugs (e.g. 
methimazole in cats), destroying dysfunctional thyroid cells with radioiodine therapy 
or finally surgically removing the gland (thyroidectomy) [89]. 
The primary effect induced by thyreostatic drugs is the inhibition of thyroid 
hormone synthesis by interfering with the TPO iodination of tyrosine residues in Tg. PTU 
(6-propyl-2-thiouracil) and methimazole (1-methyl-2-mercaptoimidazole, TAP) are the 
antithyroid drugs mainly used in the United States. In Europe and Asia mostly 
methimazole dominates whereas carbimazole (methimazole analogue) is mostly 
administered in the United Kingdom [92].  
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Table I.2: Overview of the mode of action of various dietary and therapeutic 
goitrogens [89,92,93]. 
 
           Compounds with thyreostatic effects                                Mechanism(s) of action 
Thiocyanate, 
Perchlorate 
Inhibition of the iodine-trapping mechanism  
Sulphonamides, 
Thiourea, 
Methimazole, Aminotriazole 
Blockage of organic binding of iodine and 
coupling of iodothyronines to form T4 and T3 
Lithium, 
Excess of iodide 
Inhibition of thyroid hormone secretion by an 
effect on the proteolysis of active hormone from 
the colloid 
Drugs of the central nervous system 
(e.g., phenobarbital, benzodiazepines), 
Calcium channel blockers 
(e.g., nicardipine, nifedipine), 
Steroids 
(e.g., spironolactone), 
Retinoids, 
Chlorinated hydrocarbons 
(e.g., chlordane, DDT, TCDD), 
Polyhalogenated biphenyls (e.g., PCB, PBB), 
Enzyme inducers 
Increase the peripheral metabolism of thyroid 
hormones through induction of hepatic 
microsomal enzymes 
Amiodarone 
(Anti-arrithmicum), 
Iopanoic acid 
(Hyperthyroidism treatment in cats) 
Inhibit the 5’monodeiodinase, which converts T4 
in peripheral sites (e.g., liver and kidney) to 
biologically active T3 
Natural goitrogens  
(from e.g., rapeseed, kale, turnip, cabbage) 
Inhibition of the iodine-trapping mechanism and 
disrupt signalling across the thyroid’s cell 
membranes 
Iodine-deficient diet Inhibition of iodination of Tg 
 
For propylthiouracil, blockage of the conversion of thyroxine to triiodothyronine within 
the thyroid gland and in peripheral tissues has been reported, but this effect seems to 
be clinically insignificant. Some antithyroid drugs may also induce immunosuppressive 
effects [92], which can be beneficial when treating autoimmune thyroid disorders. 
Besides specific thyroid inhibiting drugs, certain chemicals also induce a thyreostatic 
effect of which some examples are shown in Table I.2. 
A consistent finding with all of these goitrogens is the chronic hypersecretion of TSH 
due to the lack of thyroid hormone production, which by receptor-mediated events 
places the thyroid gland at greater risk of developing tumors because of constant 
stimulation [8].  
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3. BRASSICACEAE 
The genus Brassica of the Brassicaceae or Cruciferae (cross-like shape) plant family 
represents important revenues for the agricultural and horticultural industry. This genus 
comprises all sorts of cabbages and rapeseeds.  
For human consumption a large variety, e.g. cauliflower, broccoli, white 
cabbage, green cabbage, savoy cabbage, Chinese cabbage, watercress, mustard, 
and rapeseed oil, is available and included in the normal diet. Particular for this genus 
is the fact that all parts of the plant may be edible: root (rutabaga, turnips), stems 
(kohlrabi), leaves (cabbage, collard greens), flowers (cauliflower, broccoli), buds 
(Brussels sprouts, cabbage), and seeds (many, including mustard seed, and oil-
producing rapeseed). Moreover, their high glucosinolate content has caught the 
attention, as well as, the glucosinolate degradation products, which for some might 
contribute to reduction of carcinogenesis in humans (e.g.: the isothiocyanate 
sulforaphane) and have health-promoting effects [94].  
In recent years, the oil extracted from rapeseed (rapeseed oil) gained new interest 
when ‘00’ rapeseed varieties with improved fatty acid composition became 
available. These ‘00’ varieties are low not only in bitter tasting glucosinolates (GLs) but 
also in erucic acid, which is a C22 monounsaturated fat that has been shown to 
cause a wide variety of pathological changes in laboratory animals. Thereby, the 
utilization of this now healthier rapeseed oil became more relevant in the kitchen, 
either for cooking or as a dressing, alongside the traditional olive oil. In addition, 
rapeseed ‘00’ oil displays a low content in saturated fats (7%) and a high amount of 
monounsaturated fats (61%) with also a good ratio (60% oleic, 20% linoleic, 10% 
alphalinoleic acid) between the polyunsaturated fatty acids omega-6 and omega-3 
[95]. These are essential cholesterol-lowering fatty acids, which also decrease 
cardiovascular risks. Currently, rapeseed production in the EU member communities 
occupies 6.766 million hectares, up nearly 83,000 hectares from 2013, making it the 
predominant oil crop in Europe (Figure I.8) [96]. 
The high (20-50%) erucic varieties of rapeseed are not used for consumption, but find 
application in technical domains, for example as bio-degradable lubricating oil as an 
alternative to mineral oil based lubricants.  
For animal feed, rapeseed and its extraction products (rapeseed flakes, cake, 
and coarse meal) are generated as by-products from the oil industry and the 
biodiesel fuel production, which is a booming business nowadays. In order for the by-
product to be useful to the animal feed industry, only ‘00’ varieties can be used.  
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Evidently, the manipulation of rapeseed (‘0’ and ‘00’-varieties) contributed to its 
widespread application in animal and human consumption nowadays, despite its 
anti-nutritional factors (ANFs).  	  	  	  	  	  	  	  	  	  	  	  
 
Figure I.8: Graphical representation of the amount of rapeseed acres over the 
predominant countries active in this business in Europe (©Coceral, the European grain 
and oilseed traders' association).  
 
3.1. Anti-nutritional factors of rapeseed consumption 
Rapeseed can be classified according to the fatty acid content of the extracted oil 
or according to the glucosinolate content of the rapeseed extraction meal (REM). 
From rapeseed about 42-44% of oil can be extracted, consisting of a mixture of 
glycerol and fatty acids (5% saturated - 95% unsaturated), with 35% of the fatty acids 
consisting of erucic acid [27,96-98]. After oil extraction, a rapeseed product is 
delivered that contains 35% proteins, a possible valuable and cheap nitrogen source 
for animal feed [96-98].  
 
However, the presence of erucic acid and GLs are unwanted, as they are 
considered as anti-nutritional factors [21,27]. Human consumption of rapeseed oil 
with a normal erucic acid level (35%) is linked to possible cardiovascular and 
digestive problems [96]. As for the GLs a substantial intake has proven to be 
deleterious to animal health [21,26,99-101] not because of the GLs themselves but 
due to the formation of the toxic degradation products, e.g. VOTs, nitriles and 
(iso)thiocyanates [67]. In light of nutritional concerns, the industry turned their 
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attention in 1970 towards genetically engineered crops with little erucic acid present 
(< 2%), the ‘single low’ or ‘0’ varieties of rapeseed [102-104]. A major market 
constraint remained however, namely the utilisation of the high-protein meal 
generated from the oil extraction process, still contained high glucosinolate 
concentrations, limiting its utilisation. Hereupon again further genetic manipulation of 
these crops brought relief lowering the average glucosinolate content of 166 µmol g-1 
to 38 µmol g-1. These are referred to as the ‘double-low’ or ‘00’ or ‘CANOLA’ 
(CAnadian Oil, Low Acid) varieties of rapeseed [21,105], which contain little GLs and 
erucic acids. Modern ‘00’-rapeseed varieties show an even more remarkable low 
glucosinolate content of 8-15 µmol g-1 seed, thereby meeting the criteria of 25 µmol 
g-1 of glucosinolate content and the erucic acid level below 2% as set by Commission 
Regulation No 1035/2003 [106]. Nowadays, for all applications the ‘double-low’ or 
‘00’ varieties are considered as standard, for biofuel however ‘traditional’ rapeseed 
may be used with unaltered levels of erucic acid and GLs [96,97]. 
The set levels for undesirable substances in animal feeds have been described in the 
European directive 2002/32/EC [107]. Amongst these some are related to the use of 
Brassicaceae in animal feeds (Table I.3) 
 
Table I.3: Selection of Brassicaceae derived undesirable substances described in 
directive 2002/32/EC with maximum allowed levels. 
 
Undesirable substance in animal 
feed 
Maximum content mg kg-1 
relative to a feedstuff with a 
moisture content of 12% 
Products intended for animal consumption 
Volatile mustard oil 100 Feed materials (except rapeseed cakes) 
as Allyl isothiocyanate 4000 Rapeseed cakes 
 1000 Complete feeding stuffs for cattle, sheep, 
goats (except young animals) 
 500 Complete feeding stuffs for pigs (except 
piglets) and poultry  
 150 Complete feeding stuffs 
Vinal thiooxazolidone 
(Vinyloxazolidinethione) 
1000 Complete feeding stuffs for poultry 
 500 Complete feeding stuffs for young laying hens 
Indian mustard — Brassica juncea (L.) 
Czern. And Coss. ssp. intergrifolia 
(West.) Thell. 
Trace, not quantitatively 
determinable 
All feeding stuffs 
Sareptian mustard — Brassica juncea 
(L.) Czern. And Coss. ssp. juncea 
Trace, not quantitatively 
determinable 
All feeding stuffs 
Chinese mustard — Brassica juncea 
(L.) Czern. And Coss. ssp. juncea var. 
lutea Batalin 
Trace, not quantitatively 
determinable 
All feeding stuffs 
Black mustard — Brassica nigra (L.) 
Koch 39. Ethiopian mustard — 
Brassica carinata A. Braun 
Trace, not quantitatively 
determinable 
All feeding stuffs 
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3.2. Animal feed 
Feeds based on rapeseed consist of rapeseed derivatives from oil extraction, which 
produces a valuable protein-rich material, e.g. REM (rapeseed extracted meal) used 
as an animal diet enhancer. For consumption (animal-human), only rapeseed of the 
‘00’ variety may be used, characterized by a low erucic acid level (< 2%) and a 
maximum level of 25 µmol GLs per g-1 of seeds [106]. The REM can be produced in 
three commodities, rapeseed flakes, cake, or coarse meal. The type of feed formed 
depends on the oil extraction process. If cold compression (50-60 °C) occurs, 
rapeseed cake with 11-20% of fat is formed. Hot compression (80-140 °C) results in 
rapeseed flakes with a fat percentage of 6-10%. For the coarse colza meal, hot 
compression is followed by etherification and toasting with a fat percentage of 1-4% 
[97]. Moreover the concentration of GLs in rapeseed can be altered based on e.g. 
season (autumn>winter foliage) and climate (drought, temperature) [108]. This might 
explain the variation of glucosinolate content and composition of the meal between 
different producing countries. 
However, with the lowered glucosinolate content, the total dietary intake of 
rapeseed extraction products remains restricted, due to toxic degradation products 
such as OZTs, nitriles, and thiocyanates, which can still form. The level of tolerance for 
this appears to be species and age dependent [21]. Ruminants exhibit a tolerance 
level of 1.5 to 4.22 µmol of total glucosinolate content g-1 diet, whereas pigs are 
severely more sensitive with 0.78 µmol g-1 diet. Ruminants are less affected than 
monogastric animals because of the microbial degradation, which already occurs in 
the forestomach causing transformation of GLs and of their metabolites early in the 
digestion process [109]. Young animals (piglets) are also more sensitive than older. 
The ANFs (bitterness, iodine inavailability, mutagenicity, teratogenicity, goitrogenicity, 
hepatotoxicity, nephrotoxicity) induced by glucosinolate intake have an overall 
negative effect on the animals’ growth and production (milk, meat weight gain). In 
order to counter act the ANFs from rapeseed meals some treatments have been 
described to improve REM quality, like: water extraction, heat (certain time, 
temperature) and CuSO4 treatment [21]. Even though treating rapeseed meal is an 
option, it is not always economical, which on the other hand iodine supplementation 
remarkable is, with promising results in pigs and ruminants [21]. In conclusion 
administration of rapeseed meal seems no longer a problem as long as a suitable 
technology is adopted to minimize deleterious effects [21]. 
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4. ANALYTICAL METHODOLOGIES 
4.1. Principles of LC-MS based analysis 
Within this thesis the main analytical methodologies are based on LC-MS techniques, 
therefore only these will be expounded here. 
An important part of the analysis of biological samples (e.g.: urine, serum, 
faeces and muscle) lies in the pre-treatment, which is an absolute requirement for 
eliminating/reducing interfering substances in any matrix. Implementation of certain 
statistical tools, like fractional factorial designs [110-112], makes optimization of 
extraction procedures much easier nowadays. Based on a select number of tests, 
information is gathered and statistically processed making the influential factors 
apparent in order to subsequently optimize them. These methods are much more 
efficient then the on-at-the-time approach optimisation procedures. 
 
Mass spectrometrical analysis, requires hyphenation with separation 
techniques, either in the gas phase (gas chromatography (GC)) or liquid phase 
(liquid chromatography (LC)). Over the years the latter became the predominant 
technology in residue analysis since around 80% of analysed components are not 
sufficiently volatile or stable in the gas phase to be separated by GC [113]. 
Furthermore, the development of more performant LC separation columns, 
decreasing the particle size of the columns’ packing material, introduced high 
performance liquid chromatography (HPLC). HPLC was always a compromise 
between particle size causing inherently higher backpressures and the resilience of 
the columns packing material. Therefore, Ultra-high pressure liquid chromatography 
(UHPLC) columns arose on the market increasing speed, sensitivity, and resolution by 
working with sub-2 micron particles [114-117]. These columns can sustain 15,000-
19,000 psi [113]. Analytical pumps capable of operating at these ultrahigh pressures 
while delivering solvents smoothly and reproducibly in both gradient and isocratic 
separation modes were therefore made available [114,117]. With all these 
advantages UHPLC technology seems to have a bright future [118], moreover the 
market share of HPLC applications is also rising quickly with estimations of a 4 billion 
USD turnover by 2017 [113]. 
In LC, analytes are separated based on their differential affinity between a 
solid stationary phase (the column packed with particles) and a liquid mobile phase. 
To ensure optimal chromatographic separation, a proper static phase has to be 
selected based on the physico-chemical properties of the target analytes. The 
current stationary phases available on the market are characterised by a variable set 
	  Chapter I 25 	  
 
General Introduction 
	  
	   	  
of particle active groups (C18, resin (SO3-H+)) available in different particle sizes (e.g.: 
15 to below 2 µm) to separate compounds e.g.: reversed phase chromatography, 
ion exchange chromatography (e.g. amines or metal ions), hydrophilic interaction 
chromatography (highly polar water soluble analytes) [113]. 
Once the analytes have been separated in time, the liquid phase will need to be 
evaporated and ionised to allow mass-spectrometrical detection of the molecule or 
fragments based on mass-to-charge (m/z) ratio, measuring the abundance of the 
ions under vacuum conditions. In residue analysis, mass spectrometry has become 
the detector of choice for chromatographic separation [118,119]. A mass 
spectrometer can be divided into three components, the ion source, the mass 
analyser and the detector. The power of this technique lies in the fact that the mass 
spectral data generated provides valuable information about the molecular weight, 
structure, identity, and quantity with a high degree of confidence and selectivity.  
 
Earlier LC-MS systems were only successful in the detection of a limited number of 
compounds due to the limitations of the ionisation interface (a.o. direct liquid 
injection (DL)) [120]. Target analytes in biological samples are mostly non-volatile and 
potentially thermally labile, but still needed to be presented in the gaseous phase for 
analysis, which was the challenge of hyphenating of LC with MS [113,121]. In the case 
of DL the mobile phase molecules are not separated from the targeted compounds, 
causing a large low-molecular-weight solvent background signal, and subsequent 
ionisation is performed under vacuum conditions [120]. Over the years evolution 
towards other interface techniques like, thermospray (TS), which added heat and 
particle beam (PB), which desolvated at near-atmospheric pressure [120], 
broadened the application potential, but still these methods lacked one or more 
critical aspects that LC demanded (e.g.: sensitivity, applicability and stability) [120]. 
Therefore, with the introduction of atmospheric pressure ionisation (API) techniques, 
the number of compounds successfully analysed by LC-MS greatly expanded (large 
biomolecules, pharmaceutical drugs, metabolites) [121]. In API, the analyte 
molecules are ionised first at atmospheric pressure, next the ions are mechanically 
and electrostatically separated from neutral molecules. Nowadays, common API 
techniques are: electrospray ionisation (ESI), atmospheric pressure chemical 
ionisation (APCI), and atmospheric pressure photoionisation (APPI).  
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Figure I.9: Electrospray ionisation (ESI) technology [122]. 
 
During this study, all performed analyses relied on ESI (Figure I.9), which is referred to 
as a soft ionisation technique in the sense that a very little residual energy is retained 
by the analyte, and generally no fragmentation occurs upon ionization [121,123]. To 
generate gas phase ions from a liquid-phase sample the LC eluent is nebulized at 
atmospheric pressure and sprayed across a high potential difference of a few 
thousand volts from the capillary needle to the orifice of the interface [113]. Heat and 
gas flow desolvates the charged droplets, causing the droplets to shrink, subdivide, 
and eventually the repulsive force between ions with like charges exceeds the 
cohesive forces and non-fragmented ions are ejected into the gas phase. These 
charged ions are attracted to and thus proceed to the mass analyser. The heated ESI 
(HESI) interface is even better capable of mobile phase dissolvation, due to thermal 
desolvation assistance in the capillary needle [113,124]. 
During APCI, the LC solution is sprayed into a quartz heater jacket (typically 250 °C-
400 °C) creating a vapour, which is then passed over the corona discharge needle 
creating ions through gas phase ion-molecule chemical reactions [113]. Positive ions 
are formed through proton transfer, while negative ions are formed through electron 
transfer or proton loss [113,124]. 
 
During this study, two types of mass analysers hyphenated with LC and UHPLC were 
utilised, respectively, an ion trap (LTQ, Thermo Fisher Scientific) and a triple 
quadrupole (QqQ, TSQ Vantage, Thermo Fisher Scientific) mass spectrometer.  
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Figure I.10: Schematic overview of an ion trap mass analyser (LTQ) (©Vinaquips.com). 
The ion trap mass analyser (LTQ) also referred to as the quadrupole linear ion trap 
relies on the effect of oscillating electric fields contained by three hyperbolic 
electrode (entrance, ring and endcap) arrangements (Figure I.10).  The applied fields 
allow the ions to be trapped for extended periods of time and manipulated 
(consecutive tandem mass spectrometry (excitation, fragmentation and detection of 
ions)) in the process of an extended time domain [113]. The exact path of the ions is 
dependent on the voltages applied and their individual mass-to-charge (m/z) ratios. 
After trapping the precursor ions, collision activated dissociation (CAD) is applied to 
generate structural information [113]. For detecting the ions, the magnitude of the 
direct current (DC) and radiofrequency (RF) potentials are increased as well as the 
RF, forcing the ions to become unstable and to leave the trap through the exit end-
cap towards the detector [124,125,113].  
 
 
 
  
 
 
 
 
Figure I.11: Scheme of a quadrupole mass analyser (TSQ, QqQ) [122]. 
 
A quadrupole mass analyser (TSQ, QqQ) consists of three subsequent quadrupoles 
each composed of four parallel hyperbolic metal rods to which both a DC voltage 
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and an oscillating RF voltage is applied (Figure I.11). Two opposite poles are positively 
charged and the other two negatively, and their polarity switches throughout the 
analysis. The precisely applied voltages determine the trajectory of the ions down the 
flight path between the four rods. Only those ions with a specific m/z value will 
resonate along the field and complete the trajectory across the quadrupole. Non-
resonant ions will deflect form the central path, subsequently colliding with the rods 
and be lost. By quickly switching the voltages, ions of one mass after another will take 
a steady path along the rods and be detected. This creates a ‘mass filter’ [113]. The 
second quadrupole, the collision induced dissociation (CID) cell, allows 
fragmentation of ions. For quadrupole mass analysers different types of MS/MS 
experiments are possible. The four most common types used are namely product ion 
scans, precursor ions scans, neutral loss scans, but also selected reaction monitoring 
(SRM), which is considered as the most sensitive and quantitative operating mode for 
MS/MS experiments [124]. And therefore the latter has been applied in our study 
concerning the quantitative analysis of thyroid hormones in bovine serum (cfr. 
CHAPTER V).   
 
The detection of the ion trap and QqQ mass spectrometer is achieved by an 
electron multiplier, used to detect the presence of ion signals emerging from the 
mass analyser. The basic physical process that allows an electron multiplier to 
operate is called secondary electron emission. When ions hit a surface, it causes the 
electrons in the outermost area of the atom to be released, which are known as 
secondary electrons. These electrons are emitted and then accelerated through an 
electric field, which is generated by applying the proper voltage to the surface of the 
tube. The electric field forces the emitted electrons to hit the following wall, and these 
electrons, like the ion, also cause electrons to be emitted. This cascade continues 
until enough electrons are emitted to create a measurable current [113].  
 
4.2. Analysis of thyreostats in animal matrices 
In the early days, suspicion of thyreostatic abuse was based on the 
symptomatology of thyroid gland activity decrease coherent with the illicit 
administration of thyreostats in livestock. Animals administered with thyreostats would 
look sedated (muscle weakness and retarded tendon reflexes) and display mucous 
inflated skin (myxedema) caused by the deposition of mucopolysaccharides. 
Moreover their body weight would be increased due to water retention in the GI 
tract and edible tissues. Obviously, the decrease of thyroid hormones (T3, T4), which 
could be easily detected by immunological techniques, like radioimmunoassay (RIA) 
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or enzyme-linked immunosorbent assay (ELISA), could form an indication of thyreostat 
abuse [11,122]. All these parameters were rather subjective; therefore weighing the 
thyroid gland enlargement (goiter) was a less subjective non-analytical quantitative 
evaluation, which was also applicable at slaughterhouse level. Even though, false 
positive (above 60 g = suspected thyroid) results were reported for this technique, 
false negatives were almost nihil [12,14]. Besides, the histological pattern could be 
microscopically investigated, which in case of abuse would be altered [14,127,128]. 
 
Over the years a huge analytical evolution has taken place in the analysis of 
thyreostats in animal matrices, which has been reviewed by Vanden Bussche et al. 
(2009) [6]. Briefly, in the early days the chemical analysis of thyreostats from animal 
matrices consisted of a colorimetric reaction [129] and quickly moved to newer 
methods involving thin-layer chromatography (TLC) [15,130]. High performance thin 
layer chromatography (HPTLC) [12,130,131] succeeded TLC, with later on the 
development of the 4×4 HPTLC, where 4 samples and 4 standards could be 
developed simultaneously on one HPTLC plate [132-133]. 
Since the 1960s, separation methods based on GC and LC gained in popularity, due 
to the achievement of higher specificity and selectivity. With the introduction of GC 
in thyreostatic drug residue analysis, it became clear that coupling of GC with MS 
was a requirement to achieve adequate quality control criteria [134-137]. A 
milestone here was the use of derivatisation agents such as benzylchloride [134], 
pentafluorobenzylbromide (PFBBr) [135] or methylation prior to the analysis [137-140] 
resulting in lower limits of detection (LODs). Unfortunately, the recovery of certain 
thyreostatic compounds, like TAP remained low. Therefore, a more efficient method 
combining HPTLC and GC-MS analysis was developed [131] with MSTFA (N-methyl-N-
trimethylsilyl-trifluoroacetamide) derivatisation. Furthermore, a second derivatisation 
step (NBD-Cl [140], PFBBr [141-143] or 3-BrBBr [144]) was implemented and combined 
with MSTFA derivatisation, tackling recovery, repeatability and active site adsorption 
issues [144,6].  
 
Finally due to the aroused interest concerning LC, also HPLC methods were 
described for thyreostat detection in matrices such as urine, meat, serum, plasma 
and thyroid, combined with UV (ultraviolet) [145-149], electrochemical [137,148], 
chemiluminescence [150] and diode-array detection (DAD) [151], with only the latter 
one reaching a LOD of 10 µg kg-1 instead of the usual mg kg-1 range. With the 
introduction of API interfaces like ESI and APCI, LC-MS became the method of choice 
for (thyreostatic) residue control [80,152,153]. The first LC-APCI-MS method was 
	  30 Chapter I 	  
 
General Introduction 
	  
	   	  
introduced by Blanchflower et al. (1997) [152] without derivatisation. Later on, LC-MSn 
and LC-MS/MS methods in combination with ESI were developed and applied on 
matrices such as urine, faeces, muscle, liver, animal feed and hair, which obtained 
higher sensitivity and specificity by derivatisation with NBD-Cl [153] or 3-iodobenzyl 
bromide (3-IBBr) [80] (Figure I.12). Within the advantages of ion trap mass 
spectrometry, multiple stage mass spectrometry (MSn) originated for confirmatory 
purposes [154]. Evolution towards UHPLC-MS/MS methods, due to the high sensitivity, 
selectivity and thyreostat identification potential, proved derivatisation was no longer 
necessary for the analysis of thyreostats in urine [83].  
 
 
 
 
 
 
 
 
Figure I.12: Derivatisation of thiouracil with 3-iodobenzyl bromide [1]. 
 
More recently, detection has evolved towards full scan high resolution mass 
spectrometry (HRMS) approaches, which includes time-of-flight (e.g. TOF and hybrid 
TOF (Q-TOF)) and Orbitrap (e.g. single-stage (Orbitrap Exactive) or multiple-stage 
(LTQ-Orbitrap, hybrid quadrupole Orbitrap (Q-Exactive)) technologies, providing 
resolutions up to 150,000 full with at half maximum (FWHM) [155,157]. The increased 
selectivity in comparison with tandem mass spectrometry [157,158], the potential of 
detecting numerous known and unknown compounds at once, as well as, the 
possibility of post-acquisition data mining demonstrate the great potential of these 
techniques for residue analysis as a whole. Not surprisingly, an UHPLC-HESI-HRMS 
Orbitrap multi-residue method for the analysis of banned veterinary drugs including 
thyreostats has been described in bovine urine [159]. 
 
4.3. Thyreostatic drugs analysis in animal feed 
The analysis of animal feed has not been the first priority in the monitoring plan 
of thyreostats when they were banned in 1981 [20]. Most analysed matrices were of 
animal origin, including thyroid gland, muscle tissue or urine. One method resorted to 
micellar electrokinetic chromatography (MEKC) for the detection of thyreostats in 
animal feed by DAD reaching LODs of 0.4-0.6 µg g-1 in fodder and 4% peak area 
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repeatability [160]. A capillary electrophoresis (CE) with laser-induced fluorescence 
(LIF) detection method was developed in urine achieving an LOD range of 0.30 (TU)-
0.43 (PhTU) ng mL-1 [161]. Subsequently, it was applied to feed with a mean recovery 
at 0.6 µg g-1 of 78 ± 3% and RSD < 3%, but no LOD specifications in feed were 
mentioned. Thereupon a similar CE method was developed for animal feed using a 
different type of detector, an electrochemical detector and adding a solid-phase 
extraction pretreatment allowing LODs from 7.6-25 µg kg-1  (18 ng g-1 TU; 25 ng g-1 PTU) 
for various thyreostats [162]. Recently, an ion-pair based hollow fiber liquid phase 
microextraction (IP-HFLPME) coupled with HPLC-ultraviolet detection (HPLC-UV) 
method was developed for the analysis of another therapeutic synthetic thyreostat 
(methimazole) in animal feed reaching an LOD of 0.5 µg kg-1 and RSD% for feed of 
5.6% [163].  
Meanwhile also mass spectrometrical methods were developed preceded by 
either gas or liquid chromatographic separation. Similarly to other methods, the 
developed methods were originally intended for other matrices e.g. urine but applied 
to animal feed. Therefore little to no validation data were available. In this light, HPLC-
MS (LCQ ion trap) [153] and LC-MS/MS [69] detection methods with an incorporated 
derivatisation step were developed. The latter one was the first to try the extraction of 
thyreostats from Brassicaceae feeds to prove the link between feed and thiouracil 
detection in urine of livestock. In this study a one-step methanolic solid/liquid 
extraction, derivatisation, liquid liquid extraction (3-steps) and silica cartridge solid 
phase purification were followed. Vanden Bussche et al. (2011) [164] further 
optimized the procedure from Pinel et al. (2006) [69] for Brassicaceae by amongst 
others adding a hydrolysis step with the plant-derived enzyme myrosinase showing 
thiouracil could be detected in many Brassicaceae derivates (i.e. broccoli, 
cauliflower, rapeseed and coarse colza ‘00’ meal). A recent report used methanol 
and petroleum ether as extractions solvents without myrosinase followed by 
derivatisation (3-IBBR) and diethyl ether liquid liquid extraction to analyse thyreostats 
in animal feedstuff by LC-MS/MS [165]. The validation data obtained in this study were 
however disappointing, with  recoveries for TU ranging from 77.7-86.9% and CCα- CCβ-
values of respectively, 2.39 and 4.07 µg kg-1. 
 
4.4. Thyroid hormone analysis in a clinical setting 
Thyroid hormones can occur either bound to specific thyroid hormone-
binding proteins or unbound and be bioactive in the blood circulation. Between both 
fractions equilibrium is established, therefore detection of thyroid hormones must be 
able to portrait both since they have an important diagnostic potential 
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(hyperthyroidism, hypothyroidism). Both fractions require a specific procedure in order 
to be detected; for free thyroid hormone separation from bound hormone is crucial, 
whereas total hormone detection needs denaturation to also free the bounded 
fraction.  
 
4.4.1. Total thyroid hormone analysis 
Immunoassays, like RIA and ELISA, have been widely used for detection of 
unbound/bound thyroid hormones in both, animal (equine, feline, canine etc.) 
[126,166-168] and human analysis [169-171], of thyroid hormones in blood. These 
immunoassays are quite comparable, as with ELISA antibodies are labelled with an 
enzyme (chromogenic, fluorogenic or electrochemiluminescent reporters), and in 
RIAs with a radioactive label. The use of radioactive isotopes, however, requires 
appropriate licensing, storage facilities, safety devices, and record keeping, which 
increase the operating cost. As an alternative, non-radioactive immunoassay 
methods, such as, chemiluminescent immunoassays (CIA) and a chemiluminescent-
enzyme-immunoassays (CEIA) have been developed for the analysis of thyroid 
hormones in blood samples [172]. 
Regarding the analysis of the total thyroid hormone fraction, a lot of RIAs are 
commercially available and commonly accepted as the golden standard in 
veterinary medicine (e.g.: cats, dogs) [126]. In general solid-phase RIAs are used, in 
which the antibodies are immobilized to the wall of a polypropylene tube. Next, a    
25 µL aliquot of the treatment, standard (supplied with the kit) or control sample is 
added to the coated tubes. Plain tubes are used for determining the non-specific 
binding and the total counts. A 100-µl aliquot of 125I-labeled T4 is added to each tube. 
The samples are subsequently incubated, decanted and radioactivity is measured for 
1 min in a gamma counter. The concentration of T4 is determined using regression 
analysis [172]. 
Kemppainen & Birchfield (2006) [173] have studied the difference between a 
RIA marketed for use in dogs, a RIA for use in humans, a chemiluminescent enzyme 
immunoassay for use in humans, and an in-house ELISA for dog and cat serum. The 
correlation between all 4 methods proved to be good, even though the RIA 
specifically developed for dogs, consequently came up with lower concentrations in 
the higher range of the concentration spectrum, predominantly in cats. Several 
factors were enumerated, which could contribute to this lower T4 concentration, 
including: the assay used calibrators of canine origin, the lower calibration range and 
lower sensitivity of the test [173]. Because this could be important in veterinary 
diagnostics, adapted reference ranges based on the applied methods capacity 
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would be useful to adequately evaluate animals and categorize their thyroid illness. 
Significant biases for immunoassays have been reported due to either endogenous 
factors (e.g., abnormal binding proteins, dialyzable protein binding competitors, 
heterophile antibodies, autoantibodies) or in vitro factors (free fatty acids, assay 
antibodies, analogues, intrinsic dilution). Disagreement between results from different 
methods has been a perplexing problem, limiting their clinical utility [174,175]. 
Therefore over the years, increasing replacement of immunoassays took place in 
favour of more sensitive and specific MS techniques (GC-MS; LC-MS; LC-MS/MS) in 
total and free thyroid hormone applications in humans [176-181]. For total thyroid 
hormone detection in particular, laborious sample preparations were common with 
the first GC-MS applications [182,183], but over time evolution towards LC-MS based 
methods, with eventually HPLC-isotope dilution tandem MS (HPLC-ID-MS/MS) 
applications, allowing a higher throughput with a reduction of complexity in 
extraction procedures emerged [184-186]. The principle of ID-MS is surprisingly simple. 
A sample with known isotopic composition of the analyte element, but unknown 
elemental content is mixed with a known amount of spike. This spike contains the 
analyte element in a different isotopic composition, ideally enriched with the rarest 
natural isotope. After complete mixing of sample and spike the so-called sample-
spike blend or isotope-diluted sample gains a new isotope ratio that will lie between 
the isotope ratio of the sample and that of the spike. This altered isotopic-composition 
directly reflects the analyte concentration in the sample (Figure I.13). In order to 
quantify successfully with ID, a minimum of 2 stable radioactive isotopes of T4 are 
required for mass spectrometrical analysis. For total thyroid hormone analysis, bound 
and unbound T4 are measured, therefore after enriching the serum sample with 
isotopic-labelled T4, protein denaturation is applied (e.g. acetone). After 
denaturation and centrifugation the subsequent supernatant is separated in time 
based on liquid chromatography and mass spectrometrically analysed [183,187]. ID-
MS is a very quick (below 7 min run), accurate (based on ratio not signal intensity), 
specific (measures only the analyte), precise and easy way to analyze total thyroid 
hormones [184,187]. Even though, ID-MS, has some disadvantages, these are easily 
overcome by the overwhelming advantages of the technique. As a disadvantage 
may count that ID-MS is a destructive method and requires two isotopes, ideally 
completely free from any isobaric or polyatomic interferences. In case of mono-
isotopic elements ID-MS can, therefore, only be applied if a long-lived radionuclide, 
such as 129I, is available for spiking. The most important issue, however, is the mixture 
between sample and spike isotopes, since a complete isotopic equilibrium between 
sample and spike isotopes is required to have satisfying results [187]. 
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Figure I.13: Principle of isotope dilution described for lithium (6Li and 7Li) (©2014 
Wikipedia). 
 
4.4.2. Free thyroid hormone analysis 
Free thyroid hormone analysis is regarded as the most sensitive diagnostic test for 
thyroid disorders. Notwithstanding, the detection of the free fraction of thyroid 
hormones requires a specific approach for its extraction. The free thyroid hormone 
fraction should be separated from the bounded fraction without disturbing the 
physiological equilibrium between both, after which free thyroid hormone 
concentrations may be measured [188]. To this end, specific separation techniques 
can be applied: equilibrium dialysis (ED) or ultra filtration (UF) [189]. To attain a 
representative separation of both free and bounded thyroid hormone fractions, 
physiological conditions should be respected taking into account: time, temperature, 
pH, sample dilution and change in ion composition during separation [188]. Since, the 
free fraction represents ppt-level (pmol L-1) concentrations in serum, whereas total 
hormones represent ppb-levels (nmol L-1) concentrations, this potentiates its 
susceptibility to interference even more, in comparison to total hormone detection 
[184]. 
Mainly the separation of free thyroid hormones is still traditionally based on 
equilibrium dialysis (ED) in combination with immunoassays, but lately MS applications, 
like ED LC-ID-MS/MS have also been described and put forward as a human 
reference method [170,177,190]. In animals, however free thyroid hormone detection 
is as yet mostly performed with ED and immunoassay combinations [127,166-168]. 
The principle of ED is based on the affinity of thyroid hormones for their binding 
proteins. The dialysis cell contains two compartments separated by a semi-
permeable membrane, in which one compartment (donor cell) contains the serum 
sample and the other compartment (acceptor cell) contains only a protein-free 
dialysis buffer [186]. Exclusively the unbounded fraction can pass the semi-permeable 
membrane to the acceptor compartment, based on pore-size (cut-off). The dialysis 
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cell equilibrates whilst incubating, after which both donor and acceptor cells are 
analysed to calculate the free T4 concentration [191]. 
ED has the disadvantage to be a labor-intensive, imprecise, technically demanding 
and costly procedure, which is hard to implement in clinical laboratories where the 
amount of samples analyzed per day prevails [169,192]. A new current possibility 
allows performing ED batch wise using dialysis in 96-well plates [170]. Problems 
reported with ED are also related to the dilution and dialysis buffer composition [177]. 
Because of all those setbacks, UF was proposed as a valuable alternative for ED 
[179,190,193], which further led to its implementation in several North American 
laboratories for human serum analysis nowadays [169]. 
UF consists of centrifugation of undiluted serum, through a specific disposable UF 
centrifugal device mountable in the rotor of a centrifuge with a specific cut-off semi-
permeable membrane, which takes only around 30 min whereas ED takes around 24 
h [169,170,192,194]. Centrifugal force causes the unbound hormone fraction to pass 
through the membrane, therefore the conditions (37 °C, neutral pH) of centrifugation 
should closely relate to the in vivo circumstances in order to have a physiologically 
accurate view of the in vivo status of thyroid hormones [194]. Pre-washing of the UF 
filters (phosphate buffer-ultrapure water) might be called for in order to exclude 
potential interfering compounds (e.g.: glycerine) [195]. The major concerns with UF 
include: non-equilibrium, absorption, protein leakage, protein binding, wall 
adsorption and temperature control [177,194]. For example a leakage of 0.005% of 
serum protein into the ultrafiltrate will already cause an increase in concentration of 
free T4 [195]. Therefore, it is preferable that the analysis of the samples swiftly follows 
the separation and extraction procedures either through RIA or even better with mass 
spectrometrical techniques [194]. For free thyroid hormone detection in serum ID-LC-
MS/MS is a sufficiently sensitive, specific, accurate and precise method of analysis 
when accurately executed, therefore it has been put forward as a potential 
reference detection method in humans [170,183,193].  
Finally, notwithstanding the excellent performance of LC-MS/MS analysis in both free 
and total thyroid hormone analysis compared to immunoassays, it has no in-house 
potential. Medical practices (animal or human) cannot execute these analyses 
themselves unless they dispose of an elaborate laboratory facility, which is often not 
the case and makes the results not directly available for further diagnostics [169]. 
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5. INTESTINAL BACTERIA IN LIVESTOCK 
5.1. Gastro-intestinal tract of monogastric and  
polygastric animals 
The GI tract of animals can be divided into two subgroups depending on the 
anatomical segmentation of their stomach, respectively called mono- (one segment, 
e.g. pig) and polygastric animals (many segments, e.g. cow). Besides, another well-
known subdivision according to the animals feeding behaviour identifies three 
subgroups: carnivorous, omnivorous and herbivorous animals. The overall GI 
morphology in animals is greatly influenced by adaptation, nature and, frequency of 
food intake, storage need, body size and body shape [196]. 
Basically, the GI tract is a long chain of subsequent chambers, which in the 
end results in degraded feed, and resorbation of a battery of nutrients essential for 
the animal. A first step in this process takes place in the oral cavity where feed is 
grounded and homogenized with saliva with the help of a good set of teeth, which 
explicitly include grinding premolars and molars in herbivores. Also the process of 
ensalivation helps digestion and bolus formation, since saliva mainly contains mucin, 
although in pigs also starch-degrading amylase is present. Per day cows can 
produce around 200 L of saliva, which plays a role in sustaining the nearly neutral pH 
(5.5-6,5) of the rumen, whereas men only produce 1-2 L. In cows the tongue has 
filliform papillae on its surface with a highly cornified epithelial layer, creating a rough 
surface. After bolus formation in the mouth the feed is swallowed moving through the 
pharynx into the oesophagus and stomach. The monogastric stomach (Figure I.14-B) 
consists of one sac divided into different regions (Figure I.14-C). The bolus enters the 
stomach through the cardia sphincter into the non-glandular oesophageal region. 
The subsequent areas of the stomach are cardiac-gland region, which produces 
mucin to protect the stomach epithelia from chemical and mechanical 
deterioration, the fundic gland region produces besides mucin (neck cells) also 
pepsinogen (chief cells) and HCl (parietal cells) which converts pepsinogen to pepsin 
acting on proteins in the stomach. Subsequently, the feed bolus moves through the 
pyloric region where G-cells in the pyloric glands can produce gastrin that also 
stimulates HCl and pepsin production. The pyloric sphincter at the end controls the 
outgoing throughput of the stomach [197]. 
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Fig I.14 : Overview of a polygastric (ruminant) (A) and monogastric (pig) (B) digestive 
tracts. The regions (C) are represented with the following colours: yellow: 
oesophagus; green: glandular epithelium; purple: cardiac glands; red: gastric glands; 
blue: pyloric glands; dark blue: duodenum (©2014 Wikipedia and ©2012 Texas A&M 
University). 
 
In the polygastric animal four subsequent sacs act as stomach: rumen, reticulum, 
omasum and abomasum (Figure I.14-A). In general the oesophageal region of 
monogastric animals compares to the rumen, reticulum and omasum whereas the 
abomasum can be compared to the gland regions. Due to these three forestomachs 
or proventriculi, ruminants are able to utilize cellulose present in plant material. The 
ruminal environment is prone to growth of microbiota (bacteria, protozoa, fungi), 
which form cellulase and convert plant material into volatile fatty acids, CO2, 
ammonia and synthetize vitamin K and B complex vitamins. In the end even the 
microbial cells are digested. Non-protein nitrogens like ammonia and urea can be 
reincorporated in the microbial protoplasm and redigested by the organism into 
valuable amino acids. The rumen has also an oesophageal groove which when 
closed can bypass the rumen from the oesophagus directly to the omasum. In young 
milk-drinking calves this is an important feature that prevents acidosis of the rumen, 
allowing coagulation of the milk by renin in the stomach before further digestion. In 
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the rumen three phases are present: the lower liquid partially digested food, the 
middle layer with not yet entirely soaked food and the upper layer consisting of a gas 
phase (CO2, methane). The muscular sac contracts regularly mixing different layers 
together and when a high-fiber bolus blocks the cardia this will be regurgitated for 
further mastication. When the methane concentration increases above a certain 
level this is ventilated through the oesophagus and called ructus. Once feed particles 
are fine enough they pass through the reticulums’ honeycomb structure to the 
omasum or bookstomach. There, muscular laminae studded with short blunt papillae 
descending from the dorsal portion of the omasum induce a grounding motion on 
the feed bolus before entering the abomasum or ‘real’ stomach. The omasum to the 
abomasum changes abruptly into a mucus producing epithelium, with consecutively 
more or less the same gland regions as in single stomach animals.  
Finally the intestines are reached, first the small (duodenum, jejunum ileum) where 
bile (bile salt, cholesterol, lecithin, bile pigments) and pancreatic (sodium 
bicarbonate and enzymes (o.a.: amylase, lipase, trypsin)) juices indulge on the feed 
chime, degrading proteins, fats and carbohydrates. Various hormones and the 
presence of degradation products regulate all GI processes. In both the pig and cow 
the ileum terminates into the caecum and subsequently into the colon or large 
intestine (ascendens, transversum and descendens). In pigs (Figure I.14-B) the 
topography of the colon is coiled resulting in a typical cone-shaped appearance. 
The microbial population in the large intestine can degrade the cellulose present in 
the chime of high roughage single stomach animals, like horses. Since pigs are more 
omnivorous the size of the colon is more restricted than in horses and even more so in 
cows as they are fore-stomach fermenters. The rectum and anus with a sphincter 
make up the end of the GI tract [197]. 
  
 
5.2. Intestinal microbial populations in livestock 
The GI tract contains a complex and diverse population of microorganisms, which 
for most animals have not yet entirely been elucidated [198]. The distribution of 
microorganisms over the digestive tract depends on the type of fermenter, either 
forestomach fermenters (cow) with a fermentation chamber prior to the acid-
secreting part of the stomach, or hindgut fermenters, which use the caecum and 
colon as microbial fermentation chambers (pig). Herbivores can be both 
forestomach (cow) and hindgut fermenters (horse) [199]. 
In porcines the Gram-positive anaerobical organisms prevail in the intestine (e.g. 
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facultative anaerobic Streptococcus sp., Eubacteria sp., Clostridium sp., 
Lactobacillus sp., Peptostreptococcus sp. etc). If Gram-negative bacteria are 
encountered they are mostly Bacteroides sp. [200-202]. Pigs have been reported to 
posses in their hindgut: Streptococcus sp., Lactobacillus sp. (e.g. L. acidophilus), 
Eubacterium sp., Fusobacterium sp., Bacteroides sp. (B. multiacidus), Peptococcus 
sp., Peptostreptococcus (e.g. P. elsdenii), Streptococcus sp., Bifidobacterium sp. (e.g. 
B. suis, B. longum ssp. suis, B. pseudolongum ssp. pseudolongum and ssp. globosum, B. 
thermophilum, B. boum, B. choerinum), Selenomonas sp., Clostridium sp. (e.g. Cl. 
perfringens), Butyrivibrio sp., Escherichia sp. (e.g. E. coli), Prevotella sp., Ruminococcus 
sp., Veillonella sp., Leptotrichia sp.,  Anaerovibrio sp., Gemminger sp., Leptotrichia sp. 
[200,203-205]. 
Bovines have microbial activity concentrated in the rumen and the large 
intestine. The rumen contains obligate anaerobic bacteria and archaea but also 
fungi and protozoa [199,206]. Primary ruminal bacteria that break down nutrient from 
feed are carbohydrate degrading bacteria (amylolytic or cellulolytic) and proteolytic 
bacteria [206]. Secondary ruminal bacteria use degradation products from the 
primary bacteria for their metabolism, like methane producing and lactic acid 
degrading bacteria [207]. The constitution of the ruminal but also colonic microbial 
populations can be altered under the influence of diet, age, health, geographical 
location and seasonal changes [206,208]. Therefore, these variations also influence 
the quantity and nature of the fermentative end products [199]. In the rumen 
Bacteroides sp., Eubacterium sp., Peptostreptococcus sp. can also be found similar to 
those in the colon. More specific for the rumen are Ruminococcus sp., Butyrivirbrio sp., 
Streptocococcus sp., methano-bacteria (Methanobacterium sp.) [199]. 
Megasphaera sp., Butyrivibrio sp., Ruminobacter sp., Cytophaga sp., Roseburia sp. 
and Selenomonas sp. were reported exclusively in ruminal fluid according to 
Callaway et al. (2010) [208]. Most protozoa in the rumen belong to the ciliated type 
of the holotrichs, which rapidly absorb sugars and also store sugars as starch within 
their structure (reserve) and the entodiniomorphs, which feed on cellulose and 
bacteria. Some species are also carnivorous on other protozoa [199]. Hindgut 
bacteria in cattle mainly include Clostridium sp. (Cl., butyricum), Bacteroides sp., 
Porpyhyromonas sp., Ruminococcus sp., Alistipes sp., Succinivibrio sp., 
Lachnospiraceae, Prevotella, Lachnospira sp., Enterococcus sp., Oscillospora sp., 
Cytophage sp., Anaerotruncus sp., Acidaminococcus ssp., Bacillus sp., Streptococcus 
(S. bovis, S. faecium), Micrococcus sp., Escherichia sp. (E. coli, E. freundii), Klebsiella 
sp., Proteus sp., Streptomyces sp., Candida krusei (fungi), Mucor sp. (fungi) [208-210]. 
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5.3. In vitro modelling of the intestinal tract 
The GI tract can be studied, either through in vivo (live animal), or in vitro 
(simulation of the GI) experimental research. Using in vivo studies, information on the 
impact of the GI processes is gathered through sampling of the various 
compartments of the GI tract (stomach, small intestine, large intestine) and feces. In 
practice this is technically quite complicated, and in many cases fistulation of the 
animals is required, which raises ethical questions towards animal welfare. Therefore 
such trials are closely regulated and require ethical committee agreements. Overall 
an estimated twelve million animals per year are used for experimentation according 
to the EU Strategy for Protection and Welfare of animals 2012–2015. Although this is still 
a lot, nowadays, simplifying animal experiments, reducing discomfort, setting human 
endpoints and most importantly if possible electing an alternative in vitro 
experimental set-up are widely promoted. Beside, the cost of animals, housing, 
trained personnel etc. is such that setting up a series of in vivo studies, is just not 
feasible [211]. 
 
The GI tract can be imitated by using in vitro simulations and with this the invasive 
character and need for animals vanishes, which makes the procedure more cost-
effective. Moreover the amount or time of sampling is no longer an issue making it the 
more responsible choice for feed/food digestion experiments [212] Digestion 
simulations can be subdivided in dynamic and static in vitro set-ups [213]. 
The dynamic digestion simulation is constituted out of different reaction jars 
that recreate a specific phase of the GI tract (stomach, small intestine or large 
intestine). The subsequent reaction tanks are interconnected and reaction products 
can be removed or not through absorption [211]. The first developments focussed on 
specific compartments of the GI tract, like Miller & Wolin (1981) [214] who proposed a 
semi-continuous culture system, followed by Veilleux & Rowland (1981) [215] 
introducing a two phase continuous culturing system and Gibson et al. (1988) [216] 
which used a three-phase continuous culturing system.  
 The need for partially or fully integrated in vitro systems, which mimicked the 
gradual transit of ingested compounds through the digestive tract, grew increasingly 
over the years [217-219]. Currently, a well-known configuration is Simulator of the 
Human Intestinal Microbial Ecosystem (SHIME) (Figure I.15) [217]. The SHIME has 5 tank 
reactors being: stomach (1), duodenum, jejunum, ileum (2), caecum and colon 
ascendens (3), colon transversum (4) and colon descendens (5), which are all kept at 
37 °C.  
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Figure I.15: Scheme of the Simulator of the Human Intestinal Microbial Ecosystem set-
up [220]. 
 
The first two vessels (stomach and small intestine) work according to a fill-and-draw 
system, whereas the last three (large intestine compartments) are continuously stirred 
tank reactors with a total retention time of 76h. The suspensions are added with the 
necessary fluids for the specific compartment (e.g. HCl (stomach (1)), bicarbonate, 
pancreatic and bile juices (small intestine (2)), intestinal bacterial inoculum (large 
intestine (3-5)) and their pH continuously monitored and adjusted when necessary. 
Therefore, the SHIME model is recognised as a good in vitro simulator of the human GI 
in vivo process, which for static digestion simulations is less the case [221]. 
 
Similar dynamic digestion models have been developed for livestock, pigs and cattle 
in order to evaluate amongst others their feed conversion and bioavailability with 
respect to certain feeds. A dynamic digestion model was developed, simulating the 
gastric digestion of pigs [222]. This model was constructed to include the chemical 
and physical changes associated with gastric digestion, such as, enzyme release, 
digestion product removal and gastric emptying. A variation of the latter set-up was 
reported by Rivest et al. (2000) [223], which developed a system to specifically 
evaluate protein degradation in the small intestine of pigs. The main characteristics of 
the model were the following: the small intestine is divided into several segments of 
variable length but with equal digesta retention time; the rate of transfer of digesta 
between segments is based on the progression of myoelectric migration complexes; 
pancreatic and biliary secretions are poured into the first segment, whereas intestinal 
secretions enter all intestinal segments; protein hydrolysis is described by first-order 
equations; and an intestinal absorption capacity is used to estimate absorption of 
hydrolysed protein. This model is useful in the evaluation of feeds and feeding 
strategies. A more elaborate dynamic model had already been developed 
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consisting out of stomach, duodenum and proximal jejunum, distal jejunum, ileum 
and large intestine by Bastianelli et al. (1996) [224]. In each of these anatomical 
compartments, subcompartments correspond to the major biochemical components 
of feed (e.g., fats, proteins) and their products of degradation (e.g. amino acids; 
fatty acids). The major degradation and absorption events are considered as well as 
the effect of microbial activity in the large intestine. The total number of 
compartments is 44 [224].  
 
In bovines the main concern in feed digestion is the ruminal digestion, which is also 
reflected in the amount of publications concerning ruminal evaluations of feeds and 
additives based on static and dynamic in vitro digestions [220-233]. A broadly applied 
[230,237-239] dynamic in vitro ruminal system is the RUSITEC system (Figure I.16) that 
was developed by Czerkawski & Brekenridge (1977) [240] consisting of four vessels in 
which the normal rumen microbial population is sustained under strict controlled 
conditions over time [241].  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure I.16: The early Rusitec system: in vitro dynamic rumen simulation (©ikasbil.net). 
 
Furthermore, Gérard-Champod et al. (2010) [212] optimized an intestinal system to 
evaluate the effect of certain additives on digestion in veal calves. The final system 
was based on a continuous culture system comprising one glass vessel with an 
operating volume constantly maintained by a level probe controlling the outflow of 
the fermentative content. A sterile nutritive medium was introduced continuously at a 
rate of 15 mL h-1 (retention time, 80 h). The fermentative medium was permanently 
stirred, the pH was kept at a constant 6.5, and the temperature was maintained at 
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38.5 °C under anaerobic conditions. This set-up showed good in vitro in vivo 
correlation. 
Besides also mathematical models have been described e.g. by Dijkstra et al. (1992) 
[242] simulating the digestion, absorption and outflow of nutrients in the rumen. The 
model consists of 17 ruminal state variables, representing nitrogen, carbohydrate, 
lipid, and microbial and volatile fatty acid pools. Based on nutrient information of 
feed the digestion could be simulated. 
 
In comparison static in vitro digestion simulations consist of only one reaction 
tank, from which the digestion products are not removed. This simulates transit 
through the digestive tract by sequential exposure of the substrate (food/feed) to 
simulated digestion conditions (e.g. stomach, small intestine, large intestine) [219].  
These models are therefore less comparable with the in vivo dynamics, as dynamic in 
vitro simulations are. Notwithstanding, static in vitro digestion simulations are preferred 
when evaluating one phase of the digestion process (e.g. large intestine) or when 
simple food or isolated nutrients are assessed [211]. Moreover this type of model is 
simple and cheap, because it does not require a lot of specialised equipment. In 
general, a static system consists of homogenising feed, adding the adequate 
medium, adding digestion enzymes or microorganisms, stirring and adjusting pH when 
needed [211]. Single stage digestions have been described for pigs when evaluating 
glucosinolate degradation in separate small intestinal and caecal jars [243]. An 
example of a multi-stage static digestion model is the in vitro simulation of three 
subsequent enzymatic digestion steps: stomach, small intestine, large intestine in one 
reaction tank [244,245]. The digestion protocol of Boison & Fernandez (1997) [244], 
which has been specifically developed for porcine simulation, was used as an 
example in this study. With respect to the ruminal in vitro static digestion, it merely 
consists of freshly collected ruminal fluid that will then be filtered, buffered and 
conveyed into a flask for incubation (39 °C) after CO2 flushing. Many useful 
experiments have been conducted based on this general set-up adapting 
incubation time, sampling, feed type, etc [229,231-234,246,247]. 
 
5.4. Bacteria with myrosinase-like enzymatic activity 
Bacteria may own several enzymatic activities that are either permanent or 
adaptive to the gut environment [248]. These enzymes may be classified into different 
groups: oxidoreductase, transferase, hydrolase, lyase, isomerase and ligase [249]. 
One enzymatic activity, which showed in particular interesting in light of this work, 
and has been reported for several microorganisms (bacteria and fungi) involves their 
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ability to degrade GLs through the effect of a myrosinase-like enzyme (Table I.4). The 
latter bacterial factor would exert a similar effect as the plant-derived myrosinase, 
thereby inducing the formation of similar degradation products. The mechanism of 
bacterial myrosinase has been shown to potentially rely on a cell-dependent activity 
[41,43]. Palop et al. (1995) [41] described that myrosinase activity in Lactobacillus 
agilis was cell-dependent since in the absence of intact bacterial cell degradation of 
sinigrin did not occur. Cheng et al. (2004) [43] reported similarly that in cell-free 
supernatants of various Bifidobacteria sp. hydrolysis of sinigrin could not take place 
and added the fact that after sonication of cells hydrolysis did occur. This 
demonstrates intact cells were not prerequisited for myrosinase like activity. 
  
Since hydrolysis of GLs by plant-derived myrosinase elicits formation of certain 
natural goitrogenic substances, the hypothesis postulated that the same could occur 
in the intestine of animals for synthetic goitrogens. However, before potential parallels 
with plant-derived myrosinase can be made, this bacterial myrosinase activity needs 
further characterization of its mechanism.  
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Table I.4:  Overview of the reported microorganisms in literature with a glucosinolate 
degrading activity. 
 
Micro-organism 
with myrosinase activity 
Origin Glucosinolate 
source 
Reference 
Aspergillus niger AKU 3322 - Sinigrin [250] 
Apergillus clavatus (II-9) 
Fusarum oxysporum 
- Sinigrin, sinalbin [251] 
Aspergillus sp. NR-4201 - Sinigrin 
Brown mustard seed meal 
[252] 
Geotrichum candidum - Rapeseed, only partial 
goitrin degradation 
[253] 
Trichosporum cutaneum 
Bacillus cereus 
 
- Rapeseed meal 
(glucosinolates, vinyl-
oxazolidine-thiones) 
[254] 
Sphingobacterium sp. OTG1 - sinigrin [255] 
Bacteroides theitaiotamicron (II-8) Human sinigrin [42] 
Bacteroides vulgatus (BV8H1) Human Rapeseed (meal, ‘00’-
variant without peal) 
[40] 
Bifidobacterium pseudocatenulatum 
(JCM 7040) 
Bifidobacterium longum (JCM 7050) 
Bifidobacterium adolescentis (JCM 
7045) 
Human Sinigrin, glucotropaelin [43] 
Enterobacter cloacae (no 506) - - [256] 
 
Enterococcus ssp. Human - [257,258] 
Enterococcus faecalis 
Enterococcus faecium 
Human - [259] 
Paracolobactrum coliforme X3 - Sinigrin [256] 
Escherichia coli 
Paracolobactrum aerogenoides 
- Progoitrin [260] 
Escherichia coli (EM0) 
 
Human Rapeseed (meal, ‘00’-
variant without peal) 
[40] 
Lactobacillus ssp. Human - [258] 
Lactobacillus (LEM 220) Rat, 
chicken 
Rapeseed [261,262] 
Lactobacillus agilis (R16)  Sinigrin [41] 
Peptostreptococcus spp. Human Progoitrin, sinigrin [257] 
Proteus ssp. Human Progoitrin, sinigrin [257]  
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5.5. Isolation and identification of intestinal bacteria  
The isolation and identification of bacteria can be a daunting task, but over 
the years more specific, selective and reliable methods have been developed. In this 
study, we specifically focused on the identification of fecal/intestinal bacteria [263-
265].  
 
 
 
 
 
 
 
 
 
 
 
 
Figure I.17: Lactose fermentation on MacConkey agar (A-B) and in broth (C) from in 
vitro digestion simulation samples. Red-pink colonies are lactose fermenting and 
colourless-yellow indicates non-lactose fermenting colonies.  
 
The identification of bacteria generally starts with culturing of the unknown 
intestinal isolates. First, this will be done on a non-selective medium, like Brain heart 
infusion or plate count agar [265] to evaluate total growth and to enumerate the 
bacteria aerobically and anaerobically. Enumeration of specific bacterial genera 
can be achieved on selective media, like Man Rogosa Sharpe (MRS) for 
Lactobacillus and MacConkey (MacC) agar for Enterobacteriaceae [265]. 
Sometimes indication for a certain bacterial species can be achieved by the colour 
of colonies on a specific differential agar, like MacC, which is both selective, and 
differential. The bile salts and crystal violet within this agar inhibit growth of Gram-
positive bacteria, whereas the lactose can differentiate fermenting (red-pink) and 
non-fermenting (colourless-yellow) Gram-negative bacteria following the reaction of 
neutral red to pH alterations (Figure I.17). 
Nevertheless, culturing techniques do have some inherent shortcomings including the 
fact that they select only cultivable bacteria distorting the image of the whole flora 
and the fact that selective media are not entirely selective and may be toxic for 
strains within the same genus [265]. Moreover, all culturing techniques fail at 
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cultivating bacteria that are in a non-cultivable physiologic condition. Despite all 
these shortcomings culturing techniques remain powerful tools in addition to others 
[265]. 
 
Next, culture-independent techniques including microscopic analysis, enzyme 
and metabolite analysis can be applied. Microscopy can result in enumeration, 
evaluation of overall morphology and characterization of isolates (e.g. Gram 
staining). The detection of certain enzymes (e.g. β-glucuronidase) or metabolites 
(short chain volatile fatty acids) is an indirect parameter, which represents the 
metabolic activity of a specific group of microorganisms. Besides, biochemical 
evaluation of bacterial isolates can be conducted e.g. oxidative/fermentation 
glucose test (OF) or API kit. The API (analytical profile index) test is widely used in the 
Enterobacteriaceae biochemical identification [266,267]. This is a quick and easy 
biochemical miniaturized kit, which consists of 20 or more cupules containing 
dehydrated substrate. When bacterial suspensions are added and incubated at 37 
°C for 18-24 h the reaction causes a specific colour change in each well. Every colour 
reaction stands for a numerical classification, which in the end results in a numeric 
code when all wells are considered. This code will then be matched against the 
APIweb™ database in order to identify the isolate with a percentual certainty. The 
API 20E is considered one of the ‘gold standard’ methods for biochemical 
identification of enteric and Gram-negative bacteria in clinical and food laboratories 
[268]. Also belonging to the phenotypical identification procedures for bacterial 
identification are a.o. serotyping (surface antigen detection e.g. via ELISA), biotyping 
(based on biochemical and physiological properties), bacteriocin typing (bacterial 
proteolytic enzymes), phage typing (phages are bacterial viruses specific for 
particular strains) and antimicrobial susceptibility patterns [249,263-265]. All these 
phenotypical characteristics are not variable enough for differentiation between 
closely related strains [263]. Moreover, these are based on the identification of 
products of gene expression, which in turn are highly susceptible to variations in 
environmental conditions like temperature, growth phase and spontaneous mutation 
[264].  
Therefore, this has led to the development of more direct identification methods, 
called genotyping. This procedure achieves determination between strains based on 
their genetic content. Genotyping had increasing success due to its high resolution 
and the uniqueness of the fingerprinting.  
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Techniques for identification and genotyping can be divided into three main 
categories:  
1. DNA banding pattern-based methods 
2. DNA sequencing-based methods 
3. DNA hybridization-based methods 
The discriminatory ability of all these methods except for DNA sequencing is species 
dependent [263]. 
 
DNA banding pattern based methods discriminate strains based on the size of 
DNA bands (fragments) generated by amplification of genomic DNA or by cleavage 
of DNA using restriction enzymes. Amplification of DNA creates millions of copies of a 
genomic fragment, whereas restriction enzymes precisely recognize and cut target 
DNA at a defined sequence, sometimes both are applied [263]. Separation is done 
with electrophoresis (Figure I.18) where DNA fragments under the impulse of an 
electric field are travelling through a gel (e.g. agarose) separating them according 
to size and charge creating a band pattern after dying the gel e.g. with ethidium 
bromide. Also Southern blotting can be used, which combines electrophoresis-
separated DNA fragments with a filter membrane and subsequent fragment 
detection by probe hybridization with labelled probes [269].  
Amplified fragment length polymorphism (AFLP) by De Vos et al. (1995) [270] is 
a technique, which combines both amplification and enzymatic restriction cleavage. 
First digestion of genomic DNA is performed with two restriction enzymes (usually MseI 
& EcoRI) following ligation of the restriction fragments with end-specific adaptors, 
whereupon PCR (Polymerase Chain Reaction) amplification is performed. Detection 
of the fragments can be performed by gel electrophoresis, automated DNA 
sequencers, like in fluorescent AFLP (FAFLP) where amplification is performed with 
fluorescently labelled primers, which can then be easily read.  The advantages of 
AFLP include: the flexible amount of loci that can be amplified in one PCR reaction, 
the lower amount of DNA that is needed because multiple bands are derived from 
the entire genome, no prior knowledge is needed to use this system, good 
reproducibility (comparable to Pulse-Field Gel Electrophoresis (PFGE), Random 
Amplified Polymorphic DNA (RAPD), Restriction Fragment Length Polymorphism RFLP 
and better then Multilocus Sequence Typing (MLST)) and discriminating capacity, 
cost-effective and automation is possible. The disadvantages are the massive 
amount of information that is produced which requires automation and the fact that 
the DNA template should be pure and not a mixture of DNAs. 
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Figure I.18: Simple gel electrophoresis separation of DNA fragments, which after 
staining can be visualized under UV light (©2001 E Schmid). 
 
DNA sequencing relies on generating the original sequence of the 
nucleotides and discriminate strains directly based on the polymorphism within their 
DNA, giving it a high reproducibility. DNA sequencing is very nice when assessing 
differences and evolutionary changes in DNA (e.g. deletions, insertions, genes under 
positive selection like antibiotic resistance, virulence) [263,271]. Besides DNA, also 
ribosomal DNA (rDNA) or rRNA genes are commonly used for sequencing since these 
are essential for bacterial survival due to its involvement in protein synthesis. The 16S 
rRNA gene contains 974 variable bases for the domain Bacteria. Another gene, 23S 
rRNA gene contains even twice as many variable bases and is sometimes used as an 
additional marker in phylogeny analysis. Overall 16S rRNA is the most widely used 
target gene for identification, because it is highly conserved among bacteria. 
Therefore the amplification and sequencing of the 16S rRNA gene is still commonly 
used for identification and phylogenetic classification of prokaryotic species, genera 
and families. However at the strain level 16S rRNA gene is too conserved, owing to its 
low evolutionary rate, to be useful, and in particular among Enterobacteriaceae, its 
sensitivity and discriminating power has been questioned [272-276]. Moderately 
divergent populations can easily be distinguished based on S16 rRNA but with very 
closely related bacteria other means should be considered. It has been 
demonstrated that protein-coding gene sequences should be preferred for 
identification [277]. For Enterobacteriaceae for example gyrB (encodes part of DNA 
gyrase), 16S-23S intergenic spacer, infB gene (encodes an translation initiation 
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factor), ATPase β-subunit, the elongation factor Tu and rpoB 
have been described [276,278,279]. In this study rpoB gene 
sequencing was performed since it encodes for the universal 
bacterial RNA polymerase β-subunit and it is a recognized 
identification tool [278]. Reports show an evolution towards a 
combined approach that takes two or more unlinked 
phylogenetic markers into account for classification of 
bacteria to improve the understanding of the diversity and 
complexity of bacterial ecosystems [276,279]. Finally entire 
genomes can also be sequenced which provides an 
unequivocal differentiation between organisms, but this is not 
feasible in a clinical setting, due to its low time and cost-
effectiveness compared to other available partial genome 
methods [263,264]. 
 
With DNA hybridization-based methods (Figure I.19) (DNA 
macroarray or microarray studies), bacterial strains are 
discriminated by analyzing the degree of hybridization of 
their DNA to probes of known DNA sequences. When 
hybridization is > 70% the isolate can be classified as belong 
to the same species as the probe [280]. Combining this 
method with rpoB gene sequencing has been described in 
Enterobacteriaceae to delineate bacterial species and 
genus [280].  
 
Finally, HRMS analysis has lately also been introduced and shown applicability 
in bacterial identification [281-284]. Mostly used is matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). For this 
technique bacteria are embedded in a matrix whereupon a laser is unleashed, 
vaporizing the microorganism together with the matrix, leading to ionization of 
ribosomal proteins. These are the most valuable of all proteins, peptides or nucleic 
acids, because they are less influenced by culture conditions [283,284]. Subsequently, 
an electromagnetic field accelerates the ions before entering the flight tube. Each 
ion traverses the tube at a speed dependent of their molecular weight and degree 
of ionization, resulting in a specific time-of-flight for each ion. Finally, a specific 
chromatogram is constructed based on the TOF information, which is unique for a 
given species and can be matched with database spectra [284]. 
Figure I.19: DNA-
DNA hybridization 
(©2006 University of 
California Museum 
of Paleontology). 
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6. STUDY CONCEPT, AIMS AND OUTLINE 
In this thesis the elucidation of the mechanism of the natural occurrence of thiouracil 
(TU) in livestock was addressed, since this component is a EU-banned substance of 
primarily synthetic origin. At the time, certain secondary plant metabolites, called 
glucosinolates, were known to cause the natural formation of thyreostatic 
components upon plant disruption through myrosinase hydrolysis, a plant-derived 
enzyme. This suggested that glucosinolate-rich crops, predominantly from the 
Brassicaceae family could, given the right conditions, potentially form TU precursor(s). 
Subsequently, the fact that certain human intestinal bacteria had been reported to 
possess a myrosinase-like activity or the potential to degrade glucosinolates 
strengthened this hypothesis. 
Besides, TU had already been detected in bovine urine upon administration of 
Brassicaceae feedstuff [69] and the analysis of TU in animal feeds showed TU could 
be isolated from certain Brassicaceae feedstuffs upon myrosinase addition [160].  
 
 
 Figure I.1 resumes the concept of the present study, which conveys into the following 
aims: 
 Evaluate the level of involvement of intestinal microbiota in thiouracil 
formation upon Brassicaceae in vitro digestion simulations in livestock. 
 
 Prospect the influence of various glucosinolate-rich crops depending on their 
origin and pre-treatments in TU formation upon in vitro digestion in livestock. 
 
 Elucidate the mechanism bringing about thiouracil formation in livestock 
taking into account various influential parameters. 
 
 Develop and validate a routinely applicable extraction procedure for mass 
spectrometrical analysis of TU (LC-MS2) from various animal feeds. 
 
 Develop and validate an UHPLC-MS/MS detection method for thyroid 
hormones from bovine serum to allow in a later phase to evaluate the 
biological effects of endogenous versus exogenous TU. 
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Figure I.20: Crucifer-like shaped graph representing the aims of this doctoral thesis. 
 
Next to CHAPTER I, which covered the general introduction on thyreostatic 
compounds in all their facets, this work contains five additional chapters. 
In CHAPTER II the possibility of endogenous TU formation by bacterial influence is 
investigated through in vitro digestion in bovines and porcines with various 
Brassicaceae foods and feeds (rapeseed, coarse colza ‘00’ meal, broccoli, 
cauliflower).  
Subsequently, in CHAPTER III the occurrence of endogenous TU formation will be 
further explored with various pre-treatments of the porcine faecal inoculum upon 
Brassicaceae in vitro simulations and identification of TU forming bacteria is 
envisaged. 
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In CHAPTER IV extraction optimisation and validation of a mass spectrometrical 
approach for the detection of TU from various animal feeds is reported, since this 
remains a crucial control point to asses whether TU is illicitly administered or naturally 
formed.  
Then in CHAPTER V the development and validation of a thyroid hormone detection 
method in bovine serum for free and total thyroid hormones, is described. This 
method allows to investigate the physiological status of the thyroid gland in livestock 
upon Brassicaceae digestion, thereby gaining more insight in the relation between 
thyroid hormones and endogenous feed-related TU production or illicit thiouracil 
administration. 
Finally, in CHAPTER VI the general discussion will distil the main conclusions and future 
perspectives will be addressed. 
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ABSTRACT  
In recent years, the frequent detection of the banned substance thiouracil (TU) in 
livestock urine has been related to its endogenous formation following consumption 
of glucosinolate-rich Brassicaceae crops. Besides, TU residues have been recovered 
in these crops upon plant-derived myrosinase hydrolysis. 
Through in vitro bovine and porcine static digestive simulations, the influence of 
gastrointestinal digestion of Brassicaceae-derived matrices on TU formation was 
assessed. Following derivatization and LC-MS2 analysis TU was detected in colonic 
suspensions with traditional rapeseed, coarse colza ‘00’ meal, cauliflower and 
broccoli ranging from 3.47 µg kg-1 to 30.96 µg kg-1 (bovine) and from 3.55 µg kg-1 to 
26.34 µg kg-1 (porcine). In stomach and small intestinal fluids TU remained unfound, 
whereas upon rumen simulation TU was detected for coarse colza '00' meal (4.43 µg 
kg-1) and grounded traditional rapeseed (0.35 µg kg-1). The origin of this detection 
was investigated through filter-sterilizing and autoclaving the fecal inoculum causing 
a significant decrease in TU concentration, thereby reinforcing the possibility of an 
active bacterial involvement, which however was characterized with a high inter-
animal variation. In conclusion, these results support the previously proven 
endogenous origin of TU and acknowledge the active role of the gastrointestinal 
bacteria in TU formation, through production of an extracellular component. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: endogenous thiouracil, microbiota, Brassicaceae, in vitro static digestion 
simulations, LC-MS2, livestock. 
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1. INTRODUCTION 
In recent years, endogenous prevalence of thiouracil (TU) has been reported in urine 
of livestock upon ingestion of glucosinolate-rich crops belonging to the Brassicaceae 
family [1]. This has been a staggering discovery, since the European Union banned 
the use of thyreostatic drugs in livestock for fattening purposes in 1981. Thiouracil was 
until recent always considered as a synthetic, orally active thyreostatic drug, which 
upon administration inhibits the thyroid gland by decreasing the production of thyroid 
hormones: thyroxin and triiodothyronine [2].  
In livestock illegal TU administration pairs with a desired weight gain resulting from 
water retention in the digestive tract and edible tissues, which obviously degrades 
meat quality [3,4]. Because of the European Union banishment on thyreostatic drugs, 
the rightful detection of their abuse is crucial [5]. This would be the case not only for 
residue-analysis, but also for public health concerns, since thyreostats have been 
shown to exert teratogenic and carcinogenic effects, given that thiouracil is a 2b-
categorized substance [6]. 
To allow discrimination between the illicit use of TU and possible feed related TU-levels 
a need for mechanistic knowledge arose. Not surprisingly, the family of the 
Brassicaceae was singled out as one of the most probable contributors to 
endogenous TU formation, as they are not only known for their high glucosinolate 
content, but also comprise a precursor for naturally goitrogenic substances, such as, 
oxazolidine-thiones and thiocyanates. These breakdown products can be naturally 
formed upon plant cell disruption (e.g. grounding, chewing, freezing) when the 
endogenous ß-thioglucosidase, myrosinase or thioglucoside glucohydrolase (E.C 
3.2.1.147) is freed from the plant vacuoles, causing hydrolysis of the available 
glucosinolates [7-9]. As a result, several bioactive breakdown products 
(isothiocyanates, nitriles, thiocyanates, sulphates, epithionitriles, oxazolidine-2-thiones) 
are formed depending on the environmental conditions [10,11], resulting in derivates 
with natural thyreostatic properties [11,12]. 
Nowadays, growing evidence points towards the likelihood of low-level TU being 
endogenously formed upon digestion of the secondary plant metabolites, 
glucosinolates, and their degradation products [1,13]. In an attempt to confirm the 
possible link between glucosinolates and TU the research by Vanden Bussche et al. 
(2011) [13] demonstrated that plant-derived myrosinase hydrolysis of glucosinolate-
rich Brassicaceae feed and food matrices resulted in TU detection. Thereupon the 
natural status of TU in the urine of various mammalians (livestock (bovine, porcine, 
ovine, etc.), domesticated animals (canine), and humans) was investigated. The 
 68 Chapter II 
 
Chapter II  
	  
	   	  
animals displayed traces of TU, below 10 µg L-1 without any diet control [14], as for 
humans, for whom the influence of a controlled Brassicaceae diet was investigated; 
TU was retrieved in 66.7% of the samples.  
Besides plant-derived myrosinase hydrolysis, bacterial hydrolysis resulting from 
intestinal microbiota during digestion has also been linked to cause glucosinolate 
degradation [9,15,16]. For example, the hydrolysis of sinigrin, an aliphatic 
glucosinolate, was shown to be mediated by the human intestinal bacterium 
Bacteroides thetaiotamicron in gnotobiotic mice [17]. Several bacterial strains in 
animals have also been investigated for their glucosinolate degrading activity. For 
example, a Lactobacillus strain was identified capable of inducing a myrosinase-like 
enzymatic activity in vivo [18]. However, to the best of our knowledge no research 
concerning the probability of TU being formed from glucosinolates-rich Brassicaceae 
crops upon bacterial digestion has been performed.  
Consequently, the focus of the present study was to establish the potential role of the 
intestinal microbiota in TU formation upon Brassicaceae digestion in animals. This was 
performed by conducting in vitro bovine and porcine gastrointestinal static digestive 
simulations (stomach, small intestine, large intestine). Additionally, the difference 
between mono- and poly-gastric animals was evaluated by incorporating digestion 
at the ruminal level. Various Brassicaceae feed and food matrices were evaluated by 
this approach.  
 
 
2. MATERIALS AND METHODS 
2.1. LC-MS2 reagents and chemicals 
The chemical standard 2-thiouracil (TU) was obtained from Sigma-Aldrich (St. Louis, 
USA). The deuterated internal standard for TU, 6-propyl-d5-2-thiouracil (PTU-d5)19, was 
obtained from Toronto Research Chemicals Inc. (North York, Ontario, Canada). Stock 
solutions of the chemical standards were prepared in methanol at a concentration of 
200 ng µL-1. Working solutions were diluted in methanol to 1 ng µL-1 for PTU-d5 and 1 ng 
µL-1, 0.1 ng µL-1 and 0.01 ng µL-1 for TU. Solutions were stored in dark glass recipients at 
4 °C. Reagents were of analytical grade (VWR International, Merck, Darmstadt, 
Germany) when used for extraction and purification steps, and of Optima® LC/MS 
grade for LC-MS application (Fisher Scientific UK, Loughborough, UK), respectively. 
The derivatization reagent, 3-iodobenzyl bromide (3-IBBr, Sigma-Aldrich, St-Louis, USA), 
was prepared extemporaneously (2 mg mL-1 methanol). The phosphate buffer, made 
up of 0.2 M Na2HPO4 and 0.2 M KH2PO4 (Merck, Darmstadt, Germany) in deionized 
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water, was prepared and adjusted to pH 8. 
 
2.2. Feed and food samples  
Feeds and foods affiliated to the Brassicaceae family were selected, as they are 
known for their high glucosinolate content. The selected representatives were 
traditional rapeseed (Brassica napus L. partim Napoleon, Institute for Agriculture and 
Fisheries Research (ILVO), Melle, Belgium), coarse colza ‘00’ meal, broccoli (Brassica 
oleracea L. convar. botrytis L. var. cymosa) and cauliflower (Brassica oleracea L. var. 
botrytis L. subvar. cauliflora) (local Belgian produce). From these, Brassicaceae 
coarse colza ‘00’ meal (with values of erucic acid <2% and glucosinolates <25 µmol g-
1) is the only allowed feed in livestock. Mostly these rapeseed meals are restricted to 
30% on total feed basis due to deleterious effects of glucosinolates [13]. Additional 
pre-treatments (Table II.1) were applied to the feed and food matrices, consisting of 
various grounding and inactivation steps, resulting in 9 treatment groups in total. 
Grounding required the use of a mortar and for homogenization the use of a kitchen 
blender. In order to maintain glucosinolate concentrations, scientific reports mention 
limiting the water content as crucial to avoid microbial growth and prevent 
endogenous myrosinase activity. Storage temperatures of -20 °C or 25 °C are advised 
at which Brassicacea seed meals can be preserved for 30 months and presumably 
much longer providing they are protected from exposure to moisture conditions that 
promote microbial growth [20]. Therefore, all samples were ultimately freeze-dried 
and stored at -20 °C in plastic containers. In this way obtained TU concentrations for 
different feeds could be bilaterally compared based upon their dried weight 
concentrations. 
 
Table II.1: Different pre-treatments applied to the Brassicaceae representatives: 
traditional rapeseed, coarse colza ‘00’ meal, broccoli and cauliflower. 
 
Treatments Brassicaceae foods and feeds 
 Traditional rapeseed Coarse colza ‘00’ meal Broccoli 
 
Cauliflower 
2 h at 100 °C +    
5 min at 100 °C   + + 
Grounding +    
Homogenizing  + + + 
Freeze-drying + + + + 
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2.3. Preparation of buffers and broths 
Digestion (stomach, small and large intestine) and fecal inoculum buffers were 
prepared in ultrapure water and autoclaved for 15 min, at 121 °C and 1 atm to 
ensure the absence of bacterial growth. Procedures following autoclavation were all 
performed in a laminar flow cabinet in order to exclude bacterial contamination. 
Fecal inoculum buffer contained K2HPO4 (8.8 g L-1), KH2PO4 (6.8 g L-1) (Merck, 
Darmstadt, Germany) and sodium thioglycolate (1.0 g L-1) (Sigma-Aldrich, Steinheim, 
Germany).  
The stomach buffer consisted of KHCO3 (10.0 g L-1) (Sigma-Aldrich, Steinheim, 
Germany) and NaCl (5.8 g L-1) (Merck, Darmstadt, Germany), which once dissolved 
was brought to a pH of 1.5 ± 0.1 by adding 6 M HCl (37%) (Merck, Darmstadt, 
Germany). A universal pH-indicator (Merck, Darmstadt, Germany) was used as an 
additional control. The enzyme, pepsin (0.32 g L-1) (E.C. 3.4.23.2) (Sigma-Aldrich, St-
Louis, USA) was filter-sterilized (Filter Millex-GV, 0.22 µm, Millex, Cork, Ireland) and 
added to the stomach buffer after autoclavation of the latter, in order to prevent 
denaturation of the enzyme.  
Small intestinal buffer was made up of NaHCO3 (12.6 g L-1) (Merck, Darmstadt, 
Germany), Oxgall (6.0 g L-1) (Becton, Dickson and Company, New Jersey, USA) and 
pancreatin (0.9 g L-1) (Sigma-Aldrich, St-Louis, USA).  
The ruminal phosphate buffer comprised NH4Cl (1.4 g), Na2HPO4·12H2O (28.8 g) and 
NaH2PO4 (6.2 g), which were dissolved in 1 L of distilled water with a consequent pH of 
7 (Merck, Darmstadt, Germany). 
The BHI (Brain Heart Infusion) broth (Oxoïd, Hampshire, England) constituted out of a 
ready to use powder, which had to be dissolved in ultrapure water (37 g L-1). L-
cysteine (0.5 g L-1) (SAFC Supply Solutions, St-Louis, USA) was added for improvement 
of the anaerobiosis [21]. BHI broth was used to grow the fecal bacteria for 24h, which 
provided the needed macrobiotic culture for the large intestinal digestion. Simulator 
of the Human Intestinal Microbial Ecosystem broth (SHIME) was used as a medium for 
the actual large intestinal digestion. This medium consisted of (g L-1): arabinogalactan, 
1; pectin, 2; xylan, 1; mucin, 4 (all from Sigma-Aldrich, St-Louis, USA); potato starch, 3 
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany); glucose, 0.4 (Merck, Darmstadt, 
Germany); yeastcell extract, 3 (AppliChem GmbH, Darmstadt, Germany); peptone, 1 
(Oxoïd, Hampshire, England); L-cystein, 0.5 (Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany) [22]. Both SHIME and BHI broths were reboiled before use, regaining 
anaerobicity. 
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2.4. Digestion protocol 
The various in vitro digestive simulation protocols applied during this study were 
adapted from scientific literature on human and animal in vitro models, reporting 
simulation of the upper and lower gastro-intestinal tract of bovines and porcines 
[23,24]. Several parameters (e.g. transit time, solid fluid ratios etc.) were considered in 
order to obtain the most optimal protocol to evaluate thiouracil formation in livestock. 
However, even though care has been taken to simulate the in vivo situation to the 
best possible extent, it will never be able to copy it completely and therefore in vivo 
confirmation would still be usefull in a later stage [23]. 
 
2.4.1. Fecal inoculum 
In order to set up a large intestinal digestion simulation, a fecal inoculum is required. 
For this purpose fresh fecal matter was collected from adult female non-pregnant 
cows and sows from Ghent University, Faculty of Veterinary Medicine and from the 
Institute of Agricultural and Fisheries Research (ILVO, Melle, Belgium). The animals 
were housed according to animal welfare requirements, keeping them on a 
maintenance diet and antibiotic-free. The feces were kept at room temperature 
during transport before further processing was applied.  
Fecal slurry was obtained by addition of 1/5 (S/L) fecal phosphate buffered saline, 
which subsequently was homogenized in a stomacher for 10 min. The suspension was 
transferred into 50 mL falcon tubes and centrifuged at 500×g for 2 min. To the 
supernatant glycerol (99.5%) (Analar Normapur, Fontenay-sous-Bois, France) was 
added as a cryoprotectant at a 20% (v/v) ratio and gently mixed under atmospheric 
conditions, before storage at -80 °C [25]. 
 
2.4.2. Ruminal inoculum 
The ruminal fluid for the rumen simulation was collected before the morning feeding 
from three permanently cannulated cows (ILVO, Melle, Belgium) fed a hay-based 
diet ad libitum. Immediately after collection, samples were filtered through a metallic 
sieve (mesh width 1 mm) and, under CO2 flushing, diluted five-fold with a phosphate 
buffer at 39 ± 1 °C. The rumen fluid and buffer mixture was kept saturated with CO2, at 
39 ± 1 °C at all times. 
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2.4.3. Stomach, small intestinal and large intestinal  
   simulations 
Autoclaved penicillin flasks were supplemented with feed (3 g) or food (4 g) samples 
following a 1/25 (S/L) ratio. The stomach digestion was simulated through addition of 
acidified stomach buffer (pH 1.5 ± 0.1) in a 1/10 (S/L) ratio to the samples. The flasks 
were capped and incubated at 37 ± 1 °C, 150 RPM for 2h. Next, 5 mL g-1 of 
pancreatic fluid was added and incubated for 4h to simulate the small intestine. Next, 
the fecal inoculum was thawed and diluted with reboiled BHI in a 1/9 (S/L) ratio in an 
autoclaved dark penicillin flask. Before incubating the flasks, anaerobic conditions 
were established using a N2 flush system for 1h, at 1 bar alternating every 2 min with 
vacuum suction. The flasks were then incubated for 24h. This incubated bacterial 
inoculum was used for the large intestine digestion simulation, using 5 mL g-1 in 
combination with 5 mL g-1 boiled-up SHIME or BHI medium. Both were added to the 
small intestinal fluid flasks and flushed for 1h prior to incubation (72h) to ensure proper 
growing conditions for the anaerobic bacteria.  
Sampling of the different digestion phases was done as secure and standardized as 
possible using syringes, causing as little disturbance as possible to the bacterial 
environment. Stomach, small intestinal and large intestinal digestion fluids (at 0, 24, 48, 
72h of incubation) were gently stirred in order to homogenize before sampling.  
 
2.4.4. Ruminal digestion simulation 
The rumen digestion protocol consisted of 0.25 g or 1.0 g of freeze-dried feed, which 
was contained in a transparent 125 mL penicillin flask. Next, the flasks were flushed 
under alternating CO2-flow and vacuum suction for anaerobiosis [26,27]. Into every 
flask, 25 mL of a buffer-rumen fluid mixture was added. The internal standard ethane 
for GC-analyses was also added (1 mL) to the flasks, which were then incubated at 
39 ± 1 °C for 24h with an adapted RPM-program simulating ruminal contractions. 
Subsequently, samples were put in an ice bath causing a thermal shock to the 
bacteria inhibiting further growth. Gases (ethane, methane, hydrogen), pH, short 
chain fatty acids (SCFAs) and TU were then measured. A duplo blank sample (without 
feed) at the beginning of the digestion and another duplo blank sample, which 
endured the 24h incubation, were required to assess SCFA and TU production. 
Combining both values allowed quantification as blank levels could be subtracted 
from the measured values. 
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2.5. Sample extraction and purification 
Prior to the analysis of the digestion samples, sample preparation and clean up was 
needed. This procedure has been described elsewhere [28].  
Briefly, 5 mL of phosphate buffer (pH 8) was added to 1 mL of digest. The internal 
standard (PTU-d5) was added at 50 µg kg-1 followed by 100 µL of a methanolic 
derivatising solution containing 3-iodobenzyl bromide (2 mg mL-1). Upon 10 min 
sonication the derivatization was allowed to proceed in the dark at 40 ± 1 °C for 1h. 
Afterwards the pH of the reaction mixture was adjusted to 3.6 ± 0.1 and different 
liquid liquid extraction steps with 3, 2 and 2 mL of diethyl ether were applied. Once 
evaporated to dryness under a gentle N2 stream (2 bar, 50 ± 1°C) the samples were 
redissolved in 100 µL CH2Cl2 and 300 µL cyclohexane. Further sample clean up 
consisted of solid phase extraction with silica cartridges conditioned with 
cyclohexane and eluted with a mixture of hexane/ethyl acetate 40:60 (v/v). Again N2 
evaporation was applied. Samples were redissolved in 160 µL of 50:50 (v/v) 0.5% 
acetic acid and methanol. 
  
2.6. Instrumentation 
2.6.1. Control parameters: short chain fatty acids and pH 
Colonic samples of the full digestion were assessed for their short chain fatty acid 
(SCFAs) content. Fatty acid extraction consisted of 2 mL sample to which 500 µL of 
aqueous H2SO4 1:1 solution (Sigma-Aldrich, St. Louis, USA), 0.4 g of NaCl (Merck, 
Darmstadt, Germany), 400 µL internal standard 2-methylhexane (Sigma-Aldrich, St. 
Louis, USA) and 2 mL diethyl ether (Merck, Darmstadt, Germany) was added. Samples 
were shaken for 2 min and centrifuged for 3 min at 341xg. Next, the supernatants 
were collected for GC-analyses on a Di200 (Shimadzu, ‘s Hertogenbosch, 
Netherlands) with an EC-1000 Econo-Cap capillary column (1.2 µm x 25 m x 0.53 mm) 
by Alltech (Laarne, Belgium). A flame ionisation detector (FID) and a Delsi Nermag 31 
Integrator were used. N2 was used as a carrier gas with a flow of 20 mL min-1. Column 
temperature was set at 130 °C and the injector temperature at 190 °C. 
The rumen samples were analyzed in the Laboratory for Animal Nutrition and Animal 
Product Quality of the Faculty of Bioscience Engineering (Melle, Belgium) according 
to the specifications mentioned in Van Ranst et al. (2010) [29]. 
The pH was measured in both colonic and ruminal samples with an electrode pH-
meter (SevenEasy pH, Mettler Toledo AG, Scherzenback, Switzerland), which was 
calibrated before use. 
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2.6.2. Liquid chromatography multiple mass  
  spectrometry (LC-MS2) 
Detection of thiouracil was achieved with a liquid chromatograph coupled to a 
linear ion trap mass spectrometer [13]. A Finnigan Surveyor LC-system (Thermo 
Electron, San Jose, USA) was combined with a Symmetry C18 column at 30 °C (5 µm x 
150 mm x 2.1 mm, Waters, Milford, Massachusetts, USA) running on a 0.5% acetic acid 
(A) and methanol (B) 50:50 solvent combination at 0.3 mL min-1. The linear gradient 
passed off as follows for 35 min: A/B 50:50 for 3 min, increasing to 0:100 in 17 min, and 
finally re-equilibrating for 10 min at 50:50. The linear ion trap mass spectrometer LTQ 
(Thermo Electron, San Jose, USA) was fitted with a heated electrospray ionization 
probe (HESI) operating in the negative ion mode and positioned on 0.5; C; 0 (front-to-
back position (µm lines); probe depth (probe depth line); side-to-side position (+1 to -
1 marks). Applied working conditions were as follows: source voltage at 5 kV; capillary 
voltage at -50 V; tube lens voltage at -128.04 V; vaporizer and capillary temperature 
at 250 °C and 275 °C; sheath and auxiliary gas at 30 and 5 arbitrary units (a.u.), 
respectively. Measured transitions are reported in Table II.2. 
 
Table II.2: The monitored transitions by the LC-MS2 for 2-thiouracil and its internal 
standard, 6-propyl-d5-2-thiouracil. 
 
Analyte [M-H]- Product ions Collision energy (eV) 
2-thiouracil  343 182; 215; 309 44 
6-propyl-d5-2-thiouracil 390 127; 262; 356 30 
 
The concentrations of TU detected in digests can be regarded as screening results 
and thus should be considered semi-quantitative. For further validation data we refer 
to CHAPTER III where a CCα of 1.63 ng TU g-1 was reached in rapeseed digest with this 
method.  
 
2.7. Quality assurance 
Preceding the LC-MS2 analysis a standard mixture of the target compound and the 
internal standard were injected to check the operational conditions of the LC-MS2 
device. Identification of TU was based on retention time relative to the internal 
standard, and the ion ratios of the product ions according to the Commission 
Decision 2002/657/EC [30]. Every feed or food digestion simulation was conducted in 
three-fold and the internal standard was added prior to clean up.  
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2.8. Standard addition 
Quantification of TU in digestion samples was performed using the standard addition 
approach as described in Commission Decision 2002/657/EC [30]. Each sample was 
divided over 2 vials with analogous mass and volume. One aliquot, the unknown, was 
added with a mixture of 0.5% acetic acid and methanol (v/v) 50:50 and the other, 
the known, was enriched with an equal amount of analyte (thiouracil). The 
concentration of the addition solution was previously determined by analyzing 
thiouracil in digest samples and fitting these in a calibration curve in digestion buffer. 
Finally quantification was established through evaluation of the area ratios of the 
known and unknown samples using the standard addition approach13. 
 
2.9. Data handling 
All data processing was performed with XCalibur 2.0.7 (Thermo Fisher Scientific, San 
Jose, CA, USA). Statistical testing (Student’s-t-test, ANOVA) was carried out with 
Sigmaplot 12  (Systat Software GmbH, Erkrath, Germany) to assess significance (p-
value < 0.05) of the type of matrix (feed and food) and the applied treatments on the 
recovered TU yields. Normality and equal variance were prerequisited.  
 
 
3. RESULTS AND DISCUSSION 
3.1. Porcine digestion 
In the stomach and small intestinal fluids of the porcine simulation no thiouracil could 
be recovered within the methods detection limits. The probable absence or the 
negligible yield of TU in the stomach and the specific acidic conditions at those 
stages, might explain these findings. Reportedly, an in vitro digestion study in pigs also 
claimed natural goitrogens, including oxazolidine-thiones (OZTs), to fail to be 
detected under pepsin and small intestinal conditions [31]. The glucosinolate loss 
under in vitro peptic and small intestinal conditions in pigs ranged between 3-23% 
and 7-28%, respectively. Besides, the maximum activity of myrosinase occurred at 
moisture levels between 15% to 40% and a pH range of 3.5-8.0 [32], implying that the 
effect of plant enzyme myrosinase in the stomach is most probably negligible.  
Analysis of colonic digestion samples however did allow TU detection (Figure II.1).  
From this data it may be concluded that irrespective of the pre-treatment 
representatives of the Napus group (rapeseed variants) resulted in a significantly (p- 
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Figure II.1: Thiouracil yield (µg kg-1 dry matter ± standard error) of various foods and 
feeds in the large intestinal fluid of an in vitro porcine model (CCM: Coarse colza ‘00’ 
meal; RS: Rapeseed; RS_100: Rapeseed, 2h at 100 °C; G_RS: Grounded Rapeseed; 
G_RS_100: Grounded Rapeseed, 2h at 100 °C; BR: Broccoli; BR_100: Broccoli, 5 min at 
100 °C; CFL: Cauliflower; CFL_100: Cauliflower, 5 min at 100 °C). The Napus group (A) 
has a significantly (p-value < 0.05) higher TU yield than the Oleracea group (B) after 
72h.  
 
value < 0.05) higher TU formation compared to representatives of the Oleracea 
group (cauliflower and broccoli). This difference in TU recovery between the 
Oleracea and Napus matrices are with a high likelihood attributed to their difference 
in glucosinolate content. In parallel, evaluation of enzyme inactivation through 
cooking and/or grounding was performed to gain more insight in the availability and 
activity of the plant myrosinase. Heating at 100 °C for 2h (Napus group) or for 5 min 
(Oleracea group), could lead to denaturation of the plant myrosinase and the 
possible degradation of glucosinolates into certain by-products. It has been reported 
that unpressured heat treatments destroy myrosinase in for example Brassica napus 
seeds from 60 °C on and can cause glucosinolates to deteriorate and/or byproducts 
to evaporate [32,33]. Furthermore, grounding enables the release of glucosinolates 
and plant myrosinase from the feed, causing a hydrolysis reaction. This plant 
myrosinase has been shown to lead to TU formation in Brassicaceae feed [13]. 
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However, grounded rapeseed showed a significant TU decrease compared to the 
grounded previously cooked variant. No other significant differences were found 
between treated and untreated Brassicaceae matrices, implying that the potential 
effect of these pre-treatments did not significantly contribute to the whole of the TU 
formation. This coincides with the previous stomach fluid results, as in analogy the 
applied pre-treatments also left the TU formation unaffected. Coarse colza '00' meal 
showed a lower TU recovery compared to rapeseed, as it consists of '00' rapeseed, 
which is a rapeseed variant with already a low glucosinolate content (<25 µmol g-1) 
to start with  [34]. Besides, coarse colza '00' also undergoes grounding, hot pressing 
(80-140 °C), hexane extraction and toasting during its production process, which may 
negatively influence further TU formation upon digestion.  
During digestion, parameters including pH and volatile fatty acids were used to 
evaluate the proper digestion conditions. Short chain fatty acid recoveries in the in 
vitro large intestinal fluids approximated the known in vitro acetate > propionate > 
butyrate ratio, which in vivo approaches a 70 : 20 : 10 ratio in livestock [35,36]. Both 
volatile fatty acids and pH values were found within the physiological values for 
bacterial growth, which are substrate, species and animal dependent, as described 
elsewhere [35,37]. 
In general, for the porcine model it may be concluded that the large intestine is the 
main site of TU formation. In an ulterior research [13] identical Brassicaceae feeds and 
foods upon plant-myrosinase hydrolysis were analyzed for their TU content. In 
summary, TU was retrieved in the highest concentrations for broccoli, traditional 
rapeseed and coarse colza ‘00’ meal displayed (5.98 µg kg-1, 1.45 µg kg-1 and 1.59 µg 
kg-1, based on dry weight). Other samples yielded very low TU concentrations (<1.0 µg 
kg-1) (cauliflower, rapeseed cake) or undetectable signals (feeding cabbage, feed 
30% rapeseed ‘00’) due to background noise. When comparing these absolute 
concentrations, the here obtained TU concentrations upon digestion were up to a 
factor 10 higher depending on the matrix. This confirms the involvement of colonic 
digestion and most likely, microbial fermentation in the formation of TU. 
 
3.2. Bovine digestion  
3.2.1. Rumen digestion 
Reportedly ruminants are more tolerant to glucosinolate fermentation breakdown 
products at the ruminal level compared to other animals consuming forage brassica 
crops [38]. On that account, the capacity of ruminal microbiota to form TU at the 
ruminal level upon brassicaceae digestion was evaluated. Glucosinolate 
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fermentation was assessed through a static 24h in vitro rumen digestion with coarse 
colza '00' meal, whole rapeseed and grounded rapeseed fermentation in triplicate. 
But only when feed amounts were increased from 0.25 g dry weight (S/L = 1/100) to 1 
g dry weight (S/L = 1/25), thereby matching the S/L ratio of the intestinal digestion 
simulations, TU was detected in the rumen. Coarse colza '00' meal showed a TU yield 
of 4.43 ± 0.35 µg kg-1 dry matter and grounded traditional rapeseed of 0.35 ± 0.01 µg 
kg-1 dry matter. For whole rapeseed TU remained unfound in the rumen, most 
probably due to the low availability of this substrate to the ruminal bacteria [39,40]. 
Because increasing the feed amount might saturate the ruminal digestion system by 
increasing the organic matter in spite of the ruminal buffer mixture, the pH, produced 
gases and short chain fatty acids (SCFAs) were carefully analyzed for abnormalities 
[41,42]. All measured values approximated the normal physiological conditions 
required for ruminal fermentation, i.e. pH ranging from 6.0 to 6.8 and SCFA proportions 
within the expected ratios (i.e. acetate : propionate : butyrate between 70 : 20 : 10 
and 60 : 30 : 10) [42].  
Therefore, these results demonstrate the TU forming potential of the rumen microbiota 
under specific in vitro conditions, at relatively low concentrations (0.35 and 4.42 µg kg-
1 dry matter) as compared to the TU yields observed in the bovine colonic simulation 
for coarse colza ‘00’ meal and traditional rapeseed, respectively 7.86 and 30.96 µg 
kg-1 dry matter. 
 
3.2.2. Bovine colonic digestion  
Similar results as to the ones obtained in the porcine model appeared when 
evaluating the bovine colonic digestive suspension for TU (Figure II.2). In summary, the 
Napus group showed a significantly higher TU forming capacity compared to the 
Oleracea group, with coarse colza '00' meal exerting a significantly low TU recovery 
compared to the other traditional rapeseed treatment groups.  
The bovine model seemed equally unaffected by the inactivation treatments as 
even less significance (p-value > 0.05) was found between treated and untreated 
matrices then for the porcine model. Therefore, the observed TU yield variation is most 
probably due to variation in the microbial colonic population of these two species.  
 
The pH, with a reported in vivo median value of 7.4 [37], and short chain fatty acids 
(SCFAs), with a reported 70 : 20 : 10 ratio [36] were also observed in the bovine model. 
All obtained values were found within the excepted physiological ranges for 
digestion and bacterial growth [35,37]. 
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In general, for bovines the large intestine may, in line with porcines, be considered as 
the main site of TU formation, with a, respectively, minimal influence designated to 
the rumen.  
 
 
Figure II.2: Thiouracil yield (µg kg-1 dry matter ± standard error) of various foods and 
feeds in the large intestinal fluid of the in vitro bovine model (CCM: Coarse colza ‘00’ 
meal; RS: Rapeseed; RS_100: Rapeseed, 2h at 100 °C; G_RS: Grounded Rapeseed; 
G_RS_100: Grounded Rapeseed, 2h at 100 °C; BR: Broccoli; BR_100: Broccoli, 5 min at 
100 °C; CFL: Cauliflower; CFL_100: Cauliflower, 5 min at 100 °C). The Napus group (A) 
has a significantly (p-value < 0.05) higher TU yield than the Oleracea group (B) after 
72h. 
 
3.3. Uncovering the mechanism of TU formation in the  
         colon  
For both the porcine and bovine model, TU formation was only observed in the highly 
microbially populated areas of the digestive tract, i.e. the large intestine (both for the 
porcine and bovine model) and to a lesser extent in the bovine rumen. Therefore, the 
assumption was made that gastric and small intestinal digestions do not significantly 
(p-value > 0.05) alter the ultimate large intestinal TU concentration. Additional 
experiments were designed to further investigate the nature of TU formation in the 
large intestine.  
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Up till now the equilibrated SHIME medium had been used, which is specifically 
designed to maintain and not immediately boost the intestinal microbiota [22]. 
Therefore another broth was chosen to significantly enhance bacterial growth. In this 
case Brain Heart Infusion (BHI) broth, which is a liquid medium, very rich in nutrients 
and suitable for the cultivation of a broad range of bacteria, was the recommended 
choice [43]. In the presence of BHI broth traditional rapeseed (RS) and coarse 
colza ’00’ meal (CCM), as the highest and lowest TU producing feedstuffs from 
previous experiments, were incubated with the porcine and bovine inocula for a 
single-step large intestinal simulation. Frequent sampling (1, 3, 6, 24, 48, 72 h) allowed 
insight in the timescale of TU transformation throughout digestion for both species. 
Subsequently, a tipping point in TU formation was revealed for traditional rapeseed at 
24 h for the bovine model and at 48 h for the porcine model (Figure II.3).  
 
 
Figure II.3: Representation of the TU production (µg kg-1 dry matter ± standard error) 
upon digestion of coarse colza '00' meal and traditional rapeseed in the bovine and 
porcine sole large intestine digestion. A demonstrates a significant (p-value < 0.05) 
increase of TU at 48h of incubation compared to B, whereas at 72h C shows a slight, 
but significant, TU decrease compared to D. 
 
Coarse colza ‘00’ meal on the other hand showed a steady, but slow increase in TU 
concentration. The TU concentrations obtained through this experimental set-up were 
twice as high as compared to the previous full digestion approach, confirming the 
positive influence of the BHI medium on bacterial growth and TU formation. The 
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difference in tipping point between the porcine and bovine model is most likely 
influenced by interspecies microbial diversity and the subsequent species-specific 
fecal metabolite profile [44,45]. Human, primate and non-primate mammalian fecal 
microbial populations have been shown to be more similar to each other within the 
same species than between different host species [44]. Besides, bacterial diversity 
increases based upon phylogeny from carnivory to omnivory to herbivory, which 
might explain the variations we see between the bovine and porcine model, as one 
is omnivore and the other herbivore. Furthermore, the digestive bacterial population 
is subject to diet and therefore forced to co-diversify with their hosts eating behavior 
[44]. 
Thereupon, inter-animal variability was evaluated within one species (porcine), 
through comparison of the fecal inocula of 10 female porcines upon rapeseed 
colonic digestion. Eight animals originated (2-6; 8-10) from the Institute for Agriculture 
and Fisheries Research (Melle, Belgium) and two animals (1, 7) from the Faculty of 
Veterinary Medicine (Ghent, Belgium), both individual groups comprised animals of 
the same age, sex and were held under equal housing and feeding conditions 
(Figure II.4).  
 
Figure II.4: Inter-animal variation in porcines of TU abundance (µg kg-1 dry matter ± 
standard error) upon a sole colonic simulation of the same feed (rapeseed). 
 
TU production showed a significant (p-value < 0.05) inter-animal variation between 
the porcines even when they were kept under similar housing conditions. The 
coefficient of variance (CV%) of the TU concentrations at the beginning and the end 
of the 72h incubation amounted at 73% and 31%, respectively. These findings support 
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the bacterial involvement in TU formation, since the inter-animal differences in colonic 
bacterial composition and activities most probably are responsible for the observed 
differences in TU yield between various pigs. Microbial digestion of feed has previously 
been reported in literature to engender a high inter-animal variation in pigs [46]. 
Subsequently, confirmation of the mechanistic nature of the microbial formation of TU 
was envisaged and to this extent, the influence of autoclavation (121 °C, 1 atm, 15 
min) and filter-sterilization of the inoculum (0.22 µm), as well as, autoclavation of the 
rapeseed feed source (121 °C, 1 atm, 15 min) on TU detection was evaluated (n=3). 
The highest TU-producing porcine inoculum was subjected to different treatments in a 
colonic in vitro digestion and compared to a positive control.  
Autoclavation showed no significant TU formation, whereas TU formation with the 
filter-sterilized inoculum and autoclaved feed were left unaffected as compared to 
the control (Figure II.5).  
 
 
Figure II.5: Representation of the effects of preculturation, autoclavation and filter-
sterilization on TU formation (µg kg-1 dry matter ± standard error) during a porcine 
colonic rapeseed digestion simulation. Treatments A and B demonstrate significant 
(p-value < 0.05) TU lowering effect. 
 
This indicates that bacterial contamination of feed does not play a role in the 
conversion of Brassicaceae feed precursors to TU. Since filter-sterilization removes all 
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bacteria from the inoculum and still causes TU formation concurring with the positive 
control, the involvement of a bacterially produced extracellular secondary product, 
such as an enzyme involved in TU formation, may be presumed. In order to further 
justify this presumption another set-up compared a filter-sterilized inoculum to a 
positive control sample (n=3). In this particular case the inoculum was not pre-
enriched for 24h prior to the 72h incubation, which was the case for all previous 
digestions. Thereby, the effect of filter-sterilization (0.22 µm) on TU formation could be 
evaluated, since bacteria were removed from the beginning of the incubation. After 
72h of incubation the filter-sterilized inoculum was found to be 80% lower in TU 
concentration compared to the positive control. Based on these results attempts 
were made to evaluate whether this responsible enzyme could be the hypothesized 
bacterial myrosinase, alias ß-thioglucosidase or thioglucoside glucohydrolase (E.C 
3.2.1.147). To this end, the synthetically available glucosinolate, sinigrin, was added to 
colonic digestive fluids. If myrosinase was present in these suspensions, this would lead 
to the hydrolysis of sinigrin with loss of glucose, which then could be detected by an 
HPLC-ELSD system [13]. To this point we have been unsuccessful in achieving this 
conversion based upon ‘bacterial myrosinase’ in the digesta. But, when adding plant 
myrosinase extracted from Sinapis alba L. seeds (white mustard) to these sinigrin 
enriched digesta, glucose was detected, implying that the conversion is indeed 
possible within this matrix. However, literature reports cell-free supernatants of 
Lactobacillus agilis cultures to be incapable of sinigrin degradation [47] and implies a 
cell-associated activity for ‘bacterial myrosinase’. This cannot be correlated with our 
findings, as filter-sterilized precultured digesta were able to form TU in the absence of 
bacterial cells. Furthermore, when estimating the relative myrosinase amount, which 
could have been present in the digesta, based upon their TU yield, the calculated 
amount of bacterial myrosinase should have approximately ranged between 10 and 
30 times the amount of myrosinase administered in the research by Vanden Bussche 
et al. (2011) [13] for recovery of the same TU amounts in identical feed matrices. 
Therefore, if bacterial myrosinase had been formed in the digestion fluids sinigrin 
degradation should have taken place, subsequently causing glucose detection. 
These discrepancies indicate the likelihood that TU formation upon Brassicaceae 
digestion is independent of a myrosinase-like bacterial enzyme, but involves an 
unidentified bacterial enzyme or metabolite. 
 
In conclusion, the results obtained from this study strongly imply bacteria to be 
involved in the gastrointestinal formation and detection of TU in livestock. 
Brassicaceae digestion in bovine and porcine in vitro simulations showed detectable 
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TU levels in the large intestine for both models and in the rumen for bovines, although 
to a considerable lower extent. Besides, the influence of plant myrosinase was found 
negligible as inactivation treatments failed to significantly coherently decrease TU 
yields. On the other hand the influence of the bacterial population was quite 
important, as different TU yields were recovered for the same Brassicaceae feed 
within the same species. The bovine and porcine culture also reacted differently for 
some feeds. The agent responsible for the TU formation upon digestion of 
Brassicaceae matrices is likely to be a thermosensitive component with a cell-
independent activity, which resides extracellularly after bacterial formation through a 
fortuitous process, which is independent of Brassicaceae presence. Further 
investigation regarding this mediator involved in TU formation upon Brassicaceae 
digestion in livestock seems desirable. 
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ABSTRACT  
In recent years, the frequent detection of the banned thyreostat, thiouracil (TU), in 
livestock urine has been related to endogenous TU formation following digestion of 
glucosinolate-rich Brassicaceae crops. Recently, it was demonstrated that fecal 
bacteria upon in vitro digestion of Brassicaceae, induce TU detection in livestock 
(porcine livestock > bovines). Therefore, the present study intended to isolate and 
identify bacteria involved in this intestinal TU formation upon Brassicaceae digestion, 
and gain more insight in the underlying mechanism in porcines. Twenty porcine fecal 
inocula (gilts-multiparous sows) were assessed through static in vitro colonic digestion 
simulations with rapeseed. After derivatisation and extraction of the fecal suspensions, 
TU was analysed using LC-MS2. On average lower TU concentrations were observed in 
fecal colonic simulations in gilts (8.35 ± 3.42 SD ng g-1 rapeseed) in comparison to 
multiparous sows (52.63 ng g-1 ± 16.17 SD), which correlates with maturation of the gut 
microbial population with age. Further exploration of the mechanism, showed cell-
dependent activity of the microbial conversion and sustained TU-forming activity 
after subjection of the fecal inoculum to moderate heat over a time-span of up to 30 
minutes. Finally, nine TU producing bacteria were successfully isolated and identified 
by a combination of biochemical and molecular techniques as Escherichia coli (n=5), 
Lactobacillus reuteri (n=2), Enterococcus faecium (n=1), Salmonella enterica ssp. 
arizonae (n=1). This study demonstrates that endogenous formation of TU is 
Brassicaceae-induced and occurs under colonic conditions through a most likely 
myrosinase-like enzyme activity expressed by different common intestinal bacterial 
species. 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: endogenous thiouracil, rapeseed, static in vitro colonic digestion 
simulations, LC-MS2, DNA-sequencing, pig. 
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1. INTRODUCTION 
The continuous challenge of maintaining a safe and healthy food chain has lead to 
some remarkable findings regarding the occurrence of controlled or forbidden 
residues in animal husbandry. Generally, it was believed that the detection of 
banned substances in livestock could be attributed to fraudulous administration. But, 
in the last decade, this belief has been disputed by recurring discrepancies showing 
that certain forbidden substances, such as the thyreostat thiouracil (TU), may occur in 
animal matrices without a history of illicit administration [1,2]. This facilitates the 
incidence of possible false accusations of illicit use due to non-compliant TU results 
during national control plan campaigns, because in this case in particular no 
differentiation between exogenous administration and endogenous formation is yet 
routinely applicable. Thiouracil (TU), a thyreostatic drug of synthetic origin, has been 
forbidden [3] in animal production by the European Union more then three decades 
ago. The equivocal reason behind this decision was on one hand, the fraudulent 
slaughtering weight gain, which could be achieved through TU administration 
causing water retention in edible tissues and gut, inevitably deteriorating meat quality. 
On the other hand, the potential hazard for public health safety was taken into 
account since carcinogenic [4] and teratogenic effects had been described [5,6,7]. 
Consequently, the European Union demands from its member states to perform 
thyreostat analysis on diverse matrices (e.g. urine, meat). As a guideline a European 
Minimum Required Performance Limit (MRPL) was stipulated for the analytical 
detection of thyreostats, insuring detection of 100 µg L-1 or kg-1 in all matrices [8]. In 
recent years, analytical detection methods are capable to reach detection limits 
below 10 µg L-1 [9,10, 11]. As a result, low-level TU concentrations (< 10 µg L-1) were 
frequently detected in national control plans in urine of untreated livestock [12,13,2]. 
Because of this, the European Union Reference Laboratory set out a recommended 
concentration (RC) of 10 µg L-1 or kg-1 (urine and thyroid) for thiouracil [14], which 
may be considered as a technical guideline for laboratories involved in EU control 
plans, but has no legal constraining power.  
 
Pinel et al. [1] were the first to describe the possibility of a feed-related origin of TU in 
livestock. More specifically they discovered that digestion of Brassicaceae crops 
caused detection of TU (< 10 µg L-1) in bovine urine. Brassicaceae crops (e.g. 
rapeseed, cabbage) have been widely used in livestock feedstuffs for their cheap 
and high quality nitrogen content, especially during winter. Another well-known 
characteristic is however their high glucosinolate content [15]. Upon plant disruption 
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(e.g. chewing), glucosinolates, located in the idioblast cells of the plant, are freed 
from their vacuoles together with the plant-derived enzyme myrosinase (ß-
thioglucosidase, E.C 3.2.1.147), which is released from the parenchymatous tissue [15], 
causing various breakdown products (oxazolidine-thiones, nitriles, epithionitriles 
thiocyanates, isothiocyanates and thiourea) depending on pH [16,17]. Some of these 
breakdown products are natural goitrogenic substances affecting the thyroid 
function, e.g.: oxazolidine-thiones (goitrin), thiocyanates and thiourea [18]. Negative 
effects of glucosinolates on animal production are proportional to their dietary 
concentration [19] and the exploitability of glucosinolate-rich crops in the feed 
industry is consequently limited [15]. Subsequently, this has led to a minimisation of 
glucosinolate content of Brassicaceae crops with the development of ‘00’ - type 
plants, which have a low glucosinolate content (max. of 25 µmol g-1 at a moisture 
content of 9%) and erucic acid content (< 2% of the total fatty acid content) [20]. 
In order to confirm the possible link between glucosinolates and TU formation, the 
research by Vanden Bussche et al. [21] demonstrated that the interference of plant-
derived myrosinase was a necessity for the (in vitro) hydrolysis of glucosinolate-rich 
Brassicaceae food and feed matrices into TU. Additionally, the natural occurrence of 
TU in the urine of various domesticated animals, and humans was investigated. The 
animals displayed traces of TU, below 10 µg L-1 without any diet control [2], as for 
humans, for whom the influence of a controlled Brassicaceae diet was investigated, 
low-level TU was retrieved in 66.7% of the samples.  
Besides plant-derived myrosinase hydrolysis, bacterial hydrolysis resulting from 
intestinal microbiota has also been linked to cause glucosinolate degradation during 
digestion [22,23,24]. For example, the hydrolysis of sinigrin, an aliphatic glucosinolate, 
can be mediated by the human intestinal bacterium Bacteroides thetaiotamicron in 
gnotobiotic mice [25]. Several bacterial strains in animals have also been investigated 
for their glucosinolate degrading activity. For example, a Lactobacillus strain was 
capable of inducing a myrosinase-like enzymatic activity in vivo [26] and the 
Lactobacillus agilis R16 strain could degrade sinigrin and glucosinolates in brown 
mustard seed extracts [27]. The study by Kiebooms et al. [28] was the first to 
demonstrate in vitro that TU formation in bovines and porcines was influenced by a 
bacterial component and identified the large intestine, with its high microbial number 
and diversity [29,30], as the main transformation site. Concentrations up to 80 µg kg-1 
TU were registered in in vitro livestock digestion simulations with Brassicaceae.  
Consequently, the focus of the present study was to further inquire the potential and 
identity of the intestinal microbiota as well as the mechanisms involved in TU 
formation upon Brassicaceae digestion in livestock by conducting static in vitro 
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colonic digestion simulations in porcines, because of their high TU producing capacity 
[28].  
 
 
2. MATERIALS AND METHODS 
2.1. Reagents and chemicals 
The chemical standard 2-thiouracil (TU) was obtained from Sigma-Aldrich (St. Louis, 
USA). The deuterated internal standard for TU, 6-propyl-d5-2-thiouracil (PTU-d5), was 
obtained from Toronto Research Chemicals Inc. (North York, Ontario, Canada). Stock 
solutions of the chemical standards were prepared in methanol at a concentration of 
200 ng µL-1. Working solutions were diluted in methanol to 1 ng µL-1 for PTU-d5 and 1 ng 
µL-1, 0.1 ng µL-1 and 0.01 ng µL-1 for TU. Solutions were stored in dark glass recipients at 
4 °C. Reagents were of analytical grade (VWR International, Merck, Darmstadt, 
Germany) when used for extraction and purification purposes, and of Optima® LC-MS 
grade for LC-MS application (Fisher Scientific UK, Loughborough, UK), respectively. 
The derivatisation reagent, 3-iodobenzyl bromide (3-IBBr, Sigma-Aldrich, St-Louis, USA), 
was prepared extemporaneously (2 mg mL-1 methanol). A phosphate buffer, 
consisting of 0.2 M Na2HPO4 and 0.2 M KH2PO4 (Merck, Darmstadt, Germany) in 
deionized water, was prepared and adjusted to pH 8 with 6 M HCl. 
 
2.2. Feed and faeces sampling  
Traditional rapeseed (Brassica napus L. partim Napoleon, Institute for Agriculture and 
Fisheries Research (ILVO), Melle, Belgium) was used for the in vitro digestion 
experiments as a substrate for high TU production upon bacterial fermentation. The 
large intestinal in vitro digestion simulations required sampling of several porcine fecal 
inocula (FI). For this purpose fresh fecal matter was collected upon defecation from 
10 female gilts (< 8 months old) waiting for their first insemination [31] and 10 adult 
multiparous female porcines from the Institute of Agricultural and Fisheries Research 
(ILVO, Melle, Belgium) and Ghent University, Faculty of Veterinary Medicine (Ghent, 
Belgium). The animals were housed according to animal welfare requirements, 
keeping them on a standard antibiotic-free maintenance diet sustaining the general 
metabolism. The faeces aliquots were quickly transported at room temperature to the 
lab where further processing was performed. 
 
 
 92 Chapter III 
 
Chapter III 
	  
	   	  
2.3. In vitro large intestinal digestion  
2.3.1. Preparation of buffer, broth and agar  
Digestion broth media, agar media and phosphate buffered saline were prepared in 
ultrapure water (UPW), processed conform to the manufacturing guidelines (Sartorius 
stedim Biotech GmbH, Göttingen, Germany) and autoclaved for 15 minutes, at 
121 °C and 1 atm to ensure the absence of bacterial contamination and subsequent 
growth. Any procedure following autoclavation was performed in a laminar flow 
cabinet to prevent bacterial contamination. Autoclaved digestion broths, buffers 
and agar plates were all stored tightly sealed at 4 °C no longer than 1 month.  
Phosphate buffered saline, wherein the fresh faeces was suspended, contained 
K2HPO4 (8.8 g L-1), KH2PO4 (6.8 g L-1) (Merck, Darmstadt, Germany) and sodium 
thioglycolate (1 g L-1) (Sigma-Aldrich, Steinheim, Germany).  
Various liquid growth media were used throughout the different trials depending on 
the cultivated organisms (e.g. whole flora, specific bacterial isolates, etc.). For 
general preculturing and cultivation of porcine microorganisms, Brain Heart Infusion 
broth (BHI) (CM1135) (Oxoid Ltd., Hampshire, England) was used [28]. Specialized 
media were used for the cultivation of specific microbial strains: Sabouraud dextrose 
liquid medium (SDx) (CM0147) for fungi & yeasts, Wilkins-Chalgren anaerobe broth 
(WCh) (CM0643) for anaerobes, MacConkey broth (MacC) (CM0005) for coliforms 
and de Man Rogosa Sharpe broth (MRS) (CM0359) for lactic acid bacteria (Oxoid). 
Purified isolates were preserved as stocks containing Tryptic Soy broth (TSB) (CM131, 
Oxoid) and glycerol (1:3) (bidistilled (99.5%) (Analar Normapur VWR, Fontenay-sous-
Bois, France)) at -80 °C. Supplementary, the microorganisms were stored at -80 °C in 
strain-specific media in case of activity-loss in general medium (e.g. MRS broth for 
lactic acid bacteria). 
To improve anaerobic growth, L-cysteine (0.5 g L-1) (SAFC Supply Solutions, St-Louis, 
USA) was added [32] to liquid media, while broths were pre-reduced by boiling, 
which further reduced the oxygen content. 
For counting or isolation purposes agar media were made by adding bacteriological 
agar n°1 (LP0011, Oxoid) to the liquid broth medium of choice, which was heated 
until boiling and subsequently autoclaved.  
To count bacteria present in fecal digestions an automated spiral plater was used 
(100 µL per plate) (EddyJet, IUL Instruments, Led Techno NV, Heusden-Zolder, Belgium). 
Plates were incubated in sealed jars containing AnaeroGen (3.5 L) (AN00035) sachets 
(Oxoïd) in a number according to the size of the jar to attain anaerobicity.  
For the liquid digestion media, an N2-flushing system equipped with sterile filters and 
needles was applied to obtain anaerobicity in the sterile digestion flasks. In order to 
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control its efficacy and to determine the required flushing time, dummy digestions 
were supplemented with resazurin (2 mg L-1) (Sigma-Aldrich) and subsequently 
flushed causing extensive reduction of resazurin (blue) into resorufin (pink) and then 
hydroresorufin (colourless) over time, once anaerobic conditions were achieved [33]. 
 
2.3.2. Digestion protocol 
The protocol applied for the static in vitro colonic digestion simulations in the present 
study was adapted from scientific literature on simulations of the gastrointestinal tract 
of humans and porcines [34,35,28]. 
 
2.3.2.1. Fecal inoculum and preculturing 
Fecal slurry was attained by addition of 1/5 (S/L) phosphate buffered saline to the 
fresh faeces, followed by homogenisation in a stomacher for 10 minutes. The 
suspension was transferred into 50 mL falcon tubes and centrifuged at 500 × g for 2 
minutes. To the supernatants 20% (v/v) of glycerol (99.5%) (Analar Normapur) was 
added as a cryoprotectant. This mixture was gently blended together obtaining a 
fecal inoculum, which was then stored at -80 °C. 
Preculturing of the fecal inoculum before a 72 h in vitro colonic digestion was 
performed in BHI, unless mentioned otherwise (specialised media). Autoclaved 
penicillin flasks were filled with 36 mL of BHI broth and 4 mL of thawed fecal inoculum, 
flushed 1 h with N2 (1 bar) and incubated (Innova 42, Incubator shaker series, New 
Brunswick Scientific) at 37 °C, 150 rpm for 24 h (= FI24). 
In a few digestion experiments thawed glycerol stocks from specific strains (-80 °C) 
were directly added to the rapeseed in vitro digestion (72 h), instead of first 
preculturing them (100 µL of stock was added to 40 mL of BHI).  
 
2.3.2.2. Large intestinal simulation 
Autoclaved penicillin flasks were supplemented with rapeseed (1.6 g) following a 
1/25 (S/L) ratio. Subsequently, 40 mL of fluid was added consisting of a homogenous 
amount of FI24 precultered bacteria and BHI broth (1:1 ratio). The penicillin flasks were 
closed with vitton plugs allowing the establishment of anaerobic conditions after 1 h 
of flushing with N2. The flasks were then incubated for 72 h at 37 °C at 150 rpm. 
Sampling occurred at the beginning and at end of the incubation (0 h and 72 h). In 
some set-ups samples were taken at other times specific to the experiment (24 h, 48 h 
or FI24), or before any incubation (FI-80°C).   
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2.3.3. Digestion set-ups 
During a first digestion experiment, various porcine inocula (n=20) were incubated 
with rapeseed in order to detect a suitable high TU-producing fecal inoculum and to 
gain insight in the distribution of the occurrence of fecal TU formation. In a second 
experiment, the highest TU producing fecal inoculum was incubated both 
anaerobically and aerobically to evaluate the influence of oxygen on the in vitro 
digestion in BHI. In a third experiment, the influence of preculturing (24 h culturing 
before 72 h digestion), rapeseed addition, filter sterilization (0.22 µm, cellulose, 
Whatman™ syringe filters, Buckinghamshire, UK) and pasteurisation (60 °C for 0-10-30-
60 min) of the precultured faecal inoculum FI24 was investigated. Filter sterilisation 
included a preliminary high-speed centrifugation step (20 min at 13,292 × g) to 
effectively remove fecal sludge prior to the use of the sterile filters, preventing 
leakage and clogging. 
 
2.4. Bacterial identification  
2.4.1. Isolation of thiouracil producing bacteria 
The porcine inoculum with the highest TU production level was investigated for the 
presence of TU producing bacterial groups by using five different media upon in vitro 
rapeseed digestion: BHI as general medium (control), SDx for fungi & yeasts, WCh for 
anaerobes, MacC for coliforms and MRS for lactic acid bacteria (Oxoïd). As an 
exception 24 h preculturing of the faecal inoculum occurred in the respective 
specialised media instead of BHI, prior to the 72 h in vitro incubation with rapeseed 
(at 37 °C, 150 rpm). This porcine inoculum was also subjected to in vitro digestion with 
and without rapeseed addition. Next, both in vitro digestions were plated out in five 
different dilutions (1/10-1/100,000) on BHI and MacC agar plates (based on previous 
results: 3.3.1 Contributing microorganisms) with a spiral plater and incubated under 
aerobic (24 h) and anaerobic conditions (for 48 h) at 37 °C. Based on colony 
morphology, different colonies from the rapeseed in vitro digestion were picked and 
re-evaluated for TU formation upon rapeseed digestion. The bacterial digests 
producing TU were subsequently plated out in four dilutions (1/10-1/10,000) under the 
starting conditions (aerobic or anaerobic and BHI or MacC). Similarly the 
morphologically divergent bacterial colonies were picked and evaluated through 
rapeseed in vitro digestions for TU formation. Also these digests were plated out under 
the starting conditions, but also in the opposed redox status (aerobic/anaerobic) to 
evaluate facultative aerobic or anaerobic traits. Hereupon the macroscopically 
different colonies were picked and concurrently incubated in rapeseed in vitro 
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digestions (TU detection) and subjected to streaking onto a general medium agar 
(BHI) to create monocultures. Once pure monocultures were achieved, the bacterial 
colonies were picked for a last in vitro evaluation of TU formation (with and without 
rapeseed).  
 
2.4.2. Biochemical and genetic identification 
Purified monocultures were phenotypically characterized by Gram-staining and API® 
20E testing for preliminary identification (BioMe ́rieux, Marcy-l’Etoile, France). Isolates 
showing an observed TU concentration increase of more than 60%, when rapeseed 
was added versus when no rapeseed added to the in vitro digestion (Table III.2), 
were selected for further identification tests. 
For Gram-negative rods the oxidative-fermentative (OF) test developed by Hugh and 
Leifson [36] was applies, and of those capable to ferment glucose (indication for 
Enterobacteriaceae), a partial rpoB sequence was determined, as such sequences 
allow species discrimination within this family [37]. Total DNA was prepared according 
to the protocol of Niemann et al. [38]. The rpoB gene was amplified and sequenced 
using the primers described by Mollet et al. [37]. The PCR amplified rpoB gene 
product was purified using the NucleoFast 96 PCR Clean-up kit (Manchenery-Nagel, 
Düren, Germany). Sequencing reactions were performed using the BigDye® 
Terminator sequencing kit (Applied Biosystems, Foster City, CA, USA) and purified 
using the BigDye® XTerminator Purification Kit (Applied Biosystems). Sequencing was 
performed using an ABI Prism® 3130XL Genetic Analyzer (Applied Biosystems). 
Sequence assembly, the creation of a similarity matrix and the phylogenetic analysis 
were all accomplished with the use of the BioNumerics software 5.1 (Applied Maths, 
Sint-Martens-Latem, Belgium). The similarity matrix was based on a pairwise alignment 
using an open gap penalty of 100% and a unit gap penalty of 0%. The phylogenetic 
analysis was performed after including the consensus sequence in an alignment of 
rpoB sequences collected from the international nucleotide sequence library EMBL 
and from LMG reference strains. A resulting tree was constructed using the 
neighbour-joining method.  
Isolates identified through partial rpoB-sequencing, identification up to species level 
was not possible and therefore DNA-DNA hybridizations were performed. Template 
DNA for this method was isolated according to a modification of the procedure of 
Wilson [39]. Hybridizations were performed with DNA of a selected isolate and DNA of 
the type strain of Escherichia coli LMG 2092T (BCCM/LMG Bacteria Collection, Ghent, 
Belgium) that was identified as the closest phylogenetic species of these isolates. 
Hybridizations were performed in the presence of 50% formamide at 43 °C according 
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to a modification [40,41] of the method described by Ezaki et al. [42]. Reciprocal 
reactions i.e. isolate DNA used as probe against DNA of LMG 2092T (ATCC 25290) 
immobilized to a microplate well (A × B) and vice versa (B × A), were each performed 
in quadruplicate and the DNA-DNA relatedness was calculated from the mean value 
of A × B and that of B × A. 
Isolates potentially belonging to the lactic acid bacteria (Gram-positive, oxidase- 
and catalase-negative) were subjected to AFLP™ DNA fingerprinting (Keygene N.V., 
Netherlands) for further identification. For this application DNA was prepared using 
the method of Gevers et al. [43] with slight modifications. AFLP™ DNA fingerprinting 
was performed as reported previously [44] using the restriction enzymes EcoR I and 
Taq I and the primer combination E01-6-FAM/T11 [45]. The obtained profiles were 
compared with reference profiles of lactic acid bacteria taxa (including 
Bifidobacteria) present in a BCCM/LMG in house database using the BioNumerics 
software. Clustering of the profiles was done using the Dice coefficient and the 
UPGMA algorithm. 
 
2.5. Sample extraction and purification for thiouracil  
        detection 
Prior to the analysis of the digestion samples, sample preparation and clean up was 
needed. This procedure has been described [9]. Briefly, 5 mL of phosphate buffer (pH 
8) was added to 1 mL of digest. The internal standard (PTU-d5) was added at 50 µg 
kg-1 followed by 100 µL of a methanolic derivatisation solution containing 3-
iodobenzyl bromide (2 mg mL-1). Upon 10 minutes sonication, the derivatisation was 
allowed to proceed in the dark at 40 °C for 1 h. Afterwards the pH of the reaction 
mixture was adjusted to 3.6 (± 0.1) and different liquid-liquid extraction steps with 3, 2 
and 2 mL of diethyl ether were applied. Once evaporated to dryness under a gentle 
N2 stream (2 bar, 50 °C) the samples were dissolved in 100 µL CH2Cl2 and 300 µL 
cyclohexane. Further sample clean up consisted of solid phase extraction with silica 
cartridges conditioned with cyclohexane and eluted with a mixture of hexane/ethyl 
acetate 40/60 (v/v). Again N2 evaporation was applied. Samples were redissolved in 
160 µL of 0.5% acetic acid and methanol (50/50). 
 
2.6. Standard addition 
Quantification of TU in digestion samples was performed using the standard addition 
approach as described in Commission Decision 2002/657/EC [46]. Each sample was 
divided over 2 vials with analogous mass (m) and volume (V). One aliquot, the 
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unknown, was added with a mixture of 0.5% acetic acid and methanol 50/50 (VA) 
and the other, the known, was enriched with an equal amount of analyte (TU) 
(Vknown). The concentration of the addition solution was previously determined by 
analysing TU in digest samples and fitting these in a calibration curve in digestion 
buffer. This approximate estimation of the TU concentration was then spiked to the 
addition aliquot of each sample (ρA) giving rise to the area ratio of χknown. Finally, 
quantification was established through evaluation of the area ratios of the known 
and unknown samples using the standard addition approach [21]. 
Quantification was established using the following formula: Cunknown= χunknown Vunknown 
ρA VA /(χknown Vknown munknown - χunknown Vunknown  mknown), with munknown= mknown, Vunknown = 
Vknown and Cunknown= χunknown  ρA VA /(χknown - χunknown ). In this formula, C, ρ are 
concentrations, χ is the area ratio, V is the volume, m is the mass and A is identified 
analyte (TU). 
  
2.7. Instrumentation 
2.7.1. Liquid chromatography multiple mass  
   spectrometry (LC-MS2) 
Detection of TU was achieved with a liquid chromatograph coupled to a linear ion 
trap mass spectrometer [21]. A Finnigan Surveyor LC-system (Thermo Electron, San 
Jose, USA) was combined with a Symmetry C18 column at 30 °C (5 µm x 150 mm x 2.1 
mm, Waters, Milford, Massachusetts, USA) running on a 0.5% acetic acid (A) and 
methanol (B) 50/50 solvent combination at 0.3 mL min-1. The linear gradient passed off 
as follows for 35 minutes: A/B 50/50 for 3 minutes, increasing to 0/100 in 17 minutes, 
and finally re-equilibrating for 10 minutes at 50/50. The linear ion trap mass 
spectrometer LTQ (Thermo Electron, San Jose, USA) was fitted with a heated 
electrospray ionization probe (HESI) operating in the negative ion mode. Applied 
working conditions were as follows: source voltage at 5 kV; capillary voltage at -50 V; 
tube lens voltage at -128.04 V; vaporizer and capillary temperature at 250 °C and 
275 °C; sheath and auxiliary gas at 30 and 5 arbitrary units (a.u.), respectively. Based 
on its good in-house performance in urine and a secondary validation in digestion 
suspension, confirming these performance criteria (with a CCα of 1.63 ng TU g-1 
rapeseed, a mean recovery % of 102.73 ± 10.95 and a repeatability RSD% of 10.66), 
the method was found adequate for screening of TU in digests. Measured transitions 
are reported in Table III.1. 
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Table III.1: The monitored transitions by the LC-MS2 for 2-thiouracil and its internal 
standard, 6-propyl-d5-2-thiouracil. 
 
  
 
2.8. Quality assurance 
Preceding the LC-MS2 analysis a standard mixture of the target compound and the 
internal standard were injected to check the operational conditions of the LC-MS2 
device. Identification of TU was based on the retention time relative to that of the 
internal standard, and the ion ratios of the product ions according to Commission 
Decision 2002/657/EC [46]. Every in vitro digestion simulation was conducted in three-
fold and the internal standard was added prior to clean up (n=3).  
 
2.9. Data handling 
All data processing was performed with XCalibur 2.0.7 (Thermo Fisher Scientific, San 
Jose, CA, USA). Statistical testing (Student’s-t-test) was carried out with SPSS 21  (IBM, 
Belgium) to assess significance (p < 0.05) of TU yields. Normality and equal variance 
were prerequisited.  
 
 
3. RESULTS 
3.1. Porcine intestinal thiouracil formation 
TU detection resulting from 20 fecal porcine in vitro digestions with rapeseed ranged 
between 33.4 (± 0.1) and 80.5 (± 2.8) ng g-1 rapeseed for sows (S1-S10) and between 
3.3 (± 0.8) and 16.5 (± 3.4) ng g-1 rapeseed for gilts (G1-G10) (Figure III.1). The gilts were 
female porcines, which were about to be inseminated for the first time, whereas the 
sows were multiparous adult females. Statistical difference was proven (p < 0.001) 
between both life stages (sow-gilt) regarding their TU production upon rapeseed 
digestion. 
Furthermore, anaerobic and aerobic conditions were compared for the rapeseed-
based TU production. Under anaerobic conditions, TU production was significantly (p 
Analyte [M-H]- Product ions Collision energy (eV) 
2-thiouracil  343 182; 215; 309 44 
6-propyl-d5-2-thiouracil 390 127; 262; 356 30 
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= 0.015) higher compared to the aerobic digestion at the end of the incubation (T48), 
respectively, 55.04 ± 4.73 ng g-1 rapeseed and 17.70 ± 8.86 ng g-1 rapeseed. 
 
 
 
 
 
 
 
 
 
 
Figure III.1: Results of thiouracil (TU) production in 10 gilts (G1-G10) and 10 sows (S1-10) 
during in vitro digestive simulations with rapeseed (n=3) for 72 hours (ng g-1 rapeseed 
(mean ± SD)). 
 
3.2. In vitro colon digestion & thiouracil formation:  
         influential factors  
 
 
 
 
 
 
 
 
 
 
 
Figure III.2: Effect of filter sterilisation (FS) and pasteurisation (0-10-30-60 min at 60°C) of 
the pre-cultured fecal porcine inoculum (FI24) on thiouracil formation of a high-
producing porcine fecal inoculum during in vitro digestive simulation with rapeseed 
(ng TU g-1 rapeseed (mean ± SD)) (n=3) at the start (T0) and towards the end of the 
incubation (T72). 
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To explore the mechanism behind TU formation, a high TU producing porcine 
inoculum was exposed to either various periods (0-10-30-60 minutes) of pasteurization 
(60 °C) or filter sterilization (0.22 µm) or a combination of both prior to a rapeseed in 
vitro digestive simulation. No significant increase in TU formation could be 
demonstrated after 72h of digestion upon filter sterilisation in any combination with 
pasteurisation (Figure III.2). Pasteurisation alone did not affect the TU forming potential 
of the fecal inoculum since a significant (p = 0.048) TU increase similar to that of the 
control (p = 0.036) could be seen up to 30 min into pasteurisation (60 °C). Beyond this 
duration, variation in TU formation increased, but no significant difference in TU 
formation was noticed (Figure III.2).  
 
To identify the origin of the background TU levels prior to digestive simulation, in vitro 
incubations of BHI broth as such, non a priori cultivated fecal inoculum (FI -80 °C), FI24, 
rapeseed (RS) and autoclaved rapeseed (autocl. RS) in specific combinations, were 
performed (Figure III.3). Trace levels of TU in thawed fecal inoculum (T-80°C) prior to any 
incubation and in incubated (T72) BHI medium were observed. After 24h (FI24) of pre-
culturing the fecal inoculum (FI), a significant (p < 0.05) increase in TU concentration 
could be detected as compared to T0. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III.3: Overview of the effects on thiouracil formation of rapeseed (RS), 
autoclaved rapeseed (autocl. RS), and brain heart infusion by a whole porcine fecal 
inoculum at the start (T0) and towards the end of the incubation (T72). In addition, 
thawed fecal inoculum (FI-80°C) and precultured fecal inoculum (FI24) were evaluated 
for thiouracil formation (ng TU mL-1 (mean ± SD)) (n=3). 
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After 72h of incubation the in vitro digestion of FI24 and BHI without rapeseed 
produced similar amounts of TU compared to the same digestion respectively, with 
rapeseed and with autoclaved rapeseed. The digestions that did not contain FI24 
showed no significant increase of TU over time, except for BHI with rapeseed, which 
showed a significant (p = 0.027) but minor increase of TU compared to T0. 
 
3.3. Bacterial isolation and identification 
3.3.1. Contributing microorganisms 
To preliminary identify bacterial groups, potentially contributing to TU formation upon 
Brassicaceae digestion, the porcine fecal inoculum with the highest TU production 
level was incubated in one non-selective BHI and four group-specific broths. TU 
production was the highest in MacC (39.5 ± 1.9% TU) and MRS (25.8 ± 2.8% TU) media 
relative to the non-selective BHI (100% TU) (Figure III.4).  
 
 
 
 
 
 
 
 
 
 
 
Figure III.4: Overview of thiouracil production (%) by a high thiouracil producing 
porcine fecal inoculum in different broths (MacC: coliforms; MRS: lactic acid 
bacteria; SDx: anaerobes; WCh: fungi and yeasts) after pre-culturing prior to 
incubation (T0) and after 72 hours of incubation with rapeseed (T72) (% of TU 
abundance (mean ± SD)) (n=3). 
 
To identify and isolate TU producing bacterial species, the highest TU producing 
intestinal culture inoculum of a sow was selected for in vitro digestion, with and 
without rapeseed addition. Finally, thirteen fecal suspensions were found positive for 
TU after this process, from which only 8 digestions were selected with sufficient TU 
production ranging from 18.47 to 31.88 ng g-1 rapeseed. 
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Table III.2: Identification of thiouracil producing bacteria: thiouracil-% (TU%) increase 
between rapeseed (RS)-control digestions, morphological, biochemical and genetic 
identification (n.d: not defined; no ID: no matching identification from database). 
 
Identified 
bacterial 
species 
TU% 
increase 
(with vs. 
without 
RS) 
Cell 
morphology 
Gram 
stain 
Oxidase Catalase Fermentative Identification procedures 
   API® 20E Genetic 
identification  
E. coli 
 
88.1 
 
rods (0.7x1.0-
1.8 µm), single, 
pairs, 
nonmotile 
- - + + no ID rpoB sequence 
analysis, 
DNA-DNA 
hybridization 
(ATCC 25290): 
Escherichia coli 
E. coli 31.8 rods - n.d. n.d. n.d. E. coli 1 
(98.8%) 
n.d. 
E. coli 90.6 rods (0.9x1.5-
5.0 µm), single, 
pairs, 
nonmotile 
- - + + E. coli 1 
(88.3%) 
rpoB sequence 
analysis, 
DNA-DNA 
hybridization  
(ATCC 25290): 
Escherichia coli 
E. coli 26.5 rods - n.d. n.d. n.d. E. coli 1 
(88.3%) 
n.d. 
Salmonella 
enterica ssp. 
arizonae 
62.4 rods - n.d. n.d. n.d. Salmonella 
enterica ssp. 
arizonae 
(99.1%) 
n.d. 
E. coli 89.6 rods (0.9x1.5-
10 µm), single, 
pairs, 
nonmotile 
- - + + Enterobacter 
cloacae 
(38.8 %) 
rpoB sequence 
analysis, 
DNA-DNA 
hybridization  
(ATCC 25290): 
Escherichia coli 
L. reuteri 93.7 rods (1.0x1.5-
3.0 µm), single, 
pairs, 
nonmotile 
+ - - / no ID AFLP™: 
Lactobacillus 
reuteri 
L. reuteri 89.4 rods (1.0x1.5-
3.0 µm), single, 
pairs, 
nonmotile 
+ - - / no ID AFLP™: 
Lactobacillus 
reuteri 
E. faecium 82.87 cocci Ø 0.9 
µm, single, 
pairs, short 
chaines, 
nonmotile 
+ - - / Pantoea spp. 
1 (48.9%) 
AFLP™: 
Enterococcus 
faecium 
 
Next, 12 pure monocultures were achieved and investigated using API® 20E. Only four 
of these isolates could be identified directly based on the APIweb™ database: three 
as Escherichia coli (ID%: 98.0% - 88.3% - 88.3%) and one as Salmonella enterica ssp. 
arizonae (ID%: 99.1%). From the remaining isolates, 3 were not further enquired, 
because they were not producing high amounts of TU. The remaining five isolates 
showed an observed TU concentration increase of more than 80% when rapeseed 
was added to the in vitro digestion in comparison to when none was added (Table 
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III.2). These isolates and a previously by API identified E. coli representative (90.6 TU% 
increase) were selected for further identification.  
 
Three isolates were identified as Escherichia spp., probably E. coli based on rpoB 
gene sequence analyses, while three others were identified as lactic acid bacteria 
(one as Enterococcus faecium and two as Lactobacillus reuteri) based on AFLP™ 
DNA fingerprinting. One representative Escherichia isolate was additionally 
investigated through DNA-DNA hybridization. DNA of this isolate was compared with 
DNA of the type strain of E. coli LMG 2092T) and 75% DNA-DNA relatedness was found, 
which is above 70%, the value generally regarded as the limit of species delineation 
(47). Therefore, the Escherichia isolates were confirmed to belong to E. coli. In total, 
nine isolates were identified at the species level through the different identification 
procedures (Table III.2). Their respective TU increase upon rapeseed in vitro 
incubation is presented in Figure III.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III.5: Recovered thiouracil concentrations (ng g-1 rapeseed (mean ± SD)) during 
pre-cultured in vitro incubations with rapeseed (n=3) of the 9 identified TU producing 
isolates (Enterococcus faecium, Escherichia coli (a-e), Lactobacillus reuteri (a-b), 
Salmonella enterica ssp. arizonae) at the start (T0) and towards the end of the 
incubation (T72). 
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To elucidate precursors in the substrate of microbial TU formation, Lactobacillus reuteri 
and Enterococcus faecium, as high and low TU producing representatives (Figure 
III.5) were exposed to various (rapeseed, autoclaved rapeseed and no rapeseed) 
incubations. For both bacteria a similar pattern was observed with significantly (p < 
0.05) higher TU concentrations when rapeseed was added as compared to 
autoclaved rapeseed and control (no rapeseed) incubations (Figure III.6). TU 
concentrations in autoclaved rapeseed incubations were not significantly (p > 0.05) 
different from the controls. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III.6: Influence of rapeseed on thiouracil production (ng g-1 (mean ± SD)) upon 
in vitro incubation (n=3) with purified Lactobacillus reuteri and Enterococcus faecium 
(not precultured). 
 
Thereupon, Lactobacillus reuteri, Enterococcus faecium and also Escherichia coli 
were plated onto BHI agar and onto the more selective agars: MRS (Lactobacillus 
reuteri, Enterococcus faecium) and MAcC (Escherichia coli), for enumeration after 
incubation with and without rapeseed, without preculturing the organisms to 
evaluate whether the bacteria developed sufficiently over time and rapeseed 
influenced bacterial growth. Results showed the log10 ranged between 7 - 9 mL-1 at 
T72. No significant difference was found between rapeseed and control incubations 
regarding bacterial counts, except for L. reuteri, which had a positive significant (p < 
0.05) increase in bacterial count in the rapeseed digestion (8.23 ± 0.35 log10 mL-1) 
compared to the control (7.11 ± 0.35 log10 mL-1) digestion.  
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4. DISCUSSION 
In the present study, 9 cultures belonging to four different bacterial species, E. coli, E. 
faecium, L. reuteri and Salmonella enterica ssp. arizonae were isolated from porcine 
feces and identified as involved in the production of the banned thyreostat thiouracil 
upon rapeseed incubation. The mechanism bringing about endogenous thiouracil 
was further enquired by altering digestion parameters, providing strong evidence that 
an extracellular membrane-bound bacterial enzyme (myrosinase-like) formed under 
anaerobic conditions and the addition of rapeseed were pivotal in this process. 
 
The in vitro microbial intestinal TU formation observed in this study, was significantly 
different between porcine life stages. It has indeed been reported that the diversity 
of the intestinal microbiota in pigs increases with age [48,49,50], which could explain 
the higher TU producing fecal inocula derived from elder sows. Moreover, the 
presence of E. coli and Lactobacillus sp. [48,50] has been described as lower in 
young pigs. For E. coli specifically, Katouli et al. [51] showed the mean number of 
biochemical phenotypes in piglets increased as animals aged and sows normally had 
a higher number of biochemical phenotypes than their offspring. They subsequently 
reported that the dominant E. coli strains in piglets are quite different from those of 
their sows. Therefore, the number of different intestinal bacterial strains might 
potentially be important to intestinal TU formation, as well as, the present dominant 
types of a strain [51]. These findings suggest that colonic bacterial fermentation 
significantly contributes to the prevalence of endogenous thiouracil in livestock urine. 
Of course, relating these findings to in vivo data remains difficult. It is however likely 
that naturally formed thiouracil residues are excreted in urine upon absorption 
through the intestinal tract, which has been previously observed in vivo with below 10 
ppb TU concentrations upon Brassicaceae feeding in bovines [1]. Orally administered 
thyreostatic drugs have been reported to rapidly occur in urine and reach a 
cumulative total of 6.49-16.7% of the administered dose within 24h in rats [52]. 
Whether this excretion rate based on oral administration is also applicable to the 
excretion of intestinally formed TU remains to be investigated.  
Notwithstanding, the detection of TU in urine samples of livestock is a widespread 
phenomenon, but urinary residues are not consequently recorded in every animal. A 
survey study from national control plan data in France recalled 32% of TU positive 
samples in bovines (n=1089) and 80% in porcines (n=201) [53]. This study showed that 
concentrations of TU were higher in bovines than in porcines considering only 
porcines between 1 and 8 months old, which from our results show significantly lower 
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TU producing potential in vitro. In a Polish survey only 14% bovines (n=279) and 13% 
pigs (n=258) tested positive for TU, but no age categories were mentioned here [54]. 
In this context, the influence of age, gender and in a minor way country on the 
determination of a potential TU threshold value have been described in vivo [53,54]. 
 
To propose a mechanistical explanation for TU formation upon Brassicaceae 
digestion, a high producing porcine intestinal inoculum was evaluated under variable 
in vitro conditions. The use of various selective media pointed towards the 
involvement of coliform and lactic acid bacteria, which are abundantly present in 
the gut microbial communities of pigs [55,29]. Moreover, further elucidation of the 
influence of redox conditions sustained the fact that anaerobic microorganisms 
outnumber aerobic bacteria by at least a factor 3 to 5 log10 [49] in the intestinal 
environment of pigs. This explains the lower TU concentration monitored under 
aerobic conditions. Filter sterilisation showed no increase of TU concentration upon in 
vitro digestion, providing evidence for the requirement of (active) bacterial cells for 
TU formation to take place. Background TU traces present prior to incubation may be 
attributed to the pre-culturing of bacteria in the presence of other fecal constituents. 
During this period, the fecal inoculum can metabolize any feed-related remains, 
which are inherently present in the fecal suspension, consequently resulting in the 
production of TU. Indeed, when no pre-culturing was applied, TU formation was 
marginal. Pasteurisation of the pre-cultured inoculum did not significantly affect TU 
formation. It has been described that E. coli can survive at 60 °C up to 30 minutes 
depending on strain and surrounding matrix [56]. At 55 °C, inactivation is only 
achieved after 60-120 minutes in broth [56]. Although heat-treated microorganisms 
generally do not grow on agar, they can succeed in repairing damage and regain 
their potential for growth under optimal broth conditions [56]. Such events might 
explain the undisturbed TU production over the first 30 minutes of pasteurisation, while 
after 60 min bacterial survival is unlikely due to irreversible damage. In the assumption 
that the responsible (bacterial) mediator is a membrane-bound protein (myrosinase-
like enzyme), heat treatment would likely cause some degree of denaturation over 
time, but semi-reversible denaturation has been reported [57]. Moreover, β-
thioglucoside glucohydrolases remain active in a broad range of temperatures (up to 
60 °C) and pHs (5-10) [58], offering an explanation for sustained TU production upon 
pasteurization and supporting the potential hypothesis of an extracellular membrane-
bound myrosinase-like enzyme as mediating factor for TU formation. 
 
 Chapter III 107 
 
Chapter III 
	  
	   	  
The identified bacterial isolates with a TU forming ability include some of the most 
prevalent intestinal bacteria, i.e. lactobacilli, coliforms and enterococci populating 
the intestine of pigs [49,59]. Since these bacteria are common residents of the 
intestine, in many animal species, the occurrence of TU in urine of several animal 
species as reported earlier, may be easily explained [2]. Enterococcus faecium is 
known as the most prevalent Enterococcus sp. in porcines [60] and has also been 
described to metabolize glucosinolates in vitro [61]. Both Lactobacillus sp. and 
Enterococcus sp. have been demonstrated to express ß-thioglucosidase activity [62]. 
In a study with rats transfaunated with Lactobacillus sp. (LEM 220) and fed with 
rapeseed meal, an increased goitrogenicity was observed as compared to germ-
free rats [26,63]. Similar results were obtained in gnotobiotic E. coli (EM0) mice, when 
fed rapeseed meal [64]. Moreover, degradation of progoitrine, a precursor of goitrine 
(natural thyeostat), by E. coli [65] and the glucosinolate sinigrin by L. agilis (R16) [27] 
have also been described. Specifically in rodents, pigs and chickens, L. reuteri is one 
of the dominant species in the gastrointestinal tract [66]. This lactic acid bacterium 
has the capacity to form reuterin, an antimicrobial agent, and has therefore been 
proposed as a potential additive for pelleted feeds in pigs [67]. Two of the 
prerequisited characteristics for pelleting was resistance to 70 °C for 10 seconds and 
to gastric and intestinal pHs. Previously known as S. choleraesuis ser. arizonae, the 
later renamed S. enterica ssp. arizonae, has been isolated from reptiles, fowl, turkeys, 
ducks, dogs, cats, monkeys, goats, wild boars and lately from pigs [68], but no 
glucosinolate degrading or myrosinase-like capacities have been described yet for 
this taxon. 
 
To confirm Brassicaceae feed as the source for TU formation, L. reuteri and E. faecium 
as high and low TU producing bacteria, respectively, and a high TU producing 
porcine fecal inoculum were selected for incubations. Autoclaved rapeseed and 
control incubations with pure strains did not differ significantly in TU concentrations. 
Addition of rapeseed as a whole did however significantly increase TU formation 
upon incubation with pure strains, reassuring its importance as a source of TU 
precursors in line with previous in vitro [28] and in vivo [1] reports. During in vitro 
digestion with the high producing porcine fecal inoculum, TU formation did not 
significantly differ between autoclaved and non-autoclaved rapeseed administration. 
This may be explained by the prior assumption that fecal constituents present in the 
inoculum can act as precursors for TU formation when no rapeseed is added. Indeed, 
in literature it has been described that 60% of the glucosinolate content of feed 
reaches the colon unaltered in pigs and although these are mostly degraded prior to 
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defecation, many breakdown products are present in feces [69]. The autoclaved 
rapeseed and control in vitro digestions produced equal amounts of TU upon 
incubation with fecal inoculum and pure strains. Autoclaved, and thus sterile and 
possibly denaturated rapeseed may not contain the required precursors and as a 
result not differ significantly from absence of rapeseed. Oerlemans et al. [70] reported 
that at temperatures above 110 °C substantial breakdown of all glucosinolate groups 
was observed, which may also be the case during autoclavation (121 °C). Besides, it 
is possible that the rich BHI medium, which consists out of animal tissues (brain, heart), 
is additionally responsible for low TU levels in bacterial incubations without rapeseed 
or autoclaved rapeseed, since it has been reported that 2-thiouracil can be found in 
tRNA of E. coli and that N-glucosidases from E. coli extracts are able to cleave uracil 
free from DNA, which is one of its building blocks [71].  
 
Finally, the influence of the substrate (rapeseed) was evaluated on bacterial growth 
through enumeration of some of the pure strains, to assure that increased bacterial 
growth was responsible for enhanced TU formation and not feed itself. Indeed, it has 
been described that certain hydrolysis products from various Brassica crops exert in 
vitro inhibiting influences on bacterial growth of Enterobacteriaceae and certain 
Enterococci in pigs [72]. In this study however, no negative effects on bacterial 
growth were observed as a result of rapeseed administration for E. coli and E. 
faecium. In contrast, for L. reuteri minor growth stimulation was observed when 
rapeseed was added. 
The absence of effect of rapeseed on bacterial growth and its restricted growth 
stimulation in case of L. reuteri may be explained by the variety of glucosinolates 
present in rapeseed, which are mainly of aliphatic origin. In the study by Saavedra et 
al. [72] the effect of glucosinolate hydrolysis products on intestinal bacteria in pigs 
was investigated. Mainly indolic and aromatic glucosinolates, but also two aliphatics 
(sinigrin and glucoraphanin) were considered. Depending on the type of hydrolysis 
product, its concentration, as well as, the type of bacteria, which was exposed to it, 
the inhibiting effect can be hampered. From these results, it may be concluded that 
TU formation is directly related to the presence of rapeseed feed and its inherent 
glucosinolates and/or degradation products thereof, but other sources of TU 
precursors may not be excluded. 
In summary, fecal inocula of porcines in two different physiological stages of their life 
were screened for their capability to produce the banned thyreostat thiouracil upon 
rapeseed digestion, resulting in the observation of an age-increasing microbial 
capacity to produce TU. Furthermore, 9 TU forming bacteria were isolated from a 
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high-producing sow and identified as belonging to the species Escherichia coli, 
Enterococcus faecium, Lactobacillus reuteri and Salmonella enterica ssp. arizonae. 
Moreover, the mechanism behind this bacteria-mediated formation was tentatively 
characterised, demonstrating that a cell-dependent, membrane-bound, moderate 
heat resistant (60 °C up to 30 min) enzyme was involved. In addition, it may be 
concluded that rapeseed as a feed can be considered as a possible source of TU 
precursors, sustaining the hypothesis that glucosinolates subjected to a bacterial 
myrosinase-like enzyme activity from the basis of this observation. These new insights 
in endogenous TU formation in livestock, offer a mechanistical explanation for its low-
level observation, but foremost reinforce the need for a more tailored EU legislation. 
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ABSTRACT 
The use of thyreostatic drugs, like thiouracil (TU), in animal production has been 
banned for over three decades by the European Union, due to potential teratogenic 
and carcinogenic effects of its residues upon human consumption. Besides, 
thyreostats induce water retention in livestock, causing fallacious weight gain and 
deterioration of meat quality. Development of more competent analytical methods 
gave rise to sporadic TU detection in urine of untreated animals, questioning the 
actual synthetic origin TU. Research showed that TU can be formed upon digestion of 
Brassicaceae feeds in vivo and in vitro, which called for a means of differentiation 
between endogenous formation of TU and illicit administration. Therefore, in the 
present study, a routinely applicable LC ion trap MS2 method for TU analysis in animal 
feeds was optimized and validated, according to CD 2002/657/EC. A fractional 
factorial Placket-Burman design was used to optimise the extraction procedure for TU 
from Brassicaceae and non-Brassicaceae feeds. This resulted in the discrimination of 5 
influential factors (amount of feed, myrosinase, pH 7 buffer, 3-iodobenzyl bromide 
and elution solvent), for which the most optimal conditions were perfected. The limit 
of quantification for TU amounted 0.5 ng g-1. The individual recoveries for TU ranged 
between 90.9 and 99.7%. Good results for repeatability and intra-laboratory 
reproducibility (RSD%) were observed, i.e. respectively ≤ 6.0% and ≤ 5.2% for TU. 
Excellent linearity was proven based on determination coefficient (R2 ≥ 0.99) and 
lack-of-fit test (F-test, α=0.05). 
Subsequently, a selection of feeds sampled during European national monitoring 
campaigns were evaluated with the present method showing concentrations 
ranging from 0.32-20.60 ng g-1, demonstrating the relevance of the method in the 
analysis of TU from animal feeds.  
 
 
 
 
 
 
 
 
 
 
Keywords: thiouracil, animal feed, Plackett-Burman design, Liquid Chromatography 
ion trap MS (LC-MS2) 
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1. INTRODUCTION 
Thyreostats, like thiouracil (TU), are thyroid-inhibiting compounds of synthetic origin, 
which once administered cause a decrease of thyroid hormone production. Because 
of their association with illegal fattening in animal production and the subsequent risks 
of potential teratogenic [1-3] and carcinogenic effects (2B substance) [4] of their 
residues for public health, thyreostats have been banned in the European Union (EU) 
for over three decades [5]. More recently, the exclusively synthetic origin of 
thyreostats was questioned due to the sporadic, but systematic detection of low-level 
concentrations in livestock urine during national control campaigns all over the EU [6-
8], facilitated by better analytical methods [9-11] able to quantify concentrations 
below the set minimum required performance limit (MRPL) of 100 µg L-1. A first in vivo 
trial performed by Pinel et al. (2006) [12] demonstrated the endogenous origin of 
urinary TU resulting from digestion of glucosinolate-rich crops belonging to the 
Brassicaceae family. Consequently, the European Union reference laboratories (EURL) 
issued a reference document [13] suggesting low-level TU concentrations below 10 
ng g-1 were most probably originating from feed and should thus be regarded as 
compliant. 
Brassicaceae crops have been widely used in animal production because of their 
inexpensive high protein content. Nevertheless, these crops are also known for their 
high content in glucosinolates, which are secondary plant metabolites involved in the 
plant’s defence against tissue damaging pests [14]. The catabolism of glucosinolates 
as a consequence of cell disruption (e.g. chewing) followed by interaction with the 
plant-derived myrosinase (ß-thioglucosidase, E.C 3.2.1.147) [15], hydrolysis or bacterial 
digestion in the gut [16-19], results in various degradation products (oxazolidine-
thiones, nitriles, epithionitriles thiocyanates, isothiocyanates, thiourea) depending on 
specific pH conditions [20,21].  
Some of these glucosinolate-derived decomposition products own natural 
goitrogenic properties thereby negatively affecting the thyroid function, e.g.: 
oxazolidine-thiones (goitrin), thiocyanates and thiourea [22]. Others, like 
isothiocyanates, are responsible for bitterness [23,24], whereas nitriles can cause 
behaviour abnormalities (alteration in reflex behaviour, increased locomotor activity, 
circling, head twitching and occasional backward pedalling) [25]. Even more 
adverse effects can be caused by glucosinolate metabolites including besides 
goitrogenicity [22,26-28] also mutagenicity, hepatotoxicity and nephrotoxicity [25,29]. 
Negative effects of glucosinolates on animal production and growth are proportional 
to their dietary concentration [30] and therefore intimately related to their 
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exploitability in the feed industry [31]. Subsequently, this has led to the minimisation of 
glucosinolate content of Brassicaceae crops through genetic and breeding means 
with development of the ‘00’-type plants, which have a low glucosinolate content 
(max. of 25 µmol g-1 at a moisture content of 9%) [32]. Additionally, TU has been 
detected in the urine of untreated animals (porcine, bovine, ovine, canine, equine) 
and humans, who were not subjected to a Brassicaceae enriched diet. This illustrates 
the ambiguity of the problem since TU can be present, regardless of TU treatment or a 
Brassicaceae enriched diet [15]. 
 
The ability to determine whether the feed itself, Brassicaceae enriched or not, may 
contain endogenous TU levels, prior to oral consumption and gastro-intestinal 
digestion, would be a valuable tool to elucidate causal factors for the presence of 
endogenous TU. To the best of our knowledge, no such validated and routinely 
applicable method has been described, based upon a statistically optimised 
extraction procedure for thiouracil in both Brassicaceae and non-Brassicaceae 
feedstuffs. 
Therefore, the focus of the present study was to optimize a feed extraction procedure 
for TU using a fractional factorial design (Plackett-Burman) to elucidate the factors 
influencing the extraction, which subsequently could be optimized in a Central 
Composite Face (CCF) design. Moreover, this allows a quicker and more cost-
effective optimization, compared to one-at-the-time experiments. Validation of the 
ion trap mass spectrometrical method (LC ion trap MS2 detection) was performed 
according to CD 2002/657/EC [33]. Finally, its practical applicability was evaluated 
through analysis of several feed samples, which were sampled during the Irish 
national control campaign (2012-2013). 
 
 
2. MATERIALS AND METHODS 
2.1. Reagents and chemicals 
The chemical standard 2-thiouracil (TU) was obtained from Sigma-Aldrich (St. Louis, 
USA). The deuterated internal standard for TU, 6-propyl-d5-2-thiouracil (PTU-d5) was 
obtained from Toronto Research Chemicals Inc. (North York, Ontario, Canada). Stock 
solutions of the chemical standards were prepared in methanol at a concentration of 
200 ng µL-1. Working solutions were diluted in methanol to 1 ng µL-1 for PTU-d5 and 1 ng 
µL-1, 0.1 ng µL-1 and 0.01 ng µL-1 for TU. Solutions were stored in dark glass recipients at 
4 °C. Reagents were of analytical grade (VWR International, Merck, Darmstadt, 
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Germany) when used for extraction and purification steps, and of Optima® LC-MS 
grade for LC-MS application (Fisher Scientific UK, Loughborough, UK), respectively. 
The derivatisation reagent, 3-iodobenzyl bromide (3-IBBr, Sigma-Aldrich, St-Louis, USA), 
was prepared extemporaneously (2 mg mL-1 methanol). The phosphate buffer, made 
up of 0.2 M Na2HPO4 and 0.2 M KH2PO4 (Merck, Darmstadt, Germany) in deionized 
water, was prepared and adjusted to pH 8. The phosphate buffer pH 7 was made up 
in a similar way with 0.5 M Na2HPO4.H2O and 0.5 M KH2PO4. 
 
2.2. Feed samples  
The animal feeds selected for optimisation were affiliated to the Brassicaceae family, 
as they are known for their high glucosinolate content. However, nowadays only ‘00’ 
varieties are used for consumption (human-animal) due to the anti-nutritional effects 
they may cause. Therefore, a ‘00’ rapeseed derivate was chosen as the 
Brassicaceae representative. Additionally, a non-Brasscicaceae cattle feed, which 
consisted mainly of 40% linseed cake, and 20% of rolled barley and spelt (dinkel), was 
used as a blank. The 22 feed samples from the Irish national control plan campaign 
are presented in Table IV.3. Feeds were homogenised using a blender starting from a 
100 g homogenous subsample and subsequently stored in dry and dark conditions at 
4 °C.  
The myrosinase enzyme was extracted from white mustard seed (Sinapis alba L.) 
supplied by a local supplier (Mostaardfabriek Oud Huis Ferdinand Tierenteyn bvba., 
Deinze, Belgium), referred to as ‘Myro A’. To evaluate the activity of the extracted 
myrosinase, it was matched to a previous report by Vanden Bussche et al. (2011) [15], 
which compared the activity of extracted myrosinase from mustard seeds with 
synthetic myrosinase, and saw no significant differences. Moreover a mustard seed 
subsample from the supplier of Vanden Bussche et al. (2011) [15], was also 
investigated (‘Myro B’). 
 
2.3. Optimization of sample extraction and purification 
A statistical model design was used to optimize the analytical extraction procedure 
of thyreostats in animal feed. The dependent variables that might significantly affect 
the extraction efficiency were screened with a Plackett-Burman design, which is a 
fractional factorial design. Further optimization of the selected variables was 
performed with Response Surface Modeling (RSM) (i.e. Central Composite Face 
design (CCF)). In general, a fractional factorial design is a good screening approach 
since the amount of variable scenarios (trials) produced by such a model, is 
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significantly lower than that for full factorial designs. Unlike, full xk factorial designs, 
which require all combinations of x versions of each of k variables, a fractional 
factorial design only needs xk-1 [34].  
The variables that might influence the extraction of thyreostats from animal feed were 
selected from previous scientific work on the extraction of thyreostats from various 
matrices [9,15,35-39]. First a Plackett-Burman design investigated the extraction 
protocol based on non-Brassicaceae cattle feed fortified with TU. Secondly, coarse 
colza ‘00’ meal belonging to the Brassicaceae was evaluated without any TU 
fortification, thus evaluating the effect of myrosinase addition on the extraction 
procedure of TU. The 9 quantitative and 2 qualitative factors and their respective 
levels are presented in Table IV.1.  
For each feed, 12 experimental runs plus 3 central value runs sufficed to specify a 
particular combination of settings for the different variables included in the design. 
After performing the prescribed scenario on non-Brassicaceae and Brassicaceae 
feeds, the main effects of each variable were calculated. After a proven statistical 
significant analysis (p < 0.05), the critical variables (feed, 3-iodobenzyl bromide, buffer 
pH 7, elution volume) were subjected to further optimization along with the 
myrosinase variable since it had, as the above variables, a Variable Importance for 
Projection (VIP) value > 1 by response surface methodology. To this extent, a Central 
Composite Face (CCF) design was used, where star points, which represent runs 
where all but one of the factors are set at their mid-levels, are placed on the faces of 
the design matrix. This is a full two level full factorial approach enabling evaluation of 
interactions between levels. If a factor proved to be non-critical, the best level, 
according to its effect, was chosen. Generally, this will be the least time-consuming, 
cheapest or most result-effective level of the factor, which is then built into the 
protocol [40]. Based upon these results a final protocol could be assembled for 
thyreostat extraction from feed. 
The software program Modde 5.0 (Umetrics, Umea, Sweden) was used to build the 
experimental design matrix and carry out data analysis. The parameters were inserted 
into the program and depending on the purpose of the analysis (screening or RSM), 
the most adequate model was proposed by the program. Evaluation of the models 
was done through a one-way variance analysis (ANOVA) test. Significance was 
proven when p-values were smaller than 0.05. 
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Table IV.1: Plackett-Burman factors with their specific lower and upper limits for the 
optimization of the extraction of thiouracil from animal feed, respectively applied to 
non-Brassicaceae and Brassicaceae (coarse colza ‘00’ meal) feeds. 
 
 
2.4. Myrosinase preparation 
Myrosinase enzyme used in the optimisation of the extraction protocol was adopted 
from Wrede (1941) [41] as mentioned in Vanden Bussche et al. (2011) [15]. Briefly, 5 g 
of mustard seeds were grounded with 30 mL of ultrapure water. Subsequently, the 
homogenous suspension was stirred for 30 min at room temperature and centrifuged 
for 10 min at 12000 × g. To the supernatant an equal volume of 90% ethanol was 
added dropwise, whilst vortexing. After centrifugation the precipitated plaque was 
washed dropwise with 10 mL of 70% ethanol and centrifuged. The remaining 
precipitation was then redissolved in 5 mL of ultrapure water, containing 
approximately 20 mg mL-1 of the enzyme [42]. 
 
2.5. Control of myrosinase enzymatic activity 
The enzymatic activity of myrosinase was checked prior to use in order to verify the 
activity was not significantly different from the activity described in Vanden Bussche 
et al. (2011) [15], which used this enzymatic procedure in the extraction of feed. 
Glucose was detected, as it is the by-product of the unimolecular reaction between 
myrosinase and the commercially available glucosinolate sinigrin (Sigma-Aldrich, St. 
Louis, USA). To this end, a buffer pH 7 was made up from 0.1 M ammonium acetate 
and 0.025 M ammonium bicarbonate and added with 34 mM of sinigrin. Then, in a 
first experiment 1.5 mL of buffer was incubated for 4 h at 37 °C with 0-0.5-1 mL of 
freshly made-up myrosinase solution (n=3) either from the ‘Myro A’ or ‘Myro B’  (from 
the supplier of Vanden Bussche et al. 2011 [15]) mustard seeds. The hydrolysis reaction 
PB design  Variables Level 1 Level 2 
Qualitative  Liquid-liquid solvent Diethyl ether Ethyl acetate 
 Centrifugation speed 2625 × g 5907 × g 
Quantitative  Feed  0.5 g 2 g 
 Buffer pH7  5 mL 15 mL 
 Myrosinase 0 mL 0.5 mL 
 Buffer pH 8  5 mL 15 mL 
 Derivatisation (3-IBBR)  100 µL 1000 µL 
 Liquid-liquid volume  5 mL 10 mL 
 Conditioning volume  10 mL  20 mL 
 Wash volume  5 mL 10 mL 
 Elution volume  5 mL 10 mL 
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was stopped through boiling of the samples for 5 min and glucose was subsequently 
detected with HPLC-ELSD (high performance liquid chromatography coupled to 
evaporative light scattering detection) [15,43] with a gain factor of 2. Quantification 
was performed based on a buffer calibration curve (0, 0.25, 0.5, 1, 2.5, 5, 7.5 and 10 
mg mL-1). 
The quality control showed glucose production was similar (p > 0.05) at 0.5 and 1 mL 
for both mustard seeds. The concentrations were in relation with previous results 
proving a sufficiently high enzymatic activity was present to extract TU from feed 
matrices [15].  
A second experiment evaluated the effect of increasing the myrosinase amount on 
the detection of TU from coarse colza ‘00’ meal. Myrosinase solution (0-0.5-1-1.5-3 mL) 
was added to the extraction prior to the 1 h sonication and subsequent overnight 
incubation [44]. The increasing myrosinase amount 
s showed a significant (p < 0.05) decreasing trend for TU detection from feed.  
Therefore, from these control experiments, the conclusion was drawn that the 
extracted myrosinase used in the extraction optimization was of good quality and 
had sufficient enzymatic activity [15]. Moreover, an increasing amount of myrosinase 
did not increase the detection of TU, therefore a 0-0.5 mL range of myrosinase 
solution was chosen in the PB evaluation for Brassicaceae and non-Brassicaceae 
feeds. 
 
2.6. Final extraction protocol 
Feed samples were prepared using the final protocol resulting from both Plackett-
Burman designs on Brassicaceae and non-Brassicaceae feed. The extraction started 
with 10 mL of phosphate buffer (pH 7), which was added to 0.25 g of feed followed 
by vortexing, 1h of sonication and an overnight incubation at 37 °C with continuous 
rotation at 150 rpm. Next, samples were centrifuged at 10503 × g for 10 min and the 
supernatants was pored over a small amount of cotton wool placed into a funnel 
collecting the liquid into a 50 mL falcon tube. Hereupon, internal standard and 15 mL 
of phosphate buffer pH 8 were added along with 3000 µL of a methanolic 
derivatizating solution containing 3-iodobenzyl bromide (2 mg mL-1). Samples were 
sonicated for 10 minutes and left to derivatise for 1 h at 40 °C in the dark. Afterwards 
the pH of the reaction mixture was adjusted to 3.6 (± 0.1) and 3 liquid-liquid extraction 
steps of 5 mL with diethyl ether were applied, collecting only the supernatant after 
each centrifugation step (4 min at 2625 × g). The latter phase was evaporated to 
dryness under a gentle N2 stream (2 bar, 50 °C) and redissolved in 100 µL CH2Cl2 and 
300 µL cyclohexane. Furthermore, solid phase extraction with silica cartridges (10 mL, 
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500 mg SI Isolute, Biotage, Uppsala, Sweden) was conditioned with 15 mL of 
cyclohexane, washed with 7.5 mL of cyclohexane and eluted with a 3 mL mixture of 
hexane/ethyl acetate 40/60 (v/v). Again samples were evaporated under N2 and 
redissolved in 200 µL (or 160 µL, using standard addition) of methanol and 0.5% acetic 
acid (50/50), briefly vortexed and sonicated (5 min). Finally the extracts were 
centrifuged at 12304 × g for 10 min before transferring to plastic LC-MS vials. 
 
2.7. Instrumentation 
2.7.1. Liquid chromatography coupled to multiple mass  
  spectrometry (LC-MS2) 
Analysis of TU was achieved with a liquid chromatograph coupled to a linear ion trap 
mass spectrometer, which was adopted from Vanden Bussche et al. (2011) [15] and 
implemented with alterations, regarding gradient, interface gas flow, acquisition and 
divert valve time. A Finnigan Surveyor LC-system (Thermo Electron, San Jose, USA) was 
combined with a Symmetry C18 column at 30 °C (5 µm x 150 mm x 2.1 mm, Waters, 
Milford, Massachusetts, USA) running on a 0.5% acetic acid (A) and methanol (B) 
50/50 solvent combination at 0.3 mL min-1. The linear gradient was adapted over a 35 
min run: A/B 50/50 for 3 min, increasing to 0/100 in 20 min, and finally re-equilibrating 
for 10 minutes at 50/50. The linear ion trap mass spectrometer LTQ (Thermo Electron, 
San Jose, USA) was fitted with a heated electrospray ionization probe (HESI) 
operating in the negative ion mode and positioned on 0.5; C; 0 (front-to-back 
position (µm); probe depth (probe depth line); side-to-side position (+1 to -1 marks)). 
Applied working conditions were as follows: source voltage at 5 kV; capillary voltage 
at -50 V; tube lens voltage at -128.04 V; vaporizer and capillary temperature at 250 °C 
and 275 °C; sheath and auxiliary gas at 30 and 5 arbitrary units (a.u.), respectively. 
Sweep gas was increased to 2 to minimise interference and preserve the device. 
Data acquisition was now performed over the entire run and the divert valve was 
switched at 4 (0-4-20-30 min) different occasions decreasing soilage of the MS. The 
transitions of TU ([M-H]- = 343 m/z) were obtained, applying a collision energy of 44 eV 
with 182, 215, 309 (m/z) as the main product ions. The internal standard PTU-d5 ([M-H]- 
= 390 m/z) required 30 eV to fragment into its main product ions 127, 262, 356. 
 
2.7.1.1. Standard addition  
Quantification of TU in the Irish feed samples was performed using the standard 
addition approach as described in Commission Decision 2002/657/EC [33]. Each 
sample was divided over 2 vials with analogous mass (m) and volume (V). One 
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aliquot, the unknown, was added with a mixture of 0.5% acetic acid and methanol 
50/50 (VA) and the other, the known, was enriched with an equal amount of analyte 
(TU) (Vknown). The concentration of the addition solution was previously determined by 
analysing TU in feed samples and fitting these in a calibration curve in eluens. This 
approximate estimation of the TU concentration was then spiked to the aliquot of 
each sample (ρA) giving rise to the area ratio of χknown. Finally, quantification was 
established through evaluation of the area ratios of the known and unknown samples 
using the standard addition approach [15]. 
Quantification was established using the following formula: Cunknown= χunknown Vunknown 
ρA VA /(χknown Vknown munknown - χunknown Vunknown  mknown), with munknown= mknown, Vunknown = 
Vknown and Cunknown= χunknown  ρA VA /(χknown - χunknown ). In this formula, C, ρ are 
concentrations, χ is the area ratio, V is the volume, m is the mass and A is identified 
analyte (TU). 
 
2.7.1.2. Quality assurance 
Preceding the LC-MS2 analysis a standard mixture of the target compound and the 
internal standard were injected to check the operational conditions of the LC-MS2 
device. Identification of TU was based on retention time relative to the internal 
standard, and the ion ratios of the product ions according to Commission Decision 
2002/657/EC [33].  
 
2.8. Validation 
Once the extraction procedure had been optimised the analytical method was 
validated in order to show the applicability and robustness. To this extent, a validation 
protocol in accordance with the CD 2002/657 [33] was adopted, with slight 
alterations using limits of detection (LOD) and quantification (LOQ) instead of CCα 
and CCβ, which has been a common practice for the quantitation of group A 
substances in animal feed [45-47]. Moreover, animal feed is strictly speaking not 
included in food consumption for which the commission directive was initially 
developed [33]. Subsequently, non-Brassicaceae animal feed (n=20) was analysed to 
check the ruggedness. The feed samples were subsequently fortified in order to 
determine the specificity of each peak based on retention time and signal amplitude 
increase according to the fortification level (n=3). For the validation, blank feed 
samples (6 per level) were fortified with 3 different concentrations (TU: 5-10-15 ng g-1). 
The quantification was based on matrix matched calibration curves consisting of 8 
fortification levels (2.5-5-7.5-10-12.5-15-20-25 ng g-1). The linearity of the curves was 
evaluated through the coefficient of determination (R2), which should be ≥ 0.99 [33] 
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and the lack-of-fit (LOF), which is a well-known linearity evaluator [48]. The LOF was 
assessed for TU in animal feed, taking into consideration the deviation of linearity of 
the datasets by building an univariate linear regression model (SPSS 21, IBM, USA) with 
the calibration curve replicates (n=3), setting concentration as independent variable 
and the respective area ratios (e.g. area compound/area respective internal 
standard) as dependent variable. PTU-d5 was chosen as an appropriate internal 
standard [10]. 
 
2.9. Data handling 
All LC-MS2 data processing was performed with XCalibur 2.0.7 (Thermo Fisher Scientific, 
San Jose, CA, USA). Linearity evaluation was established through lack-of-fit analysis (F-
test, α=0.05) of the calibration curves in SPSS 21 (IBM, USA). Statistical testing 
(Student’s-t-test) was also carried out in SPSS 21 to assess significance (p < 0.05). 
Normality and equal variance were prerequisites. All statistical evaluation in relation 
to the designs was performed with Modde 5.0 (Umetrics, Umea, Sweden).  
 
 
3. RESULTS AND DISCUSSION 
3.1. Statistical extraction optimization of thiouracil from  
        animal feeds 
The strength of fractional designs is that they provide a significant time and effort 
reduction without losing valuable information and still produce comparable results to 
the laborious full factorial design (e.g. 16 trials versus 288 trials) [49]. The Plackett-
Burman (PB) design [50] in particular, is useful to distinguish from a large number of 
variables those variables that might affect the response of the component(s) of 
interest. PB consists of a two-level design (2k-1), which investigates k-1 variables, with k 
runs, where k is a multiple of 4. The amount of runs will generally be augmented with 3 
central points to obtain informative data about the range between the upper and 
lower limit of the variables [51]. Since fractional factorial designs, like PB, give little to 
no insight in possible interactions between the factors, implementation of a sensitivity 
analysis by means of a full factorial design (e.g. Central Composite Designs) should 
be set up with the factors that proved to be critical in the fractional factorial design 
[40,52]. Based on coefficient plots on the one hand and variable importance plots on 
the other, the effects of both feeds on TU extraction (Figure IV.1 to IV.3) could be 
evaluated. 
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Figure IV.1: (a) Variable importance plot from the Plackett-Burman design in non-
Brassicaceae feed, showing feed amount, ethyl acetate and 3-iodobenzyl bromide 
were important factors (VIP>1) in the extraction of thiouracil (TU) from feed. (b) 
Variable importance plot of TU in non-fortified Brassicaceae feed (coarse colza ‘00’ 
meal), showing variable importance for projection values > 1 for 3-iodobenzyl 
bromide, pH 7 buffer, elution volume, feed and myrosinase. These 5 factors were 
included in the response surface modelling optimization (LLE: Liquid-liquid extraction). 
V
IP
 
E
lu
tio
n 
vo
lu
m
e 
Fe
ed
 a
m
ou
nt
 
M
yr
os
in
as
e 
L
iq
ui
d/
liq
ui
d 
vo
lu
m
e 
B
uf
fe
r 
pH
 8
 
C
en
tr
ifu
ga
tio
n 
59
07
!g
  
W
as
h 
vo
lu
m
e 
3-
IB
B
R
 
C
on
di
tio
ni
ng
 v
ol
um
e 
E
th
yl
 a
ce
ta
te
  
(L
L
E
) 
B
uf
fe
r 
pH
 7
 
(a) 
3-
IB
BR
 
V
IP
 
Bu
ffe
r p
H
 7
 
El
ut
io
n 
vo
lu
m
e 
Fe
ed
 a
m
ou
nt
 
M
yr
os
in
as
e 
Li
qu
id
/li
qu
id
 
vo
lu
m
e 
Bu
ffe
r p
H
 8
 
C
en
tr
ifu
ga
tio
n 
59
07
!g
  
W
as
h 
vo
lu
m
e 
C
on
di
tio
ni
ng
 v
ol
um
e 
Et
hy
l a
ce
ta
te
  
(L
LE
) 
(b) 
	  Chapter IV 125 	  
 
Chapter IV 
	  
	   	  
In the first PB experiment blank non-Brassicaceae feed was used, which was fortified 
with TU. This design only resulted in non-significant (p > 0.05) effects, but from the VIP 
some effects could be observed (Figure VI.1-a). In general the following rule of thumb 
can be applied: Y: VIP > 1.0 (highly influential), 0.8 < VIP < 1.0 (moderately influential), 
VIP < 0.8 (less influential) and VIP < 0.5 (‘unimportant’) [51,53] 
 
In a second experiment with the same PB design, but with a non-fortified 
Brassicaceae feed 4 significant factors (p < 0.05) were found (Figure IV.2): feed 
(negative effect), buffer pH 7 (positive effect), elution volume (negative effect) and 
3-iodobenzyl bromide (positive effect). Myrosinase and buffer pH 8 were not 
significant (p < 0.05), exerting respectively a negative and positive effect.  
 
 
Figure IV.2: Coefficient plot for thiouracil in non-spiked Brassicaceae feed (coarse 
colza ‘00’ meal). Significant factors being feed (negative effect), pH 7 (positive 
effect), elution volume (negative effect), 3-IBBR (positive effect). Myrosinase 
(negative effect) and pH 8 buffer (positive effect) were almost significant (LLE: Liquid-
liquid extraction). 
 
Next, a sensitivity analysis of the critical PB factors in Brassicaceae feed was 
conducted by means of a CCF (Central Composite Face) full factorial design to gain 
insight in the possible interactions between factors [40,52]. Based on the VIP results 
(Figure IV.1-b), besides the above 4 significant factors, also myrosinase (VIP > 1) was 
included in the subsequent optimization of the factors with CCF design through 
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Response Surface Modelling (RSM) (Figure IV.3). Typically in a CCF, all scenarios per 
factor (feed amount, buffer pH 7, elution volume, 3-iodobenzyl bromide, myrosinase) 
are evaluated at low-, high- but also at mid-level ranges. These levels are the star-
points of the design and are set at the center of each face of the factorial space 
and chosen within the range of each factor [51]. Evidently, because the number of 
scenarios becomes equal to 2k, including a lot of parameters (k) becomes less 
feasible. Hence, a screening model (PB) was applied to the variables in this study, to 
limit the number of remaining variables for further optimization in the full factorial 
model with Response Surface Modeling (CCF). Finally, the amount of feed 0.25-3 g, 
pH 7 buffer 5-25 mL, 3-iodobenzyl bromide 250-3000 µL, myrosinase 0-0.5 mL and the 
elution volume 2.5-15 mL were set at different levels based on the PB results and 
evaluated within the CCF design. This showed 5 significant factors (p < 0.05) in its 
coefficient plot, i.e.: feed amount (negative effect), myrosinase (negative effect), 
elution volume (negative effect), 3-iodobenzyl bromide (positive effect) and buffer 
pH 7 (positive effect). Two significant negative interactions were also uncovered for 3-
IBBR towards elution volume and myrosinase, respectively. Consequently, these 
factors were optimized based on the RSM plots and the resulting parameters were 
built into the extraction procedure, respectively: 0.25 g of feed, 15 mL of pH 7 buffer, 
3000 µL of 3-iodobenzyl bromide, 3 mL of elution solvent and no addition of 
myrosinase.  
 
 
 
 
 
 
 
 
Figure IV.3: Example of a response surface model plot for the influence of buffer pH 7 
and the amount of Brassicaceae feed (coarse colza ‘00’ meal) on the extraction of 
thiouracil, resulting in the optimal conditions: 0.25 g of feed and 15 mL of buffer pH 7. 
 
In conclusion, the preference for the applied low feed amounts is comprehensible 
since matrix interferences increase when higher feed amounts are used and if the 
detection method is sensitive enough this should not be an issue. Matrix interferences 
causing high background noise in feeds, like feeding cabbage and meal with 30% of 
rapeseed ‘00’ have been reported, which even when fortified with 10 µg kg-1 TU, still 
2.5 
3.0 
2.0 
1.5 
1.0 
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Coarse colza ’00’ meal (g)  
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yielded a non-detectable signal with LC-MS2 [15]. Since the addition of myrosinase 
proved not requisite for TU detection, the influence of incubation and phosphate 
buffer pH 7 and to al lesser extent pH 8 [9,15], are of increasing importance to the 
extraction of TU. Another pivotal factor is the high volume of derivatisation agent, 
since too little will cause the present TU to stay underivatised, which makes it 
undetectable to the MS analyser. Overall, the adaptations made to the extraction 
procedure clearly optimized the detectability of TU in animal feed. 
 
3.2. Validation study 
Upon optimization of the extraction and analysis, the method was validated 
according to the criteria specified in CD 2002/657/EC for quantitative confirmation 
[33]. An appropriate deuterated internal standard, PTU-d5, was chosen for its 
capability to anticipate fluctuations in the signal intensity upon extraction [7,10,15]. 
The validation results are presented in Table IV.2. Spiking concentrations were based 
on the recommended concentration (RC) of 10 µg kg-1 by the European reference 
laboratories [13].  
 
3.2.1. Specificity and selectivity 
The chromatograms of 20 blanks indicated that no other matrix substances 
significantly interfered with the signals of the compound of interest, since signal-to-
noise ratios of the neighbouring background chromatographic peaks, if present, 
were never higher than 3 (Figure IV.4-a and IV.4-b). When samples were fortified, a 
significant increase of the peaks of interest at the expected retention times with a 
substantial augmentation in area and signal-to-noise ratio were observed, thereby 
proving its selectivity for the analytes of interest. In accordance with CD 2002/657/EC 
[33], analytes were identified on the basis of their relative retention time, i.e. the ratio 
of the retention time of the analyte to that of the internal standard. As a result, the 
developed method was found to be specific and selective for TU in the presence of 
matrix compounds. 
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Figure IV.4: Chromatographic representation of a blank (a) and a spiked (2.5 ng g-1) 
(b) non-Brassicaceae feed sample, showing retention time (RT), peak area (AA) and 
signal-to-noise ratio for thiouracil (TU) and its internal standard (PTU-d5). The 
chromatogram of a TU spiked non-Brassicaceae feed sample at the LOD 0.2 ng g-1 
(c). 
3.2.2. Linearity 
9-point calibration curves were elaborated in blank feed to evaluate the linearity of 
the developed method for TU detection from animal feed. The samples were fortified 
with concentrations reported under 2.8 Validation. Linearity performed well since 
determination coefficients (R2) were all ≥ 0.99 and commensurable with literature 
findings for TU analysis in fodder [54-56]. Furthermore, the regression model equations 
resulting from lack-of-fit [48] were reported to be all linear (F-test; α=0.05).  
 
3.2.3. Precision 
The precision of the developed analytical method was evaluated through 
determination of repeatability and within-laboratory reproducibility. Both validation 
parameters were evaluated by calculating their relative standard deviations (RSD%). 
To assess the repeatability, three series of six replicates at three different fortification 
levels in blank animal feed, were analyzed by the same operator under repeatable 
conditions (Table IV.2). The calculated RSD% values were excellent since values were 
well below 15% compliant with CD 2002/657/EC [33] and ranged from 5.4-6.0%. For 
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intra-laboratory reproducibility four series of six replicates of samples, at three 
fortification levels analysed by different operators on different days were evaluated. 
The calculated intra-laboratory RSD% ranged from 4.7-5.2 %, which indicates very 
good within-laboratory reproducibility, with reference to the 20% upper limit set by the 
CD 2002/657/EC [33]. In literature reports may be lower but these are based on µg g-1 
concentrations, e.g. within day RSD% of 1.9-2.6% at 0.6-1-5 µg TU g-1 and between 
day 2.6 RSD% in maize flour [55] and 3-7 repeatability RSD% at 20-200 µg TU g-1 [54]. 
Kong et al. (2009) [56] based its precision evaluation on standard solutions reaching a 
1.9 RSD% for reproducibility and 3 RSD% inter-day precision. Only recently a method 
based on LC-triple quadrupole analysis for thyreostat analysis in feedstuffs was 
published, but showed high repeatability and within-laboratory reproducibility (up to 
19.6 RSD%) [57]. 
 
3.2.4. Limits of detection and quantification 
Limits of detection (LOD) and quantification (LOQ) are the lowest levels at which a 
compound can be, respectively, identified or quantified with a signal-to-noise ratio 
(S/N) of respectively, ≥3 and ≥10. For TU the detection and quantification limits were 
theoretically calculated based on 9-point calibration curves in matrix, correlating 
concentrations to signal-to-noise values [58]. An LOD of 0.2 ng g-1 and an LOQ of 0.5 
ng g-1 were deducted and confirmed using spiked matrix-matched samples (Figure 
IV.4-c). Even though validation studies of mass spectrometrical techniques for the 
analysis of similar components in animal feed are scarce or non-existing, some studies 
did aim to develop methods for thyreostats and analogues, using other techniques. 
One method resorted to micellar electrokinetic chromatography (MEKC) for the 
detection of thyreostats in animal feed by diode array reaching LODs of 0.4-0.6 µg g-1 
of fodder and 4% peak area repeatability [54]. Thereupon a capillary electrophoresis 
combined with laser-induced fluorescence detection method showed recoveries at 
µg g-1 levels [55], which was enhanced using an electrochemical detector achieving 
LODs ranging from 7.6-25 ng g-1 for various thyreostats in feed (18 ng g-1 TU; 25 ng g-1 
PTU) [56]. Mass spectrometrical methods mentioning similar LODs for the analysis of TU 
and analogues specifically for animal feed matrices have not yet been reported to 
the best of our knowledge. Therefore the obtained results are undeniable satisfactory 
and even when compared to other mass [57] and non-mass spectrometrical 
technologies [54-56] for the detection limit of the thyreostats at hand in animal feed, 
the present method performs better. 
 
3.2.5. Mean recovery 
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As no certified reference material was available, trueness was determined as the 
mean corrected recovery by using fortified blank animal feed samples. To this extent, 
three fortification levels were considered with six replicates for each level. The present 
recoveries ranged from 90.9 to 99.7% for TU. Results were found satisfactory since the 
lowest mass fraction (10-100 ng g-1) according to the CD 2002/657/EC [33] requires 
mean recoveries between 80-120%. Reported mean recoveries ranged between 78-
81% at 0.6-1-5 µg TU g-1 [55] and in another case mean recoveries ranged between 
85-105% for various thyreostats at a concentration of 0.3 µg g-1 without further 
specifications [56]. In a singular report on LC-triple quadrupole analysis in animal 
feedstuff recoveries only ranged between 77.7-86.9% for 5-10-15 ng TU g-1 [57]. 
 
Table IV.2: Overview of the methods performance for the detection of thiouracil in 
non-Brassicaceae feed (n=128). 
Analyte 
LOD 
(ng g-1) 
LOQ 
(ng g-1) 
Nominal 
concentration 
(ng g-1) 
Recovery 
(%) 
Precision 
Repeatability 
RSD (%) 
Within-lab. 
Reprod. 
RSD (%) 
Thiouracil 0.2 0.5 5 
10 
15 
90.9±7.4 
98.9±4.8 
99.7±1.5 
6.0 
5.4 
5.7 
5.2 
5.0 
4.7 
 
3.3. Thiouracil analysis of various animal feeds 
To prove the applicability of this newly optimized method, various animal feeds (n=22) 
from the Irish control plan and coarse colza ‘00’ meal (n=1) were analysed for TU with 
the newly optimized method (Table IV.3). TU concentrations in the feeds were 
identified according to the identification point (IP) policy of 4 IPs described by CD 
2002/657/EC [33].  
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Table IV.3: Concentration (ng g-1) of thiouracil detected in various types of animal 
feeds using the newly optimized and validated LC-MS2 method (n.d.: not detected). 
 
Animal Feed ng g-1 
Vitamin mineral yeast mix n.d. 
Beef ratio creamery 11.93 
Barley and propionic acid 9.35 
Optigen 11 (non-protein-nitrogen) n.d. 
Distillers dried grains n.d. 
Cattle meal (rolled barley, rolled wheat, soya hulls, 
citrus pulp pellets, wheat distillers dried grains, sugar 
cane molasses, extracted soya bean, toasted 
extracted rapeseed, beans, vitamins and trace 
elements) 3.76 
Beef finisher meal 20.60 
Oil seed rape 10.27 
Beef finisher 5.19 
Beef feed (silage, straw, concentrate) n.d. 
Maize meal 0.32 
Mix of soya hulls, rape seed & barley 13.14 
Barley 5.35 
Ground barley & wheat 6.79 
Soya Hulls 11.56 
Mineral feed n.d. 
Beef finisher 9.98 
Maize meal 2.19 
Beef meal 8.21 
Maxammon Grain preservative n.d. 
Urea-part of Maxammon Grain preservative n.d. 
Beef meal n.d. 
Coarse colza ‘00’ meal 7.04 
 
The results show above 10 ng g-1 TU concentrations, not surprisingly, in the 
Brassicaceae oil rapeseed, but also in soya hulls and composed beef ratios 
(creamery, finisher meal) with unknown composition. Soybean meal is one of the 
major ingredients in swine rations and has also been reported to possess goitrogenic 
properties [59], which are not glucosinolate-based. In Brassicaceae crops, seeds 
	  132 Chapter IV 	  
 
Chapter IV 
	  
	   	  
have been shown to contain progoitrin as the main glucosinolate [60]. In their leaves, 
two different glucosinolate profiles have been reported depending on the type of 
Brassica crop: forage and root vegetable crops showed high levels of progoitrin, 
whereas glucobrassicanapin is the main glucosinolate for oil seed and leafy crops 
[60]. Even though a clear trend cannot be distinguished, these results do show that TU 
can be detected in Brassicaceae feeds, as well as, non-Brassicaceae feeds, which 
has not been reported yet. Moreover, the applicability of the method in various feeds 
with different consistencies and compositions has been demonstrated (Figure IV.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV.5: Chromatographic representation of detection of thiouracil and the 
internal standard PTU-d5, in respectively: oil seed rape, maize meal, beef meal. 
 
 
4. CONCLUSIONS 
This study presents a new, successfully validated LC-MS2 method for TU analysis from 
animal feeds, which differentiates itself by a statistically optimised extraction 
procedure adapted to both, Brassicaceae and non-Brassicaceae feedstuffs. The 
efficiency of the extraction and the purification steps, and the use of an adapted 
internal standard allowed obtaining a rugged method. The method was subjected to 
a careful validation according to common procedures i.e. CD 2002/257/EC 
guidelines [33].  In this validation accuracy, specificity, selectivity, repeatability, within-
laboratory reproducibility, LOD, LOQ and linearity were tested demonstrating 
excellent performance and practical applicability in various animal feeds. Currently, 
the presence of natural and exogenous TU cannot yet be differentiated. Feed 
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analysis remains, therefore, a very important tool for indirect confirmation of natural 
TU occurrence. Moreover, the latest reflection paper by the EURL [61] also advised 
the analysis of animal feed when TU concentrations above > 30 µg L-1 are 
encountered in livestock urine in national control plans. It may be clear that this 
method for the analysis of TU in Brassicaceae and non-Brassicaceae feeds could 
easily suit that purpose. 
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ABSTRACT 
Thyroid hormones are essential hormones for regulating growth and development. 
Methods to accurately monitor low-levels (ppb-ppt) of these hormones in serum are 
needed to assess overall health, both from a clinical perspective as from 
environmental contaminant or drug exposures. In general, the separation of the free 
thyroid hormone fraction from animal sera is performed through labour intensive 
equilibrium dialysis, while detection of total and free thyroid hormone fractions in 
animals is done with commercially available radioimmunoassays (RIAs). This study 
reports newly developed analysis methods for both the total and free fractions of 
triiodothyronine (T3), reverse-triiodothyronine (rT3) and thyroxin (T4) from bovine serum, 
with a much higher specificity and selectivity than commercially available RIAs. The 
bovine serum extraction procedures of total and free T3, rT3, T4 were optimised with 
fractional factorial designs and consisted of, respectively, deproteinisation followed 
by liquid-liquid extraction, 30 kDA ultrafiltration and solid phase extraction. Both free 
and total thyroid hormone UHPLC-HESI-MS/MS based analysis methods were 
successfully validated. The limits of quantification for T4, rT3 and T3 amounted 
respectively 0.04 ng mL-1, 0.05 ng mL-1, 0.03 ng mL-1 for the total fraction, and 6.6 pg 
mL-1, 2.6 pg mL-1 and 2.7 pg mL-1 for the free fraction. Individual recoveries of total 
and free thyroid hormone fractions ranged between 95.6-106.3% and 92.1-106.5%. 
Good results for repeatability and intra-laboratory reproducibility (RSD%) were 
observed, i.e. respectively ≤8.0% and ≤7.3% for the total and free fractions. Excellent 
linearity (R2 ≥ 0.99) and lack-of-fit was proven for both fractions. In conclusion, these 
methods show excellent in-house performance and possibilities for elaboration to 
application in other animal sera (e.g. feline, canine, equine).  
 
 
 
 
 
 
 
 
 
 
 
Keywords: thyroid hormone, total, free, UHPLC-MS/MS, D-optimal, Plackett-Burman, 
bovine serum 
	  Chapter V 139 	  
 
Chapter V 
	  
	   	  
1. INTRODUCTION 
The thyroid gland governs the metabolism of all species through thyroid hormone 
secretion. Therefore, the evaluation of its status through analysis of thyroid hormones is 
of great value in a veterinary clinical setting but also in other research fields where an 
overall view of the thyroid status is required. More specifically in reference to 
contaminants, like endocrine disrupting chemicals (EDC’s) (e.g.: organ chlorine 
pesticides and polybrominated diphenyl ethers)) [1-3], or to endogenous formation 
of certain residues affecting the thyroid function (e.g. thiouracil) [4,5] thyroid 
hormone analysis has proven its merits.  
The thyroid gland is histologically characterised by large-follicular tissue with a 
monolayer of cells, which produce thyroxine (T4, 90%) and triiodothyronine (T3, 10%) 
[6]. Due to the highly vascularised gland tissue, T4 and T3 can be quickly released into 
the systemic circulation. Secretion of thyroid hormones is well regulated by a 
negative feedback mechanism involving, besides the thyroid gland, the 
hypothalamus and the pituitary gland [7,6]. Circulating T4 concentration is 50-60 times 
higher compared to T3, and both hormones are also partially bound to blood proteins, 
of which the thyroid-binding globulin (TGB) is the most relevant (70-80%) besides the 
other common plasma proteins, prealbumin and albumin, which bind the remaining 
fraction [7,6]. Consequently, only a very small non-bound free fraction of these 
hormones (0.03% of total T4 and 0.3% of total T3) remains available to directly access 
the target organs and this availability is known to be influenced by the physiologic 
status of the organism and may thus alter in case of disease [8,7]. Moreover, only T3 
will exert any biologic activity since T4 needs an additional deiodination step in the 
peripheral tissues [7]. This clearly illustrates why the monitoring of free and total thyroid 
hormone concentrations, and the individual identification of both T3 and T4, is of 
major importance in a clinical setting.  
A vast amount of publications on method development for the analysis of total and 
free thyroid hormones is available, but these mostly apply to human serum and focus 
solely on free or total hormone fractions [9,10], which have been reviewed elsewhere 
[11,12].  
For human total and free thyroid hormone analysis the detection method of 
reference has been (radio)immunoassays (RIA/IA) [10-13]. But over the years, the 
evolutions in hyphenated mass spectrometry (MS) based techniques (gas 
chromatography (GC)-MS; liquid chromatography (LC)-MS and LC-MS/MS) have led 
to the increasing replacement of RIAs [14] in favour of more sensitive and specific 
mass spectrometric applications for human total and free thyroid hormone analysis 
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[15-18,10]. For total thyroid hormone analysis in particular, laborious sample 
preparations were common [19-21] with the first GC-MS applications, but the 
evolution towards LC-MS methods, with eventually high performance liquid 
chromatography isotope dilution tandem MS (HPLC-ID-MS/MS) applications, allowed 
faster and more generic analysis of total thyroid hormones in humans [22,23,9]. Free 
thyroid hormone extraction, on the other hand, is still generally based on equilibrium 
dialysis (ED) combined with immunoassays, but mass spectrometric applications have 
also been described, e.g. ED LC-ID-MS/MS, which has been put forward as a human 
reference method [16,24,12]. Nevertheless, ED has the disadvantage to be a labour 
intensive, imprecise, technically demanding and costly procedure, which is hard to 
perform in a clinical laboratory [25,11]. Therefore, ultrafiltration (UF) was proposed as 
a valuable alternative for ED [26,24,18], which further led to its implementation in 
many North American laboratories for human serum analysis nowadays [11]. The 
separation through UF takes in average about 30 min, whereas ED requires 17 h to 24 
h [25,11]. Only very few publications deal with method development for thyroid 
analysis in non-human species [10] and none are able to both asses free and total 
fractions of thyroid hormones. In animal medicine, several immunoassays are 
commercially available that detect total thyroid hormones, while the free fraction is 
generally determined by an ED immunoassay combination (e.g.: in donkeys, dogs 
and cats) [27-29]. Since thyroid hormones are involved in a variety of critical 
metabolic pathways and growth processes, it is clear that animals, veterinarians and 
researchers would benefit from the development of a fast, cost-effective and specific 
method allowing thyroid hormone monitoring. This paper therefore describes the 
development and validation [30] of rapid and sensitive methods combining ultra high 
performance liquid chromatography (UHPLC) with MS/MS detection preceded by 
two fast and cost-effective extraction procedures, for free and total thyroid hormone 
fractions in bovine serum, respectively.  
 
 
2. MATERIALS AND METHODS 
2.1.  Reagents and chemicals 
The analytes, 3,5,3’,5’-tetraiodothyronine (T4); 3,3’,5-triiodothyronine (T3); 3,3’,5’-
triiodothyronine (reverse T3; rT3) were purchased from Sigma-Aldrich (St. Louis, USA). 
The internal standard, 3,5,3’,5’-tetraiodothyronine-13C6 (T4-13C6)  was acquired from 
Toronto Research Chemicals (Toronto, CA). All used solvents and reagents were 
obtained from VWR International (Merck, Darmstadt, Germany). Solvents were of ‘pro 
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analysis’ grade when used for extraction purposes and of ‘LC-MS Optima’ grade 
when used for U-HPLC-MS/MS application. Ultrapure water (UPW) was obtained from 
a purified-water system (Sartorius Stedim Biotech, GmbH arium 611 UV, Germany).  
Primary stock solutions were prepared in LC-MS optima grade methanol (MeOH) with 
25% ammonium hydroxide (100 µL NH4OH, 12 mL-1 MeOH) according to Van Houcke 
et al., [31] at a concentration of 200 µg mL-1 and stored in dark glass flasks at -20 °C. 
Working solutions were made up in MeOH, except for total thyroid hormone 
extraction where spiking solutions were made up in ethanol (EtOH) to match the 
deproteinisation conditions.  
 
2.2.  Sample preparation 
2.2.1. Sample 
Bovine blood (Belgian Blue) was collected from Belgian slaughterhouses (without 
anticoagulant) on the slaughter line during exsanguination. Subsequently, the 
coagulated blood was centrifuged for 20 min at 2,625xg. The obtained bovine serum 
was pooled and stored at -20 °C in falcon tubes. 
 
2.2.2. Statistical designs for the extraction procedure 
Statistical model designs were used to optimise the analytical extraction procedures 
of both, total and free, thyroid hormone fractions in bovine serum. The dependent 
variables that might significantly affect the extraction efficiency were screened with 
a Plackett-Burman fractional factorial design (PB) for the free thyroid hormone 
fraction and a D-optimal experimental design for the total thyroid hormone fraction. 
These variables were selected based on a literature survey for both free and total 
thyroid fractions [32,15,22,16,9,33,23,34,26,10,35,36]. This allowed further optimisation 
with only the influential variables through response surface modelling (RSM) (i.e. 
central composite face-centered design (CCF)). If a factor proved to be non-critical 
(p>0.05), the best level according to its effect, was chosen. Generally, this was the 
least time-consuming or most result effective level of the factor, which was then built 
into the protocol [37]. 
For free thyroid analysis, the 11 selected variables and their respective levels are 
shown in Table V.1. Based on this statistical design (PB), only 12 experimental runs and 
three central value runs were required generating enough information to calculate 
the main effect of each variable and to eventually specify a particular combination 
of variable levels. Subsequently, critical variables with a significant (p<0.05) influence 
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(conditioning, wash and elution volumes) were subjected to RSM optimisation, 
resulting in the final protocol.  
 
Table V.1: Variables of the D-optimal (total thyroid hormone) and Plackett Burman 
(free thyroid hormone) designs for their respective extraction optimizations. (*: ACN= 
acetonitrile) 
 
D-optimal design Variables Level 1 Level 2 Level 3 Level 4 
Qualitative  Deproteinisation solvent MeOH Aceton EtOH ACN* 
 Deproteinisation temperature -20 °C 4 °C 20 °C  
 Clean-up/extraction No clean-up Oasis HLB SPE LLE  
 Shake manner vortex shaking   
Quantitative  Serum volume 100 µL 1000 µL   
 Shake time 15 sec 60 sec   
 Deproteinisation time 10 min 30 min   
 Centrifugation time 5 min 15 min   
PB design Variables Level 1 Level 2   
Qualitative  Conditioning solvent MeOH ACN*   
 Equilibrating solvent 5% MeOH in UPW UPW   
 Wash solvent MeOH ACN*   
 Elution solvent ACN* MeOH   
 SPE cartridge type C18 EC OASIS HLB   
Quantitative  Conditioning volume 2 mL 6 mL   
 Dilution volume (UPW) 3 mL 9.5 mL    
 Wash solvent (in UPW) 5 % 20 %   
 Wash volume 2 mL 6 mL   
 FA in elution solvent 0% 0.1%   
 Volume elution solvent 1 mL 3 mL   
 
 
For total thyroid analysis, eight variables were selected with up to four levels per 
variable, as shown in Table V.1. Therefore, a total of 26 experimental runs and three 
central value runs were needed to specify this particular combination of settings. 
After performing the prescribed scenario, the main effect of each variable was 
calculated. Subsequently, the critical variables (p<0.05) (serum volume) and the most 
potent sample preparation procedure (liquid-liquid extraction) (p>0.05) were 
subjected to further optimisation by response surface methodology (CCF design). First 
the number of liquid-liquid extraction steps was evaluated (1.5 mL-1 mL/ 3 mL-3 mL-2 
mL/ 5 mL-4 mL/ 5 mL-4 mL-3 mL). Subsequently, the volumes in the first (1.5-3 mL) and 
second (1-3 mL) liquid-liquid extraction steps were optimised along with the serum 
volume (100-1000 µL) in a CCF setup. 
The software program Modde 5.0 (Umetrics, Umea, Sweden) was used to build the 
experimental design matrix and carry out data analysis. The parameters were inserted 
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into the program and depending on the purpose of the analysis (screening or RSM), 
the most adequate model was proposed by the program. Evaluation of the models 
was done through a one-way variance analysis (ANOVA) test. Significance was 
proven when p-values were smaller than 0.05. 
 
2.2.2.1. Free thyroid hormone extraction 
After statistical evaluation, a final extraction procedure for free thyroid hormones 
(Figure V.1) was defined 
Figure V.1: Final extraction protocols after statistical optimization for free and total 
thyroid hormones in bovine serum. (*: RT=room temperature) 
FREE T3, rT3, T4 
500 µL bovine serum 
Ultrafiltration:  
Microcon, 30 kDA cut-off filter, at 
15,000xg 
30 min, 37 °C 
Add 3 mL UPW to the 360 µL yield  
Oasis HLB Solid Phase Extraction:  
• 2 mL MeOH, 2 mL UPW 
 
• Sample 
 
• Wash: 6 mL 20% MeOH in UPW 
 
• Elute: 3 mL 0.1% FA in MeOH 
Evaporate to dryness 40 °C 
Redissolve in 100 µL 0.1% FA UPW : 
0.1% FA MeOH (40:60) 
Centrifuge 10 min at 12,304xg 
Inject 25 µL full loop on the  
UHPLC-MS/MS 
TOTAL T3, rT3, T4 
1000 µL bovine serum 
Deproteinisation 30 min at RT*: 
1500 µL EtOH (2:3) & vortex 15 s  
  Centrifuge 5 min at 20,800xg at RT* 
Liquid-Liquid Extraction: 
3 mL ethyl acetate with : 
 
• 10 min mechanical shaking 
• 10 min centrifugation at 2000xg 
 
1 mL ethyl acetate with : 
 
• 10 min mechanical shaking 
• 10 min centrifugation at 2000xg 
Evaporate to dryness 40 °C 
Redissolve in 200 µL 0.1% FA UPW : 
0.1% FA MeOH (40:60) 
Centrifuge 10 min at 12,304xg 
Inject 5 µL partial loop on the  
UHPLC-MS/MS 
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Briefly, 500 µL of thawed bovine serum was centrifuged using a UF centrifugal device 
(0.5 mL, 30 kDA, Amicon, Millipore, Belgium) at 37 °C approximating physiological 
conditions [16,11], separating the bounded hormone fraction from the free thyroid 
hormone fraction. The deproteinated serum was subsequently spiked with 100 pg mL-1 
of internal standard (13C6-thyroxine) in MeOH. Next, samples were diluted with 3 mL 
UPW before performing solid phase extraction (SPE) with Oasis HLB cartridges (60 mg, 
3cc, Waters GmbH, Germany). The eluted samples were evaporated to dryness and 
redissolved in 100 µL of the initial UHPLC conditions i.e. acidified (0.1% formic acid 
(FA)) UPW and 0.1% FA in MeOH (40:60), followed by centrifugation. Finally samples 
were conveyed into the insert of a glass amber vial for analysis. 
 
2.2.2.2. Total thyroid hormone extraction 
To establish the total thyroid hormone extraction from serum (Figure V.1), 1 mL of 
thawed bovine serum was deproteinated with a total amount of 1500 µL of EtOH 
(ratio 2:3) [9], which included the internal standard 13C6-thyroxine (10 ng mL-1). The 
deproteinated fraction was removed by a short high-speed centrifugation step 
(20,800xg, 5 min at room temperature) causing a plaque to form. Subsequently, 
liquid-liquid extraction (LLE) was performed on the supernatants. Next, the pooled LLE 
supernatants were evaporated to dryness and redissolved in 200 µL of the initial 
UHPLC conditions, followed by centrifugation. This mixture was conveyed into a glass 
amber vial with insert for analysis. 
 
2.3. Instrumentation 
2.3.1. Ultra High Performance Liquid Chromatography  
Chromatographic separation of T4, T3 and rT3 was achieved by an Accela UHPLC 
system (Thermo Fisher Scientific, San José, USA), equipped with a reversed-phase C18 
Hypersil gold column (100 × 2.1 mm, 1.9 µm, Thermo Fisher Scientific, San Jose, USA) at 
a column oven temperature of 35 °C. The optimised elution gradient consisted of 
acidified (0.1% FA) UPW (A) and acidified (0.1% FA) MeOH (B) at a flow rate of 0.3 mL 
min-1 over an 8-minute run. Starting conditions of 40%(A): 60%(B) were held up for 1.7 
min, subsequently increasing to 37%(A): 63%(B) till 3.5 min, then slowly augmented to 
35%(A): 65%(B) till 3.8 min, after which the gradient increased to a 100% MeOH (B) 
until 4.5 min. Between 4.5-5.5 min 100% MeOH was sustained, followed by a steep 
decrease to the initial conditions. Injection settings for total and free thyroid hormone 
analysis methods were respectively, partial loop (5 µL) and full loop (25 µL). 
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2.3.2. Triple-Stage Quadrupole Tandem Mass  
spectrometry 
Mass spectrometric analysis was performed on a TSQ Vantage™ triple-quadrupole 
mass spectrometer (Thermo Fisher Scientific, San José, USA) equipped with a second-
generation heated electrospray ionisation (HESI-II™) interface in the positive ion mode 
using selected reaction monitoring (SRM). First MS-parameters (Table V.2), were 
optimised for each analyte separately by individually infusing the component’s 
standard (10 ng µL-1 at 5 µL min-1) and simultaneously the four most intense precursor 
ions were selected for each analyte. Subsequently, the remaining optimal 
instrumental parameter values were determined by evaluating signal intensity and 
signal-to-noise ratio of the precursor ions based on subsequent runs of a standard 
mixture under various parameter settings. Following instrumental parameters were 
found to be optimal: a cycle time of 1.2 s, a Q1 peak width of 0.70 Da and a collision 
gas pressure of 1.5 mTorr. Auxiliary, sheath and ion sweep gas were set at, 
respectively: 25, 45 and 2 au (arbitrary units). Vaporizer and capillary temperature of 
the HESI II probe were set at 395 °C and 330 °C. Finally, for the positive ion mode, the 
spray voltage was set at 4000 V.  Instrument control and data processing were 
carried out by Xcalibur 2.1 software (Thermo Fisher Scientific, San José, USA). 
 
Table V.2: Precursor and product ion m/z values of the thyroid hormones and their 
internal standard along with the respective collision energy and S-lens value. 
 
Precursor mass  
(m/z) 
Product ions  
(m/z) 
S-lens  
(V) 
Collision energy 
(eV) 
T3                651.9 198.1; 225.0; 478.9; 605.9 119 44; 44; 34; 21 
rT3              651.9 478.9; 507.9; 605.9; 634.8 131 38; 22; 21; 16 
T4               777.8 323.9; 350.9; 604.9; 731.8 144 45; 44; 40; 25 
T4-13C6       783.6 329.8; 356.8; 639.8; 737.7 136 51; 43; 25; 20 
 
2.3.3. Quality Assurance 
Prior to the sample analysis, a standard mixture of the targeted compounds was 
injected to check the operational conditions of the UHPLC-MS/MS device. To every 
sample the internal standard T4-13C6 was added at a concentration of 10 ng mL-1 
(total hormone) and 100 pg mL-1 (free hormone) prior to extraction. Identification of 
the thyroid hormones was based on their retention time relative to that of the internal 
standard and m/z ratios of selected product ions (ion ratios). After identification, the 
analyte’s concentration was calculated by fitting its area ratio in a 10-point 
calibration curve. Area ratios were determined by integration of the area under the 
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specific selected reaction monitoring (SRM) chromatogram of an analyte in 
reference to the integrated area of the internal standard. The calibration curves were 
extracted in pooled bovine serum and fortified at the following concentrations: 7.5-
15-30-60-90-120-180-360-540 ng mL-1 for T4, 0.25-0.5-1-2-3-4-6-12-18 ng mL-1 for rT3, 
0.625-1.25-2.5-5-7.5-10-15-30-45 ng mL-1 for T3 for total thyroid hormone analysis. The 
free thyroid hormone calibration curves were spiked at the concentrations of 12.5-25-
50-100-150-200-300-600-900 pg mL -1 for T4 and from 5-10-20-40-60-80-120-240-360 pg 
mL -1 for rT3 and T3. 
 
2.4. Validation 
Once the extraction procedure for both methods had been optimised, the total and 
free thyroid hormone analytical methods were validated in order to show their 
applicability and robustness. To this extent, a validation protocol in accordance with 
the CD 2002/657/EC [30] was adopted. Therefore, non-spiked bovine serum samples 
(n=20) were analysed to check the ruggedness of each method and to determine 
the endogenous levels of T4, T3 and rT3 for both the free and total thyroid hormone 
fraction. The bovine serum samples were subsequently fortified in order to determine 
the specificity of each peak based on retention time and signal amplitude increase 
according to the fortification level (n=3). This has been reported as a common 
approach when dealing with endogenous background levels [38-40]. For the 
validation of the total thyroid hormone fraction method, pooled bovine serum 
samples (6 per level) were fortified with 3 different concentrations (T4: 30-60-90 ng mL-
1, T3: 2.5-5-7.5 ng mL-1 and rT3: 1-2-3 ng mL-1). For the validation of the free thyroid 
hormone fraction method, pooled bovine serum samples were fortified accordingly: 
T3 and rT3 at 20-40-60 pg mL-1 and T4 at 50-100-125 pg mL-1. The quantification was 
based on matrix matched calibration curves consisting of 9 fortification levels. The 
linearity of the curves was evaluated through the coefficient of determination (R2), 
which should be ≥ 0.99 [30] and the lack-of-fit (LOF), which is a well-known linearity 
evaluator [41]. The LOF was assessed for free and total thyroid hormones, taking into 
consideration the deviation of linearity of the datasets by building an univariate linear 
regression model (SPSS 20, IBM, USA) with the calibration curve replicates (n=3), 
setting concentration as independent variable and the respective area ratios (e.g. 
area compound/area respective internal standard) as dependent variable. Based 
on the analysis of blank samples, an average naturally occurring concentration could 
be deduced for each analyte. The obtained values were subtracted from the 
fortified samples enabling the calculation of the actual fortified free or total thyroid 
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hormone concentrations [42,43]. Thyroxine-13C6 was selected as an appropriate 13C6-
labelled internal standard [33,16,18,10]. 
 
2.5.  Statistical analysis 
Linearity evaluation was performed for both methods through lack-of-fit analysis (F-
test) of the calibration curves in SPSS 20 (IBM, USA). All statistical evaluation in relation 
to the designs was performed with Modde 5.0 (Umea, Sweden). 
 
 
3. RESULTS AND DISCUSSION 
3.1. Statistical optimisation of free thyroid hormone  
        analysis: Plackett-Burman 
The strength of fractional designs (e.g. Plackett-Burman) is their ability to provide a 
significant time and effort reduction without losing valuable information, but still 
producing comparable results to the laborious full factorial design [44]. The PB design 
[45] is therefore a useful screening tool to distinguish from a pool of variables those 
variables that might affect the response of the component(s) of interest. Consisting of 
a two-level design (2k-1), PB investigates k-1 variables, with k runs, where k is a multiple 
of four (e.g. 11 factors, 12 runs). In comparison, an xk full factorial design requires all 
possible combinations to be tested of all (x) levels for each of (k) factors, which 
dramatically increases the amount of runs (e.g. 11 factors, 2024 trials) [46]. The 
amount of runs will generally be augmented with three center-points to obtain 
informative data about the range between the upper and lower limit of the variables 
[47]. 
In this study, the PB design was made up of 11 scientifically based factors (Table V.1), 
which enabled a first screening of the important variables in free thyroid hormone 
extraction [26,16,24,18]. This resulted in 5 significant factors (p<0.05) i.e. conditioning, 
washing and elution volume, as well as elution solvents (MeOH, acetonitrile (ACN)) 
(Figure V.2).  
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Figure V.2: The Plackett-Burman coefficients plot for free T4 with conditioning volume, 
washing volume, elution solvents (MeOH and ACN) and elution volume, as significant 
factors (p<0.05). 
 
The type of SPE cartridge did not significantly enhance extraction (p>0.05), therefore 
the Oasis HLB (3cc, 60 mg, Waters) was preferred over the C18 (EC) cartridge based 
on literature [33], as well as, an overall slight non-significant positive effect. Next, a 
sensitivity analysis of the critical PB factors was implemented by means of a CCF full 
factorial design to gain insight in the possible interactions between factors [48,37]. 
Typically in a CCF, all scenarios per factor (conditioning, washing and elution volume) 
are evaluated at low, high but also at midlevel ranges. The latters are called star-
points and are set at the center of each face of the factorial space and chosen 
within the range of each factor [47]. Evidently, because the number of scenarios 
becomes equal to 2k, including a lot of parameters (k) becomes less feasible. Hence, 
a screening model was applied to the variables in this study, so the remaining 
variables were limited in number for further optimisation in the full factorial model with 
response surface modelling (CCF). Finally, based on the evaluation of the CCF, the 
solid phase extraction parameters (conditioning (2-6 mL), wash (2-6 mL) and elution 
volume (1-3 mL)) could be optimised with respect to their effects (p>0.05) in response 
surface plots.  
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3.2.  Statistical optimisation of the total thyroid  
         hormone analysis: D-optimal design 
D-optimal designs are based on a mathematical formulation of the expected 
relations between variables [49], which mostly own, but do not require, an orthogonal 
matrix design resulting in possible correlated effect estimates. They are very useful 
when classical symmetrical designs (fractional or factorial) do not apply, e.g. the 
number of experiments chosen by a classical design is too large (e.g.: qualitative 
factors have more than two levels, which was the case here), when the experimental 
region is not regular in shape [50]. Moreover, the results of the experimental design 
can immediately be interpreted and show the effects of individual factors, indicating 
the optimal conditions, including their robustness [49]. For total thyroid hormones a D-
optimal design was chosen since various multi-level qualitative factors were included 
and the amount of runs was lower than a fractional factorial design would have 
implied [51,47]. 
The D-optimal optimisation based on nine variables (Table V.2) resulted in the 
elucidation of three significant factors (p<0.05): serum volume, mechanical vortex 
and manual shaking (Figure V.3).  
Significance could not be proven for the remaining factors, since these had merely 
non-critical (positive/negative) effects (p>0.05) on the extraction procedure. When 
the observed effect of a variable, which either aimed towards the upper or lower 
level of the chosen range, was similar for the majority of the components this level 
was built in. Since liquid-liquid extraction (LLE) had been previously described in 
literature as a potential extraction procedure for total thyroid hormones [33] and, 
since the effect of SPE (p>0.05) was not more advantageous, LLE was included in the 
RSM using a CCF design along with the serum volume (500-1000 µL). The evaluation of 
the number of liquid-liquid extraction steps resulted in a significant positive effect 
(p<0.05) for the two-step 1.5 mL-1 mL extractions. Subsequently, the optimization of 
the volumes in the first (1.5 mL-3 mL) and second (1 mL-3 mL) liquid-liquid extraction 
steps along with the serum volume (100-1000 µL) showed a positive effect (p>0.05) for 
the serum volume and an overall positive effect for the higher volume in the first 
liquid-liquid extraction step. Therefore, the most promising settings were built into the 
extraction procedure resulting in a serum volume of 1000 µL and a 3-1 mL liquid-liquid 
extraction. 
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Figure V.3: The D-optimal coefficients plot for free T4 with conditioning volume, 
mechanical vortex and manual shake, as significant factors (p<0.05). 
 
3.3.  Optimisation of UHPLC and MS-parameters 
For the elaboration of the UHPLC method, various parameters were optimised to 
overcome the lack of mass difference between T3 and rT3 (m/z 651.9) and 
subsequent similarity of their product ions (m/z 478.9-605.9), which called for their 
separation in time. Therefore, a variety of UHPLC-columns were tested under various 
flow (250-500 µL min-1) conditions: Hypersil Gold (50-100 x 2.1 mm, 1.9 µm, Thermo 
Scientific), Acquity HSS T3 (50 x 2.1 mm, 1.8 µm, Waters), C18 Sphinx RP (50 x 2.0 mm, 
1.8 µm, Machery-Nagel), Nucleodur C18 Gravity EC and Nucleodur C18 Isis EC (50-100 
x 2.0 mm, 1.8 µm, Machery-Nagel). Based on the signal-to-noise ratio, peak area, 
peak shape (asymmetry factor: 0.9-1.2) and baseline peak separation (above 1.5) 
between T3 and rT3, the Hypersil Gold (100 x 2.1 mm, 1.9 µm) column was retained. 
Two solvent combinations were tested: acidified (0.1% FA) UPW/acidified (0.1% FA) 
MeOH [15,18,20] and acidified (0.2% FA) UPW/acidified (0.2% FA) 1:1 mixture of 
MeOH:ACN [35]. Additional separation was achieved by careful optimisation of the 
gradient program. Therefore, various gradient programs with 0.1% aqueous FA and 
0.1% FA in MeOH were tested, as this was the most optimal solvent combination in 
terms of signal-to-noise ratio. The gradient program was extended to an 8 min run 
since this considerably reduced matrix interferences [11] and soiling of the column 
and MS over a large batch of samples. 
	  Chapter V 151 	  
 
Chapter V 
	  
	   	  
Before determining the optimal MS conditions, all 3 thyroid hormones and the 13C6-
labelled internal standard were infused (10 ng µL-1) into the tandem MS/MS and m/z 
values of the precursor ion, product ions and their respective collision energies and S-
lens voltages were defined (Table V.2). For every analyte (precursor ion), four 
daughter ions (product ions) with the highest signal intensity and signal-to-noise ratios 
were selected. Subsequently, optimal instrumental parameter values were 
determined by evaluating signal intensity and signal-to-noise ratio of selected 
precursor ion based on subsequent runs of a standard mixture of all four components. 
Identification of the thyroid hormones found in the bovine serum was therefore based 
on both retention time and the m/z ratio of four precursor ions. As such, the 
application of UHPLC-HESI-MS/MS with SRM allowed the detection of total and free 
T4, T3 and rT3 without significant interferences from the serum (cfr. 2.4.1 Specificity 
and selectivity). 
 
3.4.  Method validation for free and total thyroid  
         hormones 
The analytical methods were validated according to the criteria specified in CD 
2002/657/EC for quantitative confirmation [30]. An appropriate 13C6-labelled internal 
standard, T4-13C6, was chosen for its capability to anticipate fluctuations in the signal 
intensity upon extraction [16,10]. Indeed, the physico-chemical similarity between 2H- 
or 13C-labelled internal standards and the analyte of interest is known to be greater 
for 13C-labelled analogues. Moreover, the use of 13C-labelled internal standards is 
preferred for its improved ion suppression compensating ability, which is important in 
MS/MS [52]. 
Spiked thyroid hormone concentrations were based on background levels in the 
analysed bovine sera and reported concentrations. For the total thyroid hormone 
fraction, concentrations have been reported in the range of 36.0-73.0 ng mL-1 for T4, 
0.6-1.6 ng mL-1 for T3 and 0.2-0.3 ng mL-1 for rT3 in bovine serum. For the free thyroid 
hormone fraction, concentrations of 3.0-6.2 pg mL-1 for T3 and 10-18.6 pg mL-1 for T4 
have been reported in bovine serum [53,54]. All these reported concentrations [53-
58] are of course highly dependent of the physiological status of the animal (e.g. 
lactation, illness, age, bread) and thus not restrictive in any way.  
 
3.4.1. Specificity and selectivity 
Bovine serum contains a certain background level of T4, T3 and rT3 as these are 
naturally occuring hormones. The chromatograms of 20 blanks indicated that no 
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other matrix substances significantly interfered with the thyroid hormone signals, since 
signal-to-noise ratios of the chromatograhic peaks were in all cases higher than 10 
(Figures V.4 and V.5). When samples were fortified, a significant increase of the peaks 
of interest at the expected retention times with a substantial augmentation in area 
and signal-to-noise ratio were observed, thereby proving its selectivity for the analytes 
of interest. In accordance with CD 2002/657/EC, analytes were identified on the basis 
of their relative retention time, i.e. the ratio of the retention time of the analyte to that 
of the internal standard [30]. As a result, the developed method was found to be 
specific and selective for T4, T3, rT3 in the presence of matrix compounds. 
 
Figure V.4: UHPLC-MS/MS total ion chromatograms of total T3, rT3, T4 in (left) blanc 
and (right) spiked (0.625; 0.250; 7.5 ng mL-1) bovine serum	   with added internal 
standard T4-13C6 (10 ng mL-1) and respective retention time (RT), area (AA) and signal-
to-noise ratio (SN). 
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Figure V.5: UHPLC-MS/MS total ion chromatograms of free T3, rT3, T4 in (left) blank and 
in (right) spiked (10; 10; 25 pg mL-1) bovine serum with added internal standard T4-13C6 
(100 pg mL-1) and respective retention time (RT), area (AA) and signal-to-noise ratio 
(SN). 
 
3.4.2. Linearity 
A 10-point calibration curve in pooled bovine serum was used to evaluate the 
linearity of the developed method for the different compounds in both extraction 
procedures. The samples were fortified with concentrations reported under 1.3.3 
Quality assurance. For each sample the endogenous concentration, which was 
calculated as the average concentration based on the 20 non-spiked samples, was 
subtracted from the calculated total concentration. Linearity performed well since 
determination coefficients (R2) were all ≥ 0.99, which complies with similar reports 
[24,10], as well as, the EC/2002/657 directive requirements [30]. Furthermore, the 
regression model equations resulting from lack-of-fit [41] were reported to be all linear 
(F-test; α=0.05).  
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3.4.3. Precision 
The precision of the developed analytical method was evaluated through 
repeatability and within-laboratory reproducibility determination. Both validation 
parameters were evaluated by calculating their relative standard deviations (RSD%). 
To assess the repeatability, three series of six replicates at three different fortification 
levels in bovine serum were analysed by the same operator under repeatable 
conditions (Table V.3 and V.4).  
 
Table V.3: Performance characteristics of the total (T) thyroid hormone UHPLC-MS/MS 
method from bovine serum (ng mL-1). 
Analyte 
LOD 
(ng mL-1) 
LOQ 
(ng mL-1) 
Nominal 
concentration 
(ng mL-1) 
Recovery 
(%) 
Precision 
Repeatability 
RSD (%) 
Intra-lab. reprod. 
RSD (%) 
T T4 0.01 0.04 30 
60 
90 
104.4 
106.3 
97.1 
6.0 
5.4 
5.7 
5.2 
5.0 
4.7 
T T3 0.01 0.03 2.5 
5 
7.5 
103.9 
100.5 
95.6 
4.8 
3.9 
4.1 
4.4 
3.9 
3.7 
T rT3 0.02 0.05 1 
2 
3 
102.7 
97.2 
98.1 
6.2 
5.3 
2.5 
5.4 
4.9 
2.5 
 
 
Table V.4: Performance characteristics of the free (f) thyroid hormone UHPLC-MS/MS 
method from bovine serum (pg mL-1).  
Analyte 
LOD 
(pg mL-1) 
LOQ 
(pg mL-1) 
Nominal 
concentration 
(pg mL-1) 
Recovery 
(%) 
Precision 
Repeatability 
RSD (%) 
Intra-lab. reprod. 
RSD (%) 
f T4 2.2 
 
6.6 
 
50 
100 
125 
98.3 
99.8 
101.8 
6.9 
6.3 
7.5 
7.1 
6.0 
6.3 
f T3 0.9 2.7 20 
40 
60 
92.4 
106.5 
102.7 
4.2 
5.3 
6.7 
4.4 
4.8 
6.2 
f rT3 0.9 
 
2.6 
 
20 
40 
60 
92.1 
105.6 
98.7 
8.0 
6.7 
7.7 
7.1 
6.2 
7.3 
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The calculated RSD% values were excellent for the total (2.5-6.2%) and free (4.2-8.0%) 
thyroid hormone fraction since values were well below 15% compliant with CD 
2002/657/EC [30]. The intra-laboratory reproducibility was evaluated with four series of 
six replicates of samples, at three fortification levels analysed by different operators 
on different days. The calculated intra-laboratory RSD% values for free and total 
thyroid hormones ranged respectively between 4.4-7.3% and 2.5-5.4% (Table V.3 and 
V.4) for the three components over the various levels, which indicates a very good 
within-laboratory reproducibility, with reference to the 20% upper limit set by the CD 
2002/657/EC [30]. Also, in comparison to scientific literature intra-laboratory and 
repeatability RSDs are found to be within range for both total and free hormone. For 
example, HPLC-ID-MS/MS methods have been reported with RSDs ranging from 4.1-
9.0% for within-day and from 6.7-9.0% for between-day precision for free T4 and T3 in 
human serum [26,24]. For total T3 and T4 RSDs, within-day precision between 1.4-3.2% 
and between-day precision between 3.6-9.0% for total T3 and T4 have been reported 
in human serum [9]. Wang & Stapleton (2010) [10], which also worked with bovine 
serum, had intraday RSDs ranging from 1.2 to 9.6% for total T3, rT3 and T4, which 
closely correlate with our ranges. 
 
3.4.4. Limits of detection and quantification 
The limits of detection (LOD) and quantification (LOQ) are the lowest levels at which 
a compound can be identified or quantified with a signal-to-noise ratio (S/N) of 
respectively, ≥3 and ≥10. For the thyroid hormones (total and free) the detection and 
quantification limits were theoretically calculated based on 10-point calibration 
curves in matrix, correlating concentrations to signal-to-noise values.  
For total and free thyroid hormone analysis our LOD and LOQ values were remarkably 
better compared to literature (Table V.3 and V.4) [22,9,26]. For free (f) T3 and T4 LODs 
in human serum of, respectively, 0.4 pg mL-1 [24] and 2.5 pg mL-1 [26,24] (HPLC-ID-
MS/MS) have been described, which is in line with our results of 0.9-2.2 pg mL-1 with a 
UHPLC-MS/MS application. For total (T) thyroid hormones in human serum, LODs of 
0.03 ng mL-1 for TT4 (LC-ID-ESI-MS) and of 0.062 ng mL-1 for TT3 and TT4 (LC-ID-MS/MS) 
have been attained when deproteinisation, with or without LLE and SPE, was applied 
[22,9]. Reported LOQs for total thyroid hormones amount at 0.15 ng mL-1 with LC-ID-
MS/MS for TT3 and TT4 in human serum after deproteinisation [9], while an LOQ of 0.5 
ng g-1 in lyophilised human serum for TT3 and TT4 were achieved, if the analytical 
technique was preceded by deproteinisation and SPE [33]. To the best of our 
knowledge the only UHPLC-MS/MS method reported in bovine serum, acquired LODs 
in the range of 0.3-1.4 ng mL-1 for five thyroid hormones [10]. Clearly, the LODs and 
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LOQs achieved in our study in bovine serum are well below the average reported 
values for total and free thyroid hormone analysis bearing in mind a simple liquid-
liquid extraction and UF-SPE combination sufficed to achieve this with a similar 
tandem MS technique.  
 
3.4.5. Mean recovery 
As no certified reference material was available, trueness was determined as the 
mean corrected recovery by using fortified bovine serum samples. To this extent, 
three fortification levels were considered with six replicates for each level for both 
total and free fractions (Table V.3 and V.4). For each sample, background 
concentrations were deducted from the calculated concentrations when necessary. 
Results were found satisfactory for both total and free thyroid hormone methods, 
since the lowest mass fraction (10-100 ppb) according to the European directive 
2002/657/EC [30] requires mean recoveries between 80-120% and the present 
recoveries ranged for free and total thyroid hormones fractions between 92.1-106.5% 
and between 95.6-106.3%, respectively. Reportedly, total and free thyroid hormone 
recoveries for T3 and T4 in human sera have been described between 90-109% with 
(HP)LC-ID-MS/MS detection [9,24]. In comparison with the only so far developed LC-
MS/MS application in bovine serum [10] (81.3-111.9%) for total thyroid hormones, our 
newly developed method clearly performed better.  
 
 
4. CONCLUSION 
In this study, tailored extraction procedures were successfully developed for total and 
free T3, rT3 and T4 fractions, based on statistical fractional factorial designs in bovine 
serum. Both for free and total hormone fractions, one UHPLC-MS/MS detection 
method was developed and optimised operating in both the ng mL-1, as well as, low 
pg mL-1 ranges. This resulted in the successful validation of both methods according 
to CD 2002/657/EC criteria, showing a good performance in terms of linearity, 
accuracy, precision, LOD and LOQ. Both free and total thyroid hormone methods 
have the potential to be broadened to a wider use (e.g. horse, dog, cat serum) in 
accordance to Wang & Stapleton (2010) [10], who developed a method for total 
thyroid hormone on bovine serum and applied it to human serum with nice 
correlations. In this context, it must be stressed that our method allows the analysis of 
both fractions, which to the best of our knowledge has not been reported earlier. 
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Therefore, in a veterinary clinical setting our newly developed sensitive and specific 
UHPLC-MS/MS technique would allow a fast and low-labour-intensive approach to 
quantify both thyroid hormone fractions (free and total) in non-human serum (bovine) 
and provide a sensitive and fast alternative in comparison with available methods. 
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1. GENERAL RESEARCH OUTCOME 
1.1. Research positioning 
Besides administration for the purpose they were intentionally developed for, i.e. the 
treatment of ‘thyroid rush’ or hyperthyroidism in human and veterinary medicine, 
thyreostatic drugs may be used as illicit weight augmenting drugs in animal 
production. Several negative aspects have however been attributed to the misuse of 
these therapeutics including inferior meat quality (water retention), fraud (water sold 
for the price of meat) and the potential risk of teratogenic and carcinogenic effects 
from the remaining residues present in animal derived products. This is why the 
European Union enacted the banishment of thyreostats from meat production in 1981 
with a zero-tolerance limit [1]. 
In order to continuously protect the consumer from potential law violations 
concerning thyreostat abuse in animal production, a series of strong measures 
needed to be taken [1]. Amongst those, monitoring methods were developed for 
thyreostats in thyroid tissue, muscle and urine. At the very beginning, differentiation 
(compliant/non-compliant) was based on a combination of subjective factors: 
symptomatology, detection of thyroid hormones, thyroid micro- (histological 
changes) and macroscopy (weight, goiter). Eventually, the weight shifted towards 
analytical methodologies for the detection of thyreostats. More recently, the 
introduction of UHPLC allowed higher sample throughput and increased 
chromatographic resolution. With this, fast switching QqQ instruments emerged 
characterized by improved sensitivity and specificity [2-5]. These analytical 
innovations led to a more reliable detection of thyreostats with increased sensitivity. 
Clearly, if it was not for these analytical evolutions, the shear existence of natural 
occurring thyreostats would not have been discovered since these concentrations 
would simply have remained undetectable. These low-level TU (< 10 µg L-1 (RC)) 
concentrations, which were detected in livestock urine during national control plans, 
represented a violation of the zero-tolerance limit. However, based on research 
findings regarding the effect of certain animal feeds (Brassicaceae) on the excretion 
of thyreostatic compounds in bovine urine [6] and the known kinetics of synthetic 
thyreostats [7,8] it was hypothesised that the most probable source of endogenous TU 
was feed-related. Moreover, these low-level TU concentrations had negligible growth 
promoting potential (growth promoting = 5 g per day p.o.), which further enables the 
natural occurrence of TU from any potential illegitimate pursue of economical profit. 
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Because of this, thyreostats were ascribed a dual status, implying either an illicit 
administration or a feed-related origin.  
 
Within this framework, the scope of this doctoral thesis included to: 
 
 Evaluate the potential of TU formation upon ingestion of  
Brassicaceae through in vitro digestion simulations of livestock  
(CHAPTER II) 
 Elucidate the mechanism of intestinal TU formation upon in vitro 
digestion of Brassicaceae feeds (CHAPTER III) 
 Isolate and identify the intestinal bacteria involved in the formation of  
TU upon in vitro digestion of Brassicaceae feeds (CHAPTER III) 
 Optimize the extraction of TU from various animal feeds and validate 
the analytical method (CHAPTER IV) 
 Develop a sensitive and selective UHPLC-MS/MS application for the  
analysis of thyroid hormones in bovine serum to evaluate the effect of 
‘naturally occurring thyreostats’ in vivo (CHAPTER V) 
 
 
1.2. Main research findings  
The main accomplishments of this work are summarized in Figure VI.1. 
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Figure VI.1: Overview of the main realizations achieved in this work. 
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1.2.1. Elucidation of the mechanism behind thiouracil  
   formation  
The terms, natural, semi-endogenous or endogenous TU formation all refer to the 
same intraorganism formation phenomenon of a non-physiological, at that time 
alleged synthetic compound, called TU. In previous research low-level TU 
concentrations have been found in various animal species (e.g. sheep, cattle, horse, 
dogs and pigs), as well as, humans both with and without diet control [9,10]. 
Additionally, the ingestion of animal feeds containing (max. 30%) products derived 
from the Brassicaceae family (cabbage, rapeseed) has been related to the 
excretion of TU in bovine urine [6]. These findings suggest that the interaction 
between the ingestion of certain feeds and the metabolisation in the organism 
causes TU detection. Therefore in Chapter II an elaborate evaluation of the TU 
forming potential of faecal inocula of various animals (bovine and porcine) with 
addition of specific Brassicaceae feeds (whole rapeseed, grounded rapeseed, 
cooked rapeseed, coarse colza ‘00’ meal, broccoli or cauliflower) with different pre-
treatments (e.g. grounding, cooking) was performed in vitro. From this, a clear insight 
in the formation of TU throughout the digestive tract (stomach/rumen, small intestine 
and large intestine) was obtained in mono- and polygastric animals. Clearly, the 
influence of microorganisms in this process was proven, since TU was detected in the 
most densely populated areas of the GI tract upon Brassicaceae addition, i.e. the 
colon and to a minor extent the rumen. The concentration of TU detected upon in 
vitro digestion of the different feeds also depended on the GL content. Coarse colza 
‘00’ meal for example, with a restricted GL content was consistently the lowest TU 
producing feed, regardless of the inoculum. Grounding and heating of feeds did not 
affect TU formation in a colonic in vitro digestion. Moreover, a high variability 
between (bovine and porcine) and within species was found in TU formation. Indeed, 
a high variability of the intestinal microbial population has been described, even 
within one species, as many influential factors, like age, feed, physiological status etc. 
can vary this equilibrium [11-13]. Overall the porcine colonic in vitro digestions 
produced the highest TU concentrations compared to bovines. Therefore, this model 
was chosen for further experiments to elucidate the mechanism of TU formation.  
 
Furthermore some preliminary experiments are described in Chapter II, which 
intended to characterise the potentially myrosinase-like enzyme activity of colonic 
suspensions upon in vitro digestions with rapeseed. These experiments confirmed the 
involvement of bacteria in the formation of TU during in vitro Brassicaceae digestions. 
Filter sterilization and autoclavation of the not pre-cultured faecal inoculum showed 
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a significant decrease of TU formation during subsequent in vitro Brassicaceae 
digestions. At this stage however, the hypothesis of a non-myrosinase-like bacterial 
precursor was briefly envisaged based on the fact that in pre-cultured inocula, TU 
formation after filter sterilisation was increased, which was not the case when non-
pre-cultured inocula were used. This finding pointed towards a potential non-cellular 
activity, which could not be related to myrosinase-like enzymatic activity, since 
bacterial myrosinase had been reported to possess a cell-dependent activity [14,15]. 
Furthermore, the incubation of Brassicaceae colonic in vitro digestion suspensions at 
the end of the digestion with sinigrin, a GL, was not capable in producing glucose, 
although addition of synthetic myrosinase (purified from mustard seed, Sinapsis alba 
L.) did induce sinigrin hydrolysis with subsequent glucose formation. This purified plant-
derived myrosinase from Sinapsis alba L. could degrade sinigrin since this is the 
second most abundant GL within white mustard seeds (sinalbin > sinigrin) [16]. In 
rapeseed other glucosinolates (progoitrin, gluconapin and 4-hydroxy-glucobrassicin) 
are dominant [16,17] than sinigrin [17,18]. As such, it was however too precarious to 
conclude that the suspected TU forming myrosinase-like bacterial activity is not 
present because of different glucose production compared to the activity of the 
plant-derived myrosinase of mustard seed. The bacterial myrosinase activity, which is 
also able to form TU, is potentially more adapted to the GLs abundant in rapeseed. 
This has also been reported for degradation of GLs by intestinal bacteria, showing 
that pre-culturing bacteria in a sinigrin enriched medium induced their subsequent 
sinigrin degrading activity rate compared to control cells grown on glucose [19]. 
Furthermore, the Brassicaceae family contains a variety of myrosinase enzymes. 
However, not much is known about their properties or the role of their iso-enzymes 
[20,21]. In this light, it is likely that also different types of bacterial myrosinase-like 
enzymes can be formed and that proving the myrosinase-like hypothesis with indirect 
detection methods will also depend on the physico-chemical characteristics of the 
bacterial equivalent.  
 
A more in depth evaluation of the mechanistical background of TU formation in 
Chapter III, included amongst others proof that the presence of bacteria was 
prerequisited by double filter sterilisation, which similarly confirmed the previous 
results, showing a decrease in TU. Trough pasteurisation it was shown that TU could be 
formed upon treatment of the bacterial inoculum with moderate heat (60 °C) for a 
specific (max. 30 min) period of time, after which the effect seemed lost. Although 
heat-treated microorganisms generally do not grow on agar, they can succeed in 
repairing damage and regain their potential for growth under optimal broth 
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conditions [22]. Such events might explain the undisturbed TU production over the first 
30 minutes of pasteurisation, while after 60 min bacterial survival is unlikely due to 
irreversible damage. Inactivation of certain plant-derived myrosinases also shows 
resistance to a range of temperatures (30-65 °C (for rapeseed)) depending on the 
crop after which inactivation sets in [23]. Moreover, it has been described that 
certain proteins can regain activity after moderate heat inactivation [24]. Besides, E. 
coli has been reported to survive up to 30 min at 60 °C, dependent on strain, medium 
and optimal conditions, which is comparable to the present results [22]. At 55 °C, 
inactivation is only achieved after 60-120 min in broth [22]. Therefore, in the 
assumption that the responsible (bacterial) mediator is a membrane-bound protein 
(myrosinase-like enzyme), heat treatment would likely cause some degree of 
denaturation over time, but semi-reversible denaturation has been reported [24]. 
Moreover, β-thioglucoside glucohydrolases remain active in a broad range of 
temperatures (up to 60 °C) and pH (5-10) [25] offering an explanation for sustained TU 
production upon pasteurization and decreased TU production upon double filter 
sterilisation, thereby supporting the hypothesis of an extracellular membrane-bound 
myrosinase-like enzyme as mediating factor for TU formation.  
 
As a second part of elucidating the mechanism of TU formation, in Chapter III, TU 
forming bacteria were successfully isolated and identified from rapeseed colonic 
digestion simulations of porcines. Besides, a higher rate of intestinal TU formation was 
noted under anaerobic conditions. To the best of our knowledge, no previous reports 
have been published describing the identification of TU forming bacteria in porcines. 
The nine common intestinal bacteria that were identified belonged to 4 different 
species (E. coli, E. faecium, L. reuteri and Salmonella enterica ssp. arizonae) and 
provide a first insight into the potential actors of the endogenous TU formation 
process. A β-glucosidase GLs degrading myrosinase-like enzymatic activity has been 
described for all the identified bacterial species [19,26-31]. Strains of the genera of 
Escherichia, Lactobacillus and Bifidobacterium have been reported to produce 
surface-associated extracellular proteins/peptides [32]. Interestingly, these bacteria 
are common intestinal bacteria in both porcines and bovines [33-40].  
 
With respect to rapeseed as a source of TU, autoclavation thereof caused an 
insignificant decrease in TU formation compared to a positive non-autoclaved 
rapeseed control when incubated with pre-cultured faecal inoculum, in Chapter II. 
The postulated explanation for this was that faecal debris present in the inoculum can 
act as precursor for TU when no rapeseed is added. In Chapter III, this was confirmed 
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since the addition of rapeseed to faecal inoculum did not increase TU formation 
significantly as compared to a control. Indeed, in literature it has been described that 
60% of the GL content of feed reaches the colon unaltered in pigs and although 
these are mostly degraded prior to defecation, many breakdown products are 
present in faeces [41]. When only autoclaved rapeseed  (Chapter III) was incubated, 
TU formation was negligible. When however non-autoclaved rapeseed was 
incubated again without faecal inoculum a slight increase of TU was observed in 
comparison with autoclaved rapeseed. In vitro degradation of the aliphatic 
glucosinolates sinigrin, progoitrin and gluconapin as well as the aromatic 
glucosinolate sinalbin by phytophatogenic fungi of Brassica has been described [42]. 
But, because these TU increases never exceeded the background level of TU in 24 h 
pre-cultured faecal inoculum, it is highly unlikely that contamination would 
significantly contribute to endogenous TU formation, as previously stated (Chapter II).  
Next, to further confirm Brassicaceae were in fact needed for TU formation, blank, 
autoclaved rapeseed and rapeseed incubations were performed with two TU 
producing strains, i.e. L. reuteri and E. faecium, thereby omitting the influence of 
degraded GL faecal constituents. Since addition of rapeseed as a whole did 
significantly increase TU formation upon incubation with pure strains, its importance as 
a source of TU precursor in line with previous in vivo [6] research was confirmed. 
Furthermore, the enumeration of pure strains E. coli, L. reuteri and E. faecium showed 
no growth inhibiting effects due to rapeseed [43] addition in the in vitro simulations. 
 
From Chapter II the inter- and intra-species variation of in vitro intestinal TU formation 
became clear. When, however, evaluating the relation between the age of the 
animals and TU detection in livestock urine, literature has indicated that young 
bovines have been reported to have higher concentrations of TU in their urine in 
comparison to adult cattle and porcines [44-46]. In the present study the TU forming 
activity in porcine in vitro colonic digestions was observed to increase with age 
(Chapter III). Taking into consideration several threshold studies [44-46] it should be 
noted that these only inquired the presence of TU in urine of young porcines. 
Therefore, the relatively low TU concentrations in porcines might be more related to 
the selected subgroup (1-8 months) and only to a lesser extent to the effect of 
rapeseed in their diet [44,45]. Moreover, taking into account the newly identified TU 
producing bacterial strains in porcines, this finding is also supported by scientific 
literature, since these specific bacterial strains are more present in young calves (high 
TU producing) and older porcines, whereas less in young porcines [39,34,47,48].  
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In conclusion, the anaerobic process of TU formation was tentatively characterised as 
an interaction between rapeseed (Brassicaceae) and bacteria, with the latter 
producing a membrane-bound extracellular enzyme sustaining moderate heat, but 
not autoclavation expressing a glucosinolate (myrosinase-like) degrading activity.  
 
However, to be able to extrapolate and confirm these in vitro findings there is need 
for in vivo testing. The concentrations detected in vitro are based on the interaction 
between high glucosinolate content traditional rapeseed and inocula or bacterial 
strains, without intestinal cell wall interactions (absorption, secretion, etc.). These 
values can therefore not unilaterally be transposed to the live situation in the animal 
since mostly low glucosinolate feeds are commonly used nowadays. However, these 
results do show intestinal transformation is possible based on the interaction between 
certain bacteria and Brassicaceae feedstuffs. Also, the intestinal formation process 
has been shown to be susceptible to certain factors (oxygenation, heat, becteria 
etc.). An in vivo study would enable further evaluation of the process, showing if 
feeding low glucosinolate Brassicaceae (max. 30%) based feedstuffs upon digestion 
is the sole inducer of TU occurrence in livestock urine. More importantly, it could 
potentially demonstrate if TU formed intestinally upon Brassicaceae digestion and TU 
administration, indepently, have a different influence on TU concentrations but also 
the presence of potential biomarkers in livestock urine. Besides, absorption and 
excretion kinetics of TU, as well as, thyroid hormone patterns could be evaluated in 
parallel with the evaluation of other influential factors (e.g.: age, gender, species). At 
the moment such an in vivo study is on going at our laboratory, called the 
THYREOMERK FOD-project (cfr. 1.3 Future perspectives).   
 
1.2.2. Feed analysis developments 
The main goal of Chapter IV involved the optimization of a robust detection method 
for TU in various animal feedstuffs from Brassicaceae and non-Brassicaceae origin. 
Literature reports are very scarce regarding specific methodologies for thyreostat 
analysis from animal feedstuffs [6,49-51]. The developments for thyreostat detection 
by Pinel et al. (2005) [2] on a triple quadrupole mass spectrometer in rapeseed and 
cabbage did not enable TU detection. It was only when the method was adapted 
by Vanden Bussche et al. (2011) [52], who added a hydrolysis step with plant-derived 
myrosinase to the extraction procedure that the presence of TU could be discovered 
in various Brassicaceae vegetables, seeds and meals. In this research, the extraction 
protocol was optimized for both Brassicaceae and non-Brassicaceae feedstuffs, since 
both are being administered to animals but little to no information is available 
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regarding their TU status. Surprisingly, after statistical Plackett-Burman optimization 
myrosinase was ruled out as a major influential factor in the detection of TU in 
Brassicaceae and other feedstuffs. This confirmed a preliminary result, which showed 
adding various amounts (0-3 mL) of myrosinase to the feed extraction procedure 
from Vanden Bussche et al. (2011) [52] decreased TU detection from coarse colza 
‘00’ meal. The influence of sonication, over night incubation of the feed in a pH 7 
buffer and the optimization of the extraction steps are probably much more 
important and make the addition of plant-myrosinase superficial. Whether the 
detected thiouracil is originating from TU present in the feed and/or TU formation 
based on a precursor cannot be determined. It is, however, not unthinkable that 
during the incubation of feed in buffer solution residual myrosinase activity (plant or 
microbial) might cause slight TU formation.  
The LOD of 0.2 µg TU kg-1 achieved by this method is well below the 10 µg kg-1 RC, 
and the previous 150 µg kg-1 achieved by the method described by Pinel et al. (2005) 
[2]. To the best of our knowledge this is the first method that was successfully 
validated for TU in feedstuffs and proved applicable for different types of fodders, 
obtained through the national control plan of Ireland upon positive urine testing for 
TU.  
 
Method developments for thyreostats in animal foodstuffs, have gained increasing 
attention lately, as the latest 2014 Reflection paper (Natural growth promoting 
substances in biological samples) by the European Reference Laboratories included 
feed analysis as part of the control plan [53]. This paper stated that undoubtable low-
levels of TU that occasionally are detected in samples of urine are the result of TU 
precursors present in animal feed. Moreover, since several studies independently 
[53,44-46] indicate that urinary TU levels can exceed the current RC of 10 µg L-1, it was 
suggested to increase the RC up to 30 µg L-1. Indeed, research showed [53] that the 
administration of TU with a double daily dose of 2.5 g p.o. in cattle displayed mg L-1 
instead of µg L-1 concentrations of urinary TU (Figure I.2), which is the dosage (5 g per 
day) that has to be administrated to observe the expected weight gain, illustrating 
the fact that higher (ppm-range) urinary levels should be expected upon illicit 
administration. On that account pleading for a higher TU limit  (30 µg TU L-1) seems 
defendable [44].  
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Fig VI.2: Excretion of thiouracil in urine over a 14-day period in a young heifer, which 
was administered 5 g thiouracil per day (2*2.5 g p.o.) [42]. 
 
 
In case this new urinary RC is exceeded, a new strategy is proposed in the Reflection 
paper, including the analysis of the administered feed with and without myrosinase 
hydrolysis as reported by Vanden Bussche et al. (2011) [52]. A flowchart (Figure I.3) 
shows the mode of action to either confirm or refute that feed is the source of TU 
detection in urine. When no direct link can be established between TU in urine and 
feed samples, follow-up investigations on the farm are required. Lastly, the 
stabilisation (pH=1, EDTA) [54] of urine samples and minimisation of freeze-thaw cycles 
is also encouraged since reports have shown detection can thereby be impaired, 
resulting in underestimation of thyreostat concentrations [4,53]. 
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Figure VI.3: Decision flow chart for thiouracil findings in bovine urine. Feed was 
extracted with (‘Act. Feed’) and without (‘Feed’) myrosinase addition [53]. (*: After 
activation no significant increase in thiouracil concentration was seen)  
 
 
1.2.3. Thyroid hormone analysis developments 
Thyroid hormones are essential to sustain a normal functioning metabolism, even 
though the thyroid gland is one of the smaller organs of the organism. These 
hormones influence a variety of pathways and organs e.g. the metabolic rate 
(carbohydrate and lipid metabolism), growth, the cardiovascular, the reproductive 
and the central nervous system [55]. Therefore, the assessment of thyroid hormone is 
an essential parameter in the clinical evaluation of thyroidal disorders in animals and 
humans.  
The analysis of thyroid hormones, however, presents many challenges. Firstly, the fact 
that thyroid hormones can be either bound to transporter proteins, or remain free in 
the bloodstream, while maintaining an equilibrium, which is an important parameter 
in diagnostics. Therefore, this physiological equilibrium (free:bound) should be 
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reflected by analysis without suffering from potential deviations mainly inflicted by 
inappropriate sample preparation conditions. Secondly, the analysis itself might be a 
challenge since concentrations can go down to low ppt-levels (e.g. for free thyroid 
hormones in animals). For that reason, a powerful and sensitive detection tool is 
necessary. Third is the sample preparation and subsequent extraction that needs to 
be adapted to the fraction (free or bound), which will be analysed. The most 
common factors, that have been described to exert an influence on the final results, 
are e.g. the use of serum separator tubes, time interval prior to centrifugation, 
centrifugation temperature [56], effect on whole blood, serum and plasma of storage 
temperature and time [57]. Besides, endocrine diagnostic testing can be affected by 
many clinical factors (medication, illness, stress concurrent illnesses and individual 
characteristics (age, breed, gender and reproductive status). Therefore, by 
minimizing the effect of sample handling and treatment at least the non-
physiological variability can be omitted, increasing the correlation between the 
results and the physiological state of the animal, which in turn improves the reliability 
of the final diagnostic. 
The thyroid hormone analysis method (Chapter V) was developed in agreement with 
previous scientific reports with respect to sample pre-treatment. For example, serum 
was obtained from fully clothed whole blood which was directly centrifuged and 
serum samples were stored at -20 °C, freeze-thaw cycles were minimized, 
centrifugation temperatures approximated body temperature and extracted 
samples were analysed the same day [56-58]. Moreover, since most thyroid hormone 
detection methods used in veterinary medicine rely on ELISA, RIA or alternatively CLA 
[59,60], the present method, using mass spectrometry as a detection technique, is 
unique for veterinary purposes. Although MS had been already broadly introduced 
and even accepted as a golden standard in human thyroid hormone analysis 
[56,58], no reports on veterinary applications were available. Furthermore, the UHPLC-
MS/MS method was sensitive enough to analyse both free and total thyroid hormone 
samples after different extraction procedures were applied. Total thyroid hormone 
included deproteinisation and liquid-liquid extraction whereas free thyroid hormone 
needed separation through ultrafiltration and solid phase extraction. For the 
separation of the free hormone fraction ultrafiltration was elected above equilibrium 
dialysis, because the latter is commonly used in animals but proves to be more labour 
intensive and costly [56].  
Ultimately, the goal of the development of this thyroid hormone UHPLC-MS/MS 
method is to evaluate the effect of endogenous TU formation in livestock, based on 
the ingestion of different diets. Within the THYREOMERK FOD-project (RF12 6260), this 
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method will be used to evaluate the thyroid status of animals under various 
Brassicaceae and non-Brassicaceae diets (cfr. 1.3 Future perspectives). 
Finally, with respect to the thyroid hormone detection method, we believe it could 
easily lend itself to different other species, beside bovines, broadening its field of 
application in veterinary medicine, considering minor optimizations would be 
performed.  
 
 
1.3. Future perspectives 
Despite of the findings reported in this study with respect to the endogenous status of 
TU, some questions still remain. Potential research paths may amongst others include 
discovering a biomarker that allows differentiating endogenous formation from 
exogenous administration of thyreostats, further investigation of potential other feed 
sources that sustain TU formation, evaluation of the risk of low-level natural TU through 
consumption in vivo. Eventually, all these will provide a strong base for an adapted 
legislative framework. Notwithstanding, derogations and adaptation of the EU 
legislation may already be made based on the current results and knowledge. 
 
1.3.1. Discriminating endogenous from exogenous  
   thiouracil 
At the time, a direct discrimination between endogenous and exogenous TU has not 
yet been achieved. The investigation of a potential biomarker that would render 
differentiation possible is still on-going e.g. the THYREOMERK FOD-project. This project 
is a cooperation between our laboratory (Laboratory for Chemical Analysis) and the 
CER (Centre d'Economie Rurale, Marloie, Belgium), aiming amongst others to set a 
threshold for TU in urine based on the thorough statistical evaluation of control plan 
data from national reference laboratories all over Europe (e.g.: Belgium, Ireland, 
Norway, Poland, Netherlands). This will allow a more accurate differentiation 
between compliant and non-compliant urine samples. Moreover, it will evaluate the 
effect of administering thiouracil, feeding Brassicaceae and non-Brassicaceae 
fodders in a bovine in vivo study on the basis of TU detection (urine, feed) and thyroid 
hormone detection (serum). Eventually, the in vivo collected urine will be pivotal to 
finding a specific biomarker for the differentiation of endogenous TU formation based 
on an untargeted high-resolution mass spectrometry (HRMS) approach. Several types 
of HRMS techniques exist with variable resolving power, for example ToF with 10 000-
40 000 full width half maximum (FWHM), the Fourier transform ion cyclotron resonance 
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(FT-ICR) and Fourier transform Orbitrap MS with usually 100 000-140 000 at 200 m/z and 
for the latest generation more than 240 000 at 400 m/z can be achieved [61,62]. The 
use of HRMS is highly encouraged for biomarker investigations, as these techniques 
posses besides this high resolving power, also high mass accuracy, sensitivity, 
dynamic range and make post acquisition data mining possible [63,64]. This latter 
aspect is quite interesting as full scan spectra of matrices from control, TU treated, 
and rapeseed fed animals could be evaluated untargetedly. This type of approach 
requires a highly generic sample preparation in order to preserve as many unknown 
components as possible [65]. For now however, only one targeted HRMS application 
has been described in bovine urine by Léon et al. (2012) [66] for a multi-residue 
analysis of 87 banned or non-regulated veterinary drugs (a.o. steroid hormones, β-
agonists, resorcylic acid lactones (RAL), stilbens, tranquillizers, nitroimidazoles, 
corticosteroids, NSAIDs, amphenicoles, thyreostats, etc.), including thyreostats. Léon 
et al. (2012) [66] applied a generic approach identical for all components called 
QuEChERS (Quick, Easy, Cheap, Effective, Rugged, and Safe), which was based on 
buffered extraction with acetonitrile and dispersive-SPE, achieving detection for all 
components with a mass deviation less than 5 ppm at 50,000 FWHM. Except for 6-
phenyl-2-thiouracil, the method reached a CCβ of 10 µg L-1 for all considered 
thyreostats (including TU), which is equal to the RC. According to the CD/2002/657 
[67] the CCβ should be below the RC, which is also indicated for detection of low-
level concentration of TU in urine originating from animal feed. Further optimization in 
this area would therefore be advisable.  
In the case of natural thiouracil differentiation, a new untargeted method remains to 
be developed. If successful this type of approach will need the assistance of specific 
mathematical algorithm-based statistical data mining software due to the large 
amount of acquired spectral data in HRMS. These types of software can perform 
trend (multivariate) analysis to identify compounds (m/z) that vary with dosage, time, 
or other trend classifications (e.g. TU administration or Brassicaceae feed 
administration). Statistically rigorous data mining tools have the power to compare 
hundreds of LC/MS data files at once, by prefiltering complex data, greatly reducing 
the number of compounds that need to be evaluated and significantly decreasing 
time spent on identification. The latter can be performed using public domain user-
selected databases. Plot visualization of the data can help discriminate the 
significantly influential m/z values from the less influential and disclose certain 
patterns. Besides, identification of the potential biomarker metabolite of interest, 
quantitative method validation should also be conducted evaluating the 
performance of the method, similarly to the well-known evaluation parameters 
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described in the CD/2002/657 [67] (e.g. sensitivity, precision, recovery). Untargeted 
approaches typically use relative quantification (i.e. reporting of metabolite(s) 
instrument response relative to an internal standard or another metabolite(s) level 
such as the sum of all metabolite abundance). Whereas, absolute quantification 
(determination of the absolute concentration of a metabolite) through correlation of 
its instrument response to that of a known concentration series of the same 
metabolite is commonly used in targeted metabolite(s) analysis [68]. 
Furthermore, these HRMS techniques, like Orbitrap and ToF, can be hyphenated with 
an ion trap (e.g. LTQ-Orbitrap) or a triple quadrupole (Q-Exactive, QqToF) allowing 
structural elucidation and identification of the potential biomarker/metabolite 
through fragmentation. Regarding quantification, 4 IPs are required for group A 
substances according to the CD/2002/657 [67] and each HRMS ion earns a minimum 
of two IPs, therefore two molecular ions (HRMS) (often deliberately combined with 
C13/C12 ratio’s) or one quantitative molecular ion and one confirmatory product ion 
(hybrid HRMS) suffice to confirm any substance [62].  
 
Once biomarkers for differentiation of endogenous TU would be available, evaluation 
of these biomarkers in other matrices (besides urine), which would have been 
confirmed with TU presence (e.g. thyroid), should be performed as well. Although it is 
not certain that the urine biomarker would automatically be present in other 
matrices. Potential matrices should be foremost easy to sample and might therefore 
include faeces, but also saliva or even breath. In the latter case natural TU would 
need to cause specific volatile organic compounds (VOCs) to be exhaled in breath, 
which would be significantly different from exogenous administration. In humans, 
research on breath has been performed for pre-clinical disease markers [69], but 
lately also in bovines disease differentiation based on VOCs has been proven [70]. It 
remains however to be seen whether a discriminating biomarker is present in other 
matrices then urine for natural TU. The practical on-site biomarker evaluation of a 
subset of animals would then be possible if portable sensitive and selective devices 
were available, which would make evaluation of the animals quicker, less time and 
labour intensive. This type of analysis, however, has still a long ‘optimization road’ to 
go before a practical application can be foreseen. Notwithstanding, the 
combination of a preliminary biomarker screening method and confirmatory mass 
spectrometrical analysis could be foreseen in this way. Such combination has already 
been put forward for hormone abuse in cattle [71]. 
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Regarding the applied methodology for the endogenous TU discriminating biomarker 
quest, other methods besides HRMS, like isotope ratio MS, may also be considered in 
the differentiation of endogenous versus exogenous TU. This approach enables 
precise measurements of stable isotope ratios (12C/13C) within a sample resulting from 
fractionation patterns inherent to the endogenous or exogenous origin of the 
compound. This procedure has been widely used in the differentiation of steroids 
[63,72-74] and has been lately put forward for evaluation of its applicability in the 
differentiation of corticosteroids [53]. 
 
1.3.2. Legislation: is an adaptation required? 
Based on the current legislation surrounding thyreostat abuse, it may be stated that 
certain actions should be taken to resolve the duality concerning thyreostats. The 
current zero-tolerance [1] for thyreostats in animal matrices is still held on to by way of 
precaution, but at this time the dual status of TU has been proven [6,9,10,52,75], 
which should also be acknowledged by the EU by providing a more adapted 
legislative framework. Future European legislation should, therefore, include 
derogation clauses for TU detection coming from an endogenous source (feed-
related). Since the RC currently at hand [76] has no power of law, it would be 
opportune that the EU would adopt a TU reference concentration (or threshold) 
below which TU is accepted to be of endogenous origin in order to clarify the present 
situation. The proposition to develop a reference point for action (RPA) (Council 
Regulation (EC) No 470/2009) [77] was a step in the good direction, but the actual 
elaboration of an RPA level for thyreostats and its implementation is still awaited. 
Moreover, with the increasing amount of threshold research regarding thyreostats 
[44-46], setting a RPA or threshold value should be feasible on a country-based level. 
Thresholds values for TU in urine samples were proposed at 95% and 99% for France 
amounting at 5.7 µg.L-1 and 9.1 µg.L-1 in male adult bovines (6-24 months), 3.1 µg.L-1 
and 8.1 µg.L-1 in female adult bovines (6-24 months), 7.3 µg.L-1 and 17.7 µg.L-1 in calves 
(< 6 months), 3.9 µg.L-1 and 8.8 µg.L-1 in female adult bovines (> 24 months), 2.9 µg.L-1 
and 4.1 µg.L-1 in porcines (1-8 months) [44]. Poland had 95th and 99th percentiles for TU 
below 4.50 and 14.85 µg L-1 for bovine urine samples and below 2.35 and 6.80 µg L-1 
for porcine samples. Even though, the results of both countries were concurrent a 
country-based assessment seems advisable, in order to potentially discriminate inter-
country variations [45]. 
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1.3.3. Application of analytical developments 
Finally, the analytical methods developed in this study for thyroid hormones in bovine 
serum and TU in animal feed could be used for scientific purposes.  
 
The evaluation of clinical changes concerning the thyroid status and the effect of 
endogenous/exogenous TU could be evaluated. The elaboration of the thyroid 
hormone detection method to other species should be pursued in order to create an 
alternative for current detection in veterinary medicine.  
 
The detection method for TU in Brassicaceae and non-Brassicaceae feed could also 
be used as a screening tool for animal feeds before administration (upon 
manufacturing) or as a control parameter when a positive urine sample is 
encountered in order to trace the origin back to the ingested feed. Additionally, a 
broad evaluation of a large variety of animal feeds with known compositions and 
known-manufacturing processes could clarify and potentially lead to classification of 
animal feeds according to their potential to form TU in vivo, which should be 
confirmed in live animals. In general practice, it is not feasible to link back TU positive 
urines to the originally ingested feed. Consequently, parallel ran samplings of feed 
and urine could make a closer follow up possible [53].  
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At present, thyreostatic drugs, including thiouracil (TU), are still banned from livestock 
production in the European Union. This banishment is based on the illegal weight gain 
they cause, as well as, the potential teratogenic and carcinogenic effects their 
residues might induce. About a decade ago, the occurrence of low-level 
concentrations (< RC of 10 µg L-1) of TU in livestock urine raised the awareness for a 
potentially other origin than illicit administration. Over the years, the hypothesis of a 
feed-related origin (Brassicaceae) was put forward, but the complete elucidation of 
this natural TU formation remained unfulfilled. Clarification was, however, urgently 
needed since, sensu stricto, any concentrations of TU in livestock urine were a 
violation of law, subsequently leading to economical consequences. In this doctoral 
research, the natural TU formation in livestock was investigated through an in depth 
multi-disciplinary approach, including analytical developments, static in vitro 
gastrointestinal simulations and microbiological approaches. 
 
In Chapter I a general introduction is given concerning the different thyreostatic 
drugs and their effect on thyroid function. The mechanisms of action of the 
thyreostatic effect instigated by synthetic and natural occurring goitrogens, as well 
as, the anatomy and physiology of the thyroid gland, were discussed. Furthermore, 
the duality induced by the possibility of natural occurrence of thyreostats and their 
banned status in animal production, required an overview of the current legislative 
framework surrounding thyreostats. The Brassicaceae, which are believed to lie at the 
basis of the natural occurrence of thyreostats, were commented on with respect to 
their application in the animal and human diet. Subsequently, a short preface on LC-
MS analysis was given followed by an overview of the analytical evolutions 
concerning the detection of thyreostats in animal matrices and animal feed, and the 
detection of thyroid hormones in blood. Finally, the potential of bacterial influence on 
the occurrence of thyreostats in animal urine evolving from the ingestion of animal 
feed was discussed. Consequently, an overview of the most common microbiological 
identification techniques was displayed. 
Following the introduction the conceptual framework and the aims of this work were 
elaborated on. 
 
In Chapter II an investigation into the natural TU formation was performed using static 
in vitro digestion (stomach/rumen, small intestine, large intestine) simulations of 
bovines and porcines with addition of various Brassicaceae representatives 
(traditional rapeseed, coarse colza ‘00’ meal, broccoli, cauliflower). Thereby aiming 
to prove the formation of TU was possible in the GI tract and to locate its main 
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formation site, which turned out to be the large intestine. The influence of several pre-
treatments applied to feed (e.g. grounding) and faecal inoculum (e.g. 
autoclavation) were evaluated to give a first insight into the mechanistic basis of 
natural TU formation. Furthermore, inter-species and intra-species variations were 
demonstrated. 
 
In Chapter III a more in depth assessment of the influential factors concerning TU 
formation upon Brassicaceae in vitro porcine colonic digestion was performed. 
Various alterations in the incubation protocol were investigated; including pre-
treatments of the inoculum (filter sterilization, pasteurisation, autoclavation, pre-
culturing, anaerobicity) and Brassicaceae feed (autoclavation, omission). Based on 
the results from Chapters II & III, the process of natural TU formation could be 
tentatively elucidated as an anaerobic interaction between Brassicaceae and 
intestinal microorganisms, producing a membrane-bound extracellular enzyme 
sustaining moderate heat, but not autoclavation, with glucosinolate degrading 
activity (myrosinase-like activity). 
Moreover, a high TU producing porcine faecal inoculum allowed isolation and 
identification of common TU producing intestinal bacteria (Escherichia coli, 
Enterococcus faecium, Lactobacillus reuteri and Salmonella choleraesuis ser. 
arizonae), which have been reported in both bovines and porcines. The influence of 
age, most likely as a result of age-related gastrointestinal microbial changes on TU 
production was established as well. Finally, it could be concluded that TU formation is 
directly related to the presence of rapeseed feed and its inherent glucosinolates 
and/or degradation products thereof, but other sources of TU precursors may not be 
excluded.  
 
Chapter IV describes the optimization of an extraction procedure for TU from 
Brassicaceae and non-Brassicaceae feeds based on a fractional factorial Plackett-
Burman (PB) design with subsequent validation of the LC-MS2 detection method. The 
limit of quantification in animal feeds amounted to 0.5 µg kg-1 with both, repeatability 
and within-laboratory reproducibility (RSD%), below 6%. Satisfying recoveries were 
attained, ranging between 90.9 and 99.7% for TU. Finally, the applicability of the 
method was proven on 22 Brassicaceae and non-Brassicaceae feed samples 
obtained through the Irish national control plan following positive urine monitoring. 
 
In Chapter V an UHPLC-MS/MS method was developed and validated for both free 
and total thyroid hormones (T3, rT3 and T4) in bovine serum. Two separate extraction 
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procedures were developed by means of Plackett-Burman and D-optimal designs. 
The limits of quantification for T4, rT3 and T3 were respectively 0.04 ng mL-1, 0.05 ng mL-
1, 0.03 ng mL-1 for the total fraction, and 6.6 pg mL-1, 2.6 pg mL-1 and 2.7 pg mL-1 for 
the free fraction. Individual recoveries of total and free thyroid hormone fractions 
ranged between 95.6-106.3% and 92.1-106.5%. Good results for repeatability and 
intra-laboratory reproducibility (RSD%) were observed, i.e. respectively ≤8.0% and 
≤7.3% for the total and free fractions. This method will prove its benefits when 
evaluating the long-term effects of endogenous TU on the thyroid function, in for 
example in vivo studies designed to evaluate the impact of natural thyreostats on 
thyroid health. 
 
In Chapter VI some general conclusions were formulated and future perspectives 
discussed. Briefly, this study contributed to the general understanding of natural TU 
detection in livestock urine. More specifically, it offered a potential mechanism for 
gastrointestinal TU formation upon Brassicaceae feed digestion in livestock. Indeed, 
several TU forming bacterial strains, which are common intestinal species in livestock 
(porcine, bovine), were isolated and identified. Based on these results the following 
future developments are foreseen: the discovery of a biomarker or the development 
of an analytical method that allows differentiation of the now proven naturally 
occurring TU in livestock, as well as, an adaptation of the legislative framework, which 
seems vital. In this context, a thorough evaluation of the long-term health effects of 
these low-level natural TU residues should be made as well, since man and animal are 
potentially chronically exposed to those through consumption of products from 
animal origin and Brassicaceae crops. Besides, the analytical methods developed in 
this work, could also contribute to the identification of natural thyreostats in livestock, 
through evaluation of the effect of natural thyreostats on the thyroid function in vivo 
or by assessing TU in animal feeds to correlate possible findings with suspected low-
level TU positive urine samples, as prescribed by the 2014 EURL Reflection paper. 
Moreover, the thyroid hormone UHPLC-MS/MS method could after further 
optimization easily lend itself to other species (e.g. dogs, cats and horses), which 
would mean a great improvement in current veterinary medicine, since MS methods 
have not yet been implemented, as opposed to human medicine. 
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Tot op heden is het gebruik van thyreostatica, zoals thiouracil (TU), tijdens de dierlijke 
vetmesting verboden in de Europese Unie. Dit omwille van de illegale 
gewichtstoename die ze veroorzaken, evenals door de teratogene en carcinogene 
effecten die hun residuen met zich mee kunnen brengen.  
Het laatste decennium werden sporadisch lage TU-concentraties (<RC van 10 µg L-1) 
gedetecteerd in de urine van voedselproducerend vee, waardoor het idee ontstond 
dat er mogelijks een andere oorzaak dan illegale toediening aan de basis zou 
kunnen liggen van de detectie van lage TU-concentraties. In de loop der jaren werd 
de hypothese van een voedingsgerelateerde oorsprong (Brassicaceae) naar voren 
geschoven, maar de volledige opheldering van deze natuurlijke TU-vorming bleef 
onvervuld. Aangezien sensu stricto, iedere TU-concentratie in urine een overtreding 
van de wet vormt en vervolgens kan leiden tot economische sancties, is de 
ontrafeling van deze problematiek wel hoogst noodzakelijk. Daarom werd in dit 
doctoraatsonderzoek het ontstaansproces van natuurlijke TU-vorming in 
voedselproducerende dieren onderzocht door een diepgaande multidisciplinaire 
aanpak, wat zowel de ontwikkeling van analytische methoden, de toepassing van 
microbiologische benaderingen en statische in vitro gastro-intestinale simulaties 
omvatte.  
 
In Hoofdstuk I wordt een algemene inleiding gegeven over de verschillende 
thyreostatica en hun effect op de schildklierfunctie. De mogelijke 
werkingsmechanismen van het schildklierremmend effect veroorzaakt door 
synthetische en natuurlijk voorkomende goitrogenen wordt belicht, alsmede de 
anatomie en fysiologie van de schildklier. Bovendien vereist de dualiteit die ontstond 
door het mogelijks natuurlijk voorkomen van thyreostatica en hun verboden statuut 
binnen de dierlijke voedselproductie, een overzicht van het huidig wettelijk kader 
omtrent thyreostatica. De Brassicaceaegewassen, die vermoedelijk aan de basis 
liggen van de natuurlijke aanwezigheid van thyreostatica in vee, worden eveneens 
besproken met betrekking tot hun consumptie door mens en dier. Vervolgens wordt 
een korte algemene inleiding over LC-MS-analyse gegeven, gevolgd door een 
overzicht van de evolutie van de analytische technieken enerzijds, voor de opsporing 
van thyreostatica in dierlijke matrices en diervoeder, en anderzijds, voor de detectie 
van schildklierhormonen in het bloed. Tot slot wordt besproken hoe de detectie van 
lage thyreostaticaconcentraties in dierlijke urine zou beïnvloed kunnen worden door 
de activiteit van bacteriën op Brassicaceaediervoeders, wat gevolgd wordt door  
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een noodzakelijk overzicht van de meest voorkomende microbiologische 
identificatietechnieken.  
Na de introductie werden het conceptueel kader en de doelstellingen van dit werk 
uiteengezet.  
 
In Hoofdstuk II wordt het onderzoek naar de natuurlijke TU-vorming in varkens en 
runderen, dat met behulp van statische in vitro digestie simulaties (maag / pens, 
dunne darm, dikke darm) met toevoeging van diverse Brassicaceaevariëteiten 
(traditioneel koolzaad, koolzaad '00' schroot, broccoli en bloemkool) werd 
uitgevoerd, beschreven. Hieruit bleek dat de vorming van TU in vitro kon plaatsvinden 
in het maagdarmkanaal, en dat de belangrijkste vorming zich situeerde ter hoogte 
van de dikke darm. De invloeden van verschillende voorbehandelingen van 
diervoeders (bv. pletten) en fecaal inoculum (bv. autoclaveren) werden 
geëvalueerd om een eerste interpretatie aangaande de mechanistische basis van 
de natuurlijke TU-vorming te kunnen vormen. Bovendien werden inter- en 
intraspeciesvariaties met betrekking tot TU-vorming aangetoond. 
 
In Hoofdstuk III werd een diepgaandere evaluatie van de factoren die de vorming 
van TU beïnvloeden, uitgevoerd op basis van in vitro Brassicaceae 
varkenscolonsimulaties. Verschillende variaties op het incubatieprotocol werden 
onderzocht, waaronder voorbehandelingen van het fecaal inoculum (bijvoorbeeld 
filtersterilisatie, pasteurisatie, autoclavering, opkweken, anaerobiciteit) en het 
Brassicaceaevoeder (autoclavering, weglaten ervan). Gebaseerd op de 
teruggevonden resultaten (Hoofdstuk II en III) werd het proces van natuurlijke TU-
vorming voorlopig gekarakteriseerd als een anaerobe interactie tussen Brassicaceae 
en intestinale micro-organismen. Deze laatste zouden op hun beurt een 
membraangebonden extracellulair enzyme produceren dat bestand is tegen matige 
hitte, maar niet tegen autoclavering en dat een glucosinolaatafbrekende werking 
(myrosinase-achtige activiteit) bezit.  
Daarnaast werd de isolatie en identificatie van TU-producerende bacteriële 
stammen (Escherichia coli, Enterococcus faecium, Lactobacillus reuteri en 
Salmonella enterica ssp. arizonae), die zowel bij runderen als bij varkens reeds 
gerapporteerd werden, uitgevoerd met behulp van een sterk TU-producerend fecaal 
inoculum (varken). Tevens kon vastgesteld worden dat leeftijd een rol speelt in de 
intestinale TU-vorming, dit waarschijnlijk als gevolg van leeftijdsgerelateerde 
microbiële veranderingen. TU-vorming bleek ook rechtstreeks verband te houden 
met de aanwezigheid van koolzaadvoeders en de aanwezige glucosinolaten en/of 
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afbraakproducten daarvan, maar daarnaast mogen ook andere bronnen van TU-
precursoren niet uitgesloten worden.  
 
Hoofdstuk IV beschrijft de optimalisatie van een extractieprocedure voor TU uit 
Brassicaceae- en niet-Brassicaceaevoeders op basis van een fractioneel factorieel 
Plackett-Burmanmodel (PB) met de daaropvolgende validatie van de LC-MS2-
detectiemethode. De bepalingsgrens in diervoeders bedroeg 0.5 µg kg-1 met zowel 
voor herhaalbaarheid als voor de intralaboratorium reproduceerbaarheid (RSD%) 
waarden onder de 6.0%. Een toereikende terugvinding, variërend tussen 90.9 en 
99.7%, werd bereikt voor TU. Uiteindelijk werd de toepasbaarheid van de methode 
aangetoond op 22 Brassicaceae- en niet-Brassicaceaevoedermonsters afkomstig 
van het Ierse nationale controleplan, die verkregen werden na opvolging van TU-
positieve urinestalen.  
 
In Hoofdstuk V werd een UHPLC-MS/MS methode ontwikkeld en gevalideerd voor 
zowel vrije als totale schildklierhormonen (T3, rT3 en T4) in bovien serum. Twee 
afzonderlijke extractieprocedures werden ontwikkeld door middel van PB en D-
optimale modellen. De respectievelijke kwantificatiegrenzen voor T4, rT3 en T3 
bedroegen 0.04 ng mL-1, 0.05 ng mL-1, 0.03 ng mL-1 voor de totale fractie, en 6.6 pg 
mL-1, 2.6 pg mL-1 en 2.7 pg mL-1 voor de vrije fractie. Individuele terugvinding van 
totaal en vrij schildklierhormoonfracties varieerde tussen 95.6-106.3% en 92.1-106.5%. 
Goede resultaten voor de herhaalbaarheid en de intralaboratorium 
reproduceerbaarheid (RSD%) werden waargenomen, respectievelijk ≤8.0% en ≤7.3% 
voor de totale en vrije fracties. Deze methode zal zijn voordeel bewijzen bij het 
evalueren van de langetermijneffecten van endogeen TU op de schildklierfunctie. Dit 
kan bijvoorbeeld in in vivo studies, die de impact van natuurlijke thyreostatica op de 
schildklierwerking wensen te evalueren. 
 
In Hoofdstuk VI worden enkele algemene conclusies geformuleerd en 
toekomstperspectieven besproken. Kortom, heeft deze studie bijgedragen tot een 
beter inzicht betreffende de detectie van natuurlijk TU in dierlijke urine door het 
verlenen van een mechanistische uitleg voor de gastrointestinale TU-vorming door 
Brassicaceaevertering in vee. Sterker nog, een aantal TU-vormende 
bacteriestammen, die gemeenschappelijke intestinale soorten zijn in vee (varkens, 
runderen), werden geïsoleerd en geïdentificeerd. Op basis van deze resultaten 
werden toekomstperspectieven geformuleerd, die o.a. het zoeken naar een 
biomerker voor differentiatie van het inmiddels bewezen natuurlijk voorkomen van TU 
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in vee en de aanpassing van het wettelijk kader, beoogden. In deze context zou 
eveneens een grondige evaluatie van de langetermijneffecten van deze lage 
natuurlijke TU-residuen op de gezondheid van mens en dier moeten gemaakt 
worden, aangezien een mogelijke chronische blootstelling door consumptie van 
producten van dierlijke oorsprong en Brassicaceaegewassen niet kan uitgesloten 
worden. Daarnaast zullen de analytische methoden die in dit werk ontwikkeld 
werden eveneens kunnen bijdragen aan het verdere onderzoek naar natuurlijke 
thyreostatica in vee. Dit, enerzijds, in het kader van een in vivo evaluatie van het 
effect van natuurlijke thyreostatica op de schildklierfunctie en, anderzijds,  door de 
beoordeling van TU in diervoeders zodat de resultaten teruggekoppeld zouden 
kunnen worden aan TU-positieve urinemonsters, zoals voorgeschreven door de 2014 
EURL discussienota. Bovendien zou de ontwikkelde UHPLC-MS/MS detectiemethode 
voor de analyse van schildklierhormonen in bovien serum zich na enige verdere 
optimalisatie eenvoudig kunnen lenen tot toepassing voor andere diersoorten (zoals 
honden, katten en paarden). Dit zou alvast een grote verbetering betekenen in de 
hedendaagse diergeneeskunde, aangezien MS-methoden daar nog niet toegepast 
worden, dit in tegenstelling tot de humane geneeskunde.  
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students) at the Faculty of Veterinary Medicine 
Merelbeke, Belgium. 
 
Oct. 2013 Update Laboratory Animal course: ‘Changes in 
the legislation on the protection of experimental 
animals’ by Prof. K. Hermans (Ethical committee 
president), Faculty of Veterinary Medicine, 
Merelbeke, Belgium. 
 
Mar. 2014 PhD-course: ‘Proteomics: Mass spectrometry 
data handling’ by Flemish Institute of 
Biotechnology-Bioinformatics training and 
services (VIB-BITS), Ghent, Belgium. 
 
Apr. 2014  PhD-course: ‘Basics of biology for engineers’ at 
Imec Academy, University of Leuven, Belgium. 
 
May 2014 Laboratory Animal course: ‘Species-specific 
welfare in the laboratory: rats and mice’ by Dr. 
H. Blom at the Faculty of Veterinary Medicine, 
Merelbeke, Belgium. 
 
Sept-Dec. 2014  Research assistant on the THYREOMERK FOD-
project (RF12/6260) at the Laboratory of 
Chemical Analysis, Faculty of Veterinary 
Medicine, Merelbeke, Belgium. 
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PUBLICATIONS 
Wille, K., J. A. L. Kiebooms, M. Claessens, K. Rappé, J. Vanden Bussche, N. Van Praet, 
E. De Wulf, P. Van Caeter, R. C. Janssen, H. F. De Brabander, L. Vanhaecke. 2011. 
Development of analytical strategies using U-HPLC-MS/MS and LC-ToF-MS for the 
quantification of micropollutants in marine organisms. Analytical and Bioanalytical 
Chemistry 400:1459–1472. 
Vanden Bussche, J., J. A. L. Kiebooms, N. De Clercq, K. Wille, K. Bekaert, Y. 
Deceuninck, B. Le Bizec, H. F. De Brabander, L. Vanhaecke. 2011. Feed or food 
responsible for the presence of low-level thiouracil in urine of livestock and humans? 
Journal of Agricultural and Food Chemistry 59:5786-5792. 
Kiebooms, J. A. L., J. Vanden Bussche, L. Y. Hemeryck, V. Fievez, L. Vanhaecke. 2012. 
Intestinal microbiota contribute to the endogenous formation of thiouracil in livestock. 
Journal of Agricultural and Food Chemistry, Journal of Agricultural and Food 
Chemistry, 60:7769–7776. 
Kiebooms, J. A. L., J. Wauters, J. Vanden Bussche, L. Vanhaecke. 2014. Validated ultra 
high performance liquid chromatography-tandem mass spectrometry method for 
quantitative analysis of total and free thyroid hormones in bovine serum. Journal of 
Chromatography A 1345:164–173. 
 
Kiebooms, J. A. L., J. Wauters, J. Vanden Bussche, K. Houf, P. De Vos, S. Van Trappen, 
I. Cleenwerck and L. Vanhaecke. 2014. Identification and characterisation of 
thiouracil forming bacteria upon porcine in vitro digestion of Brassicaceae feed. 
Applied and Environmental Microbiology, 80(23):7433-7442.  
 
Kiebooms, J. A. L., J. Wauters, J. Vanden Bussche, D. Healey and L. Vanhaecke. 2015. 
Validation of a quantitative method using liquid chromatography coupled to multiple 
mass spectrometry for thiouracil in feedstuffs used in animal husbandry. Analytical 
and Bioanalytical Chemistry, in press (DOI: 10.1007/s00216-014-8347-x). 
 
Wauters, J., J. Vanden Bussche, B. Le Bizec, J. A. L. Kiebooms, G. Dervilly-Pinel, S. 
Prevost, B. Wozniak, S. S. Sterk, D. Gronningen, D. Kennedy, S. Russell, P. Delahaut, and 
L. Vanhaecke. 2014. Towards a new European threshold to discriminate illegally 
administered from naturally occurring thiouracil in livestock. Journal of Agricultural 
and Food Chemistry, submitted. 
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Without peer review  
 
Vanden Bussche, J., J. A. L. Kiebooms, N. De Clercq, K. Wille, K. Bekaert, Y. 
Deceuninck, B. Le Bizec, H. F. De Brabander, L. Vanhaecke. 2011. First evidence of a 
natural origin for banned drug that plumps up livestock. Press release for the 
American Chemical Society (ACS) Office of Public Affairs’ Weekly PressPac. 
 
Abstracts 
Kiebooms, J. A. L., J. Vanden Bussche, H. F. De Brabander and L. Vanhaecke. 2011. 
Brassicaceae derived food and feed responsible for low level thiouracil residues. 
Koninklijke Vlaamse Chemische Vereniging (KVCV) Symposium: Mass Spectrometry in 
Food and Feed, Merelbeke, Belgium. 
 
Kiebooms, J. A. L., J. Vanden Bussche, H. F. De Brabander and L. Vanhaecke. 2011. 
Brassicaceae derived food and feed responsible for low level thiouracil residues. 
EuroFoodChem XVI: Translating food chemistry into health benefits, Gdanks, Poland.  
Polish Journal of Food and Nutrition Sciences. 61(suppl. 1):21-P8. 
 
Kiebooms, J. A. L., J. Vanden Bussche, H. F. De Brabander and L. Vanhaecke. 2012. 
Does gastrointestinal digestion affect low level thiouracil residues upon Brassicaceae 
derived food and feed consumption? Residues of Veterinary Drugs in Food: 
proceedings of the EuroResidue VII conference, Egmond-aan-Zee, Netherlands. 
 
Kiebooms, J. A. L., J. Wauters, J. Vanden Bussche and L. Vanhaecke. 2013. Plackett-
Burman design for the extraction of thyreostats with LC-MS2 detection in Brassicaceae 
feeds. Recent Advances in Food Analysis (RAFA), 6th International symposium, Prague, 
Czech Republic. 
 
Kiebooms, J. A. L., J. Wauters, J. Vanden Bussche and L. Vanhaecke. 2013. Plackett-
Burman design for the extraction of thyreostats with LC-MS2 detection in Brassicaceae 
foods and feeds. KVCV Symposium: Trends in Food Analysis VII, Ghent, Belgium 
 
Kiebooms, J. A. L., J. Wauters, J. Vanden Bussche and L. Vanhaecke. 2014 Thyroid 
hormones in livestock serum: extraction optimization by fractional factorial design 
followed by UHPLC-MS/MS detection. 13th International Symposium on Hyphenated 
Techniques in Chromatography and Separation Technology (HTC-13), Bruges, 
Belgium. 
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Kiebooms, J. A. L., J. Wauters, J. Vanden Bussche and L. Vanhaecke. 2014. 
Optimization of thyreostat analysis from animal feeds by Plackett-Burman and LC-MS2. 
Seventh International Symposium on Hormone and Veterinary Drug Residue Analysis, 
Ghent, Belgium. 
 
Kiebooms, J. A. L., J. Vanden Bussche and L. Vanhaecke. 2014. Isolation and 
identification of thiouracil forming bacteria from livestock feces. Seventh International 
Symposium on Hormone and Veterinary Drug Residue Analysis, Ghent, Belgium. 
 
 
Conferences, workshops and 
seminars 
v ‘HRMS mass spectrometry: Orbitrap operations training course’ by Thermo 
Scientific, September 13th -14th, 2010, Merelbeke, Belgium.   
 
v Belgian Association for Meat Science and Technology (BAMST) Symposium: 
Energie- en zoutreductie in vlees en vleesproducten - October 21th, 2010, 
Merelbeke, Belgium. 
 
v Seminar on latest technologies in sample preperation and solid phase 
extraction, by Dionex Benelux, February 2011, Antwerp, Belgium.  
 
v KVCV Symposium: Mass Spectrometry in Food and Feed (poster presentation): 
June 9th, 2011, Merelbeke, Belgium.  
Title: “Brassicaceae derived food and feed responsible for low level thiouracil 
residues” - Kiebooms, J. A. L., J. Vanden Bussche, H. F. De Brabander and L. 
Vanhaecke. 
 
v Euro Food Chem XVI Congress: Translating food chemistry in health benefits 
(poster presentation): July 5th-8th, 2011, Gdansk, Poland.  
Title: “Brassicaceae derived food and feed responsible for low level thiouracil 
residues” - Kiebooms, J. A. L., J. Vanden Bussche, H. F. De Brabander and L. 
Vanhaecke. 
v EuroResidue VII Conference (oral presentation): May 14th-16th 2012, Egmond-
aan-Zee, The Netherlands. 
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Title: “Does gastrointestinal digestion affect low level thiouracil residues upon 
Brassicaceae derived food and feed consumption?” - Kiebooms, J. A. L., J. 
Vanden Bussche, H. F. De Brabander and L. Vanhaecke. 
 
v 13th International Symposium on Hyphenated Techniques in Chromatography 
and Separation Technology (HTC-13) (poster presentation): January 28th-31st 
2013, Bruges, Belgium. 
Title: “Thyroid hormones in livestock serum: extraction optimization by 
fractional factorial design followed by UHPLC-MS/MS detection” – Kiebooms, 
J. A. L., J. Wauters, J. Vanden Bussche and L. Vanhaecke. 
v Koninklijke Vlaamse Chemische Vereniging (KVCV) Symposium: Trends in Food 
Analysis VII (poster presentation): Septemeber 19th 2013, Ghent, Belgium. 
Title: “Plackett-Burman design for the extraction of thyreostats with LC-MS2 
detection in Brassicaceae foods and feeds” - Kiebooms, J. A. L., J. Wauters, J. 
Vanden Bussche and L. Vanhaecke.  
 
v Recent Advances in Food Analysis (RAFA), 6th International symposium (poster 
presentation): November 5th-8th 2013, Prague, Czech Republic. 
Title; “Plackett-Burman design for the extraction of thyreostats with LC-MS2 
detection in Brassicaceae feeds” - Kiebooms, J. A. L., J. Wauters, J. Vanden 
Bussche and L. Vanhaecke.  
 
v Seventh International Symposium on Hormone and Veterinary Drug Residue 
Analysis (oral presentation): June 2nd -5th 2014, Ghent, Belgium. 
Title: “Isolation and identification of thiouracil forming bacteria from livestock 
feces” - Kiebooms, J. A. L., J. Vanden Bussche and L. Vanhaecke. 
 
v Seventh International Symposium on Hormone and Veterinary Drug Residue 
Analysis (poster presentation): June 2nd -5th 2014, Ghent, Belgium. 
Title: “Optimization of thyreostat analysis from animal feeds by Plackett-
Burman and LC-MS2” - Kiebooms, J. A. L., J. Wauters, J. Vanden Bussche and L. 
Vanhaecke. 

	  	  
	  
  
 	  
 	  
Dankwoord 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  Dankwoord 209 	  
 
Dankwoord 
	  
	   	  
Beste Lezer, 
 
 
Dit deel van mijn doctoraat is de plaats voor een woord van dank aan alle personen 
die mij in de loop van de afgelopen vier jaar hebben geholpen en gesteund op 
persoonlijk en wetenschappelijk vlak. 
 
Alles begon in het laatste jaar van mijn studies diergeneeskunde toen ik op zoek was 
naar een onderzoeksonderwerp voor mijn thesis. Ik had toen Optie paard achter mij 
gelaten en ging resoluut voor Optie onderzoek. Op dat ogenblik wilde ik iets nieuws 
proberen, een nieuwe uitdaging, onder het motto ‘je kan altijd bijleren’. Uiteindelijk 
viel mijn keuze op de ontwikkeling van analytisch methoden voor het onderzoek naar 
pharmaceuticals in biota uit het Noordzee kust-ecosysteem, dat deel uitmaakte van 
een Europees risicoanalyse project (INRAM). Dit sprak mijn idealistische kant aan, 
aangezien ik een klein steentje kon bijdragen aan iets veel groters.  
De aanstekelijke gedrevenheid van mijn promotor, toen nog Lynn, maar 
tegenwoordig Professor Vanhaecke, en de uitstekende begeleiding van Klaas, 
maakten dat het een top jaar werd.  
Geboeid door het onderzoek begon ik in september 2010 vervolgens aan mijn 
doctotaatsreis door de analytische chemie. Wie had dat ooit gedacht? Ik zeker niet 
maar het was toch zover gekomen en ik was blij. Het ontrafelen van mogelijks 
endogene vorming van thyreostatica in vee was een reis met ups en downs, zoals 
ieder doctoraatsonderzoek weliswaar. Gelukkig maakten een ervaren thyreostatica 
veteraan, Professor De Brabander en vervolgens een jongere veterane, Julie, mij 
wegwijs in dit onderwerp, waarvoor dank! Een maand later, in oktober, vertrok ik 
reeds naar Nantes om mij verder te verdiepen in de wondere wereld van de  
residuanalyse (Saraf, LABERCA). Mijn ogen gingen open, want er was nog zoveel te 
leren en dat heb ik kunnen doen, waarvoor dank Professor De Brabander en 
Professor Le Bizec. Deze vierjarige reis werd één prachtig avontuur. Elk congres, elke 
samenwerking, iedere nieuwe vondst … ze brachten je altijd wel iets bij. Een continu 
leerproces waar ik kortweg intens van genoten heb.  
Het mag duidelijk zijn dat dit alles niet mogelijk zou zijn geweest zonder de bijdrage 
van een groot aantal personen, waaronder: 
 
Professor Vanhaecke, Lynn, bedankt voor al je hulp, je begeleiding, je gedrevenheid 
en zoveel meer. Je was er altijd met raad en daad voor mij. Ik denk dat ik in naam 
van alle doctoraatsstudenten kan zeggen dat we echt geluk hebben met een 
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promotor als jij! Ik wens je alvast een heel mooie toekomst toe en veel succes met het 
labo!  
 
Prof. De Zutter en Prof Houf, wil ik danken voor de goede samenwerking en de 
mogelijkheid om mijn microbiologische experimenten uit te voeren bij LHT. 
 
Beste juryleden, bedankt om mijn doctoraatsthesis zo zorgvuldig na te lezen en te 
verbeteren. 
  
Vervolgens zou ik al mijn collega’s en ex-collega’s van LCA en LHT willen bedanken 
voor het gezelschap en de leuke gesprekken. Het zou niet hetzelfde geweest zijn 
zonder jullie! 
 
Klaas, het was een eer je eerste en enige thesisstudente te zijn, bedankt voor alles! 
 
De post-doc’s, Julie en Jella bedankt voor jullie bijdragen aan mijn doctoraat. Jella, 
bedankt voor de leuke samenwerking en de juiste woorden die je altijd bleek te 
vinden als er iets mis ging. Ik wens je heel veel succes met alles!... Want niet te 
vergeten alles komt altijd goed! 
 
De doc’s van LCA, Lieselot, Anneleen, Gabriel, Lieven, Nathalie, Kaat bedankt voor 
de vriendschap en de brainstormmomenten, waarvan ik zeker ben dat ze ons altijd 
wel iets hebben bijgebracht! Mijn ex-thesisstudente en ex-eilandgenootje aan de 
bureau, Lieselot, en mijn huidig eilandgenootje, Anneleen, het was mij een 
genoegen J. We hebben ongelooflijk veel plezier gemaakt samen, bedankt dat jullie 
er altijd voor mij waren! Lieselot, zorg goed voor ons klein palmboompje, zo blijft het 
tropisch bureau-eiland bestaan. Gabriel, thanks for your friendlyness and your great 
stories about Chilli, good luck to you too! Lieven, we zijn samen begonnen en nu 
verdedigen we op twee dagen van elkaar. Zeer uitzonderlijk maar wel heel erg 
aangenaam om samen in hetzelfde schuitje te zitten. We konden altijd raad zoeken 
bij elkaar en dat maakte het allemaal een stuk minder eng. Ik wens je alvast heel 
veel succes en bedankt! Nathalie, jij ook nog veel succes met de laatste loodjes eind 
volgend jaar en Kaat, succes met je MIPs!  
Karolien, onze laatste doc aanwinst, ik wens je heel veel moed en succes met je 
onderzoek en hopelijk vind je het hier ook aangenaam vertoeven. 
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Joke, Dirk en Mieke bedankt voor jullie hulp bij de zovele extracties en het oplossen 
van massaspectrometrische problemen. Jullie waren fantastisch! 
 
De doctoraatsstudenten en collega’s van LHT. Over de jaren heen zijn we 
uitgegroeid tot steeds een hechtere LCA-LHT groep, wat het alleen maar fijner 
maakte. Gerty, Ellen, Natasha, Julie, Glynnis, Laïd, Tomasz, Bavo, Sandra, Martine, 
Inge, Carine, Lieve, Johan …& Co bedankt voor jullie gezelschap! Gerty, Ellen, 
Natasha, bedankt voor de resto-afspraakjes op woensdag. Sandra en Martine, 
bedankt voor jullie hulp en advies bij het opkweken en identificeren van mijn 
bacteriën. Sorry, voor de soms geurige in vitro digesties. Carine, bedankt dat je altijd 
het zonnetje van het labo was. Voor mij werkte het alvast aanstekelijk! 
 
Soetkin, bedankt om de administratieve kant van het doctoreren zo goed te regelen 
voor ons. Wat zouden we zonder jou doen? 
 
Bedankt ook aan mijn thesisstudenten, die mij over de jaren hebben bijgestaan. 
 
Vervolgens, wil ik mijn familie (papa, mama, Laurent, Marraine, nonkel Wies, Mamilou, 
and last but not least, Nico) en vrienden bedanken voor de steun die ze mij geboden 
hebben in de afgelopen vier jaar voor ‘dat doctoraat’ waar ze het onderwerp niet 
helemaal van vatten. Hopelijk is alles nu wat duidelijker.  
Merci du fond du coeur! Je vous adore! 
 
Aan al diegene die nog niet vernoemd werden, eveneens bedankt voor jullie 
bijdrage aan dit doctoraatsonderzoek, want alle beetjes helpen. Ik wens jullie allen 
het allerbeste toe en wie weet kruisen onze wegen elkaar nog in de toekomst. 
 
Tot slot, draag ik mijn doctoraat op aan mijn overleden grootvader, Bonpapa, die mij 
zoveel geleerd heeft en steeds mijn nieuwsgierigheid wist te stimuleren. Merci à toi! 
T’étais le meilleur! 
 
 
 “Poppeke gezien, kasken dicht”                   Julie 
           1 december 2014 
 

	  	  
	  

